{"title":"All Research Peptide and Molecule","description":"\u003ch3 data-start=\"542\" data-end=\"620\"\u003e\u003cstrong data-start=\"545\" data-end=\"620\"\u003ePremium Research Peptides and Advanced Compounds for Pioneering Science\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"622\" data-end=\"1226\"\u003ePRG supports scientific progress by supplying laboratories with high-quality research peptides and advanced molecular compounds. Our focus is on providing materials that help teams explore complex biochemical systems with clarity, consistency, and confidence. Every item in our catalog is produced with attention to structural accuracy and reproducibility, enabling researchers to advance cellular and metabolic investigations without interruption. Through strict quality oversight and a commitment to dependable performance, we aim to support laboratories carrying out sophisticated scientific projects.\u003c\/p\u003e\n\u003ch3 data-start=\"1233\" data-end=\"1308\"\u003e\u003cstrong data-start=\"1236\" data-end=\"1308\"\u003eEmpowering Discovery with Research Peptides and Laboratory Solutions\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1310\" data-end=\"1745\"\u003eOur catalog includes a broad range of research materials suited for teams studying mitochondrial behavior, cell repair mechanisms, and metabolic pathways. All compounds are sourced from trusted European producers, selected for their adherence to the highest scientific standards. From synthesis to packaging, analytical controls are applied throughout production, ensuring that each batch meets the expectations of modern laboratories.\u003c\/p\u003e\n\u003cp data-start=\"1747\" data-end=\"2098\"\u003eResearchers rely on staple compounds such as \u003cstrong data-start=\"1792\" data-end=\"1800\"\u003eNAD+\u003c\/strong\u003e, \u003cstrong data-start=\"1802\" data-end=\"1817\"\u003eGlutathione\u003c\/strong\u003e, and other specialized molecules to support investigations across cellular biology and metabolic science. These materials form the foundation for experiments that aim to decode complex pathways and uncover new insight into cellular function under controlled laboratory conditions.\u003c\/p\u003e\n\u003ch3 data-start=\"2105\" data-end=\"2164\"\u003e\u003cstrong data-start=\"2108\" data-end=\"2164\"\u003eCustom Compounds for Specialized Scientific Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2166\" data-end=\"2579\"\u003ePRG recognizes that many research programs require targeted materials designed for specific investigative goals. We collaborate with research teams who have precise experimental needs, offering compounds that reflect current scientific questions and emerging interests. Our continuously expanding portfolio includes molecules suitable for advanced cellular studies, metabolic modeling, and mitochondrial analysis.\u003c\/p\u003e\n\u003cp data-start=\"2581\" data-end=\"3012\"\u003eAmong these selections, \u003cstrong data-start=\"2605\" data-end=\"2620\"\u003eGlutathione\u003c\/strong\u003e remains an important antioxidant for studying redox balance and cellular resilience. For teams examining mitochondrial outcomes, \u003cstrong data-start=\"2750\" data-end=\"2802\"\u003eRetatrutide – Advanced Research Molecule (20 mg)\u003c\/strong\u003e offers a valuable option for pathway-focused exploration. All compounds are manufactured according to rigorous scientific standards, providing confidence and consistency for professional research environments.\u003c\/p\u003e\n\u003ch3 data-start=\"3019\" data-end=\"3096\"\u003e\u003cstrong data-start=\"3022\" data-end=\"3096\"\u003eFlagship Products and Laboratory Solutions Featuring Research Peptides\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3098\" data-end=\"3507\"\u003e\u003cstrong data-start=\"3098\" data-end=\"3107\"\u003eSS-31\u003c\/strong\u003e is one of the defining components of our research lineup. Its relevance in mitochondrial studies has made it a cornerstone tool for laboratories investigating cellular adaptation and mitochondrial protection. PRG offers SS-31 in two high-purity formats—\u003cstrong data-start=\"3361\" data-end=\"3379\"\u003e50 mg per vial\u003c\/strong\u003e and \u003cstrong data-start=\"3384\" data-end=\"3402\"\u003e20 mg per vial\u003c\/strong\u003e—each produced with a meticulous quality process designed to ensure dependable, reproducible performance.\u003c\/p\u003e\n\u003cp data-start=\"3509\" data-end=\"3828\"\u003eEvery batch of SS-31 is manufactured with traceable quality controls. These measures help support studies involving mitochondrial dynamics, cellular defense mechanisms, and energy regulation. PRG’s reputation for reliability is reinforced by our consistent global distribution and attention to detail in every shipment.\u003c\/p\u003e\n\u003ch3 data-start=\"3835\" data-end=\"3904\"\u003e\u003cstrong data-start=\"3838\" data-end=\"3904\"\u003eCommitment to Excellence and Transparency in Research Peptides\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3906\" data-end=\"4258\"\u003eWe operate with full transparency at each stage of production. Detailed analytical documentation accompanies every shipment, allowing laboratories to trace each batch back to its manufacturing run. Research teams benefit from support services that streamline project planning, ensure fast delivery, and maintain clarity throughout the ordering process.\u003c\/p\u003e\n\u003cp data-start=\"4260\" data-end=\"4680\"\u003eInnovation guides our work at PRG. We continue to invest in advanced tools and analytical systems that keep us at the forefront of mitochondrial and metabolic research. Each compound undergoes extensive review to confirm compliance with strict laboratory standards. Whether researchers focus on metabolism, cellular pathways, or biochemical modeling, our materials are built to support every phase of scientific inquiry.\u003c\/p\u003e\n\u003ch3 data-start=\"4687\" data-end=\"4748\"\u003e\u003cstrong data-start=\"4690\" data-end=\"4748\"\u003eAdvanced Laboratory Compounds and Specialty Selections\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"4750\" data-end=\"4874\"\u003e\u003cstrong data-start=\"4750\" data-end=\"4767\"\u003eL-Glutathione\u003c\/strong\u003e\u003cbr data-start=\"4767\" data-end=\"4770\"\u003eA widely used antioxidant supporting cellular defense studies.\u003cbr data-start=\"4832\" data-end=\"4835\"\u003e(Reference data available via PubChem.)\u003c\/p\u003e\n\u003cp data-start=\"4876\" data-end=\"4968\"\u003e\u003cstrong data-start=\"4876\" data-end=\"4884\"\u003eNAD+\u003c\/strong\u003e\u003cbr data-start=\"4884\" data-end=\"4887\"\u003eA central molecule for examining energy flow and metabolism in research settings.\u003c\/p\u003e\n\u003cp data-start=\"4970\" data-end=\"5075\"\u003e\u003cstrong data-start=\"4970\" data-end=\"4985\"\u003eRetatrutide\u003c\/strong\u003e\u003cbr data-start=\"4985\" data-end=\"4988\"\u003eA preferred selection for teams conducting metabolic and mitochondrial pathway studies.\u003c\/p\u003e\n\u003cp data-start=\"5077\" data-end=\"5179\"\u003e\u003cstrong data-start=\"5077\" data-end=\"5086\"\u003eSS-31\u003c\/strong\u003e\u003cbr data-start=\"5086\" data-end=\"5089\"\u003eA trusted choice for investigating mitochondrial resilience and energy-related mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"5181\" data-end=\"5341\"\u003e\u003cstrong data-start=\"5181\" data-end=\"5226\"\u003eBacteriostatic Water and Buffered Salines\u003c\/strong\u003e\u003cbr data-start=\"5226\" data-end=\"5229\"\u003eEssential laboratory components used to maintain precise handling and stable conditions in scientific workflows.\u003c\/p\u003e\n\u003cp data-start=\"5343\" data-end=\"5651\"\u003eThese offerings serve research teams across academic, pharmaceutical, and institutional environments. PRG emphasizes reproducibility, data integrity, and quality at every step, providing laboratories with dependable tools for advancing studies in metabolism, mitochondrial activity, and cellular performance.\u003c\/p\u003e\n\u003ch3 data-start=\"5658\" data-end=\"5706\"\u003e\u003cstrong data-start=\"5661\" data-end=\"5706\"\u003eAdvancing Research with Trusted Materials\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5708\" data-end=\"6158\"\u003eOur mission is to support laboratories as they push the boundaries of scientific understanding. Every peptide, buffer, and molecular compound in our collection is produced to meet stringent research expectations and undergoes analytical verification to ensure accuracy. As scientific teams pursue new discoveries, PRG remains a reliable partner—delivering materials designed to uphold consistency and scientific excellence at every stage of research.\u003c\/p\u003e","products":[{"product_id":"epithalon-25mg","title":"Epithalon 25mg – Research Peptide","description":"\u003ch3 data-section-id=\"178uri\" data-start=\"443\" data-end=\"503\"\u003eEpithalon – Telomere and Pineal Signaling Research Peptide\u003c\/h3\u003e\n\u003ch3 data-section-id=\"rzkdgm\" data-start=\"505\" data-end=\"516\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"518\" data-end=\"847\"\u003eEpithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). The peptide was originally developed by Professor Vladimir Khavinson and colleagues based on the amino acid composition of epithalamin, a natural peptide complex derived from the pineal gland.\u003c\/p\u003e\n\u003cp data-start=\"849\" data-end=\"1051\"\u003eIn research settings, Epithalon is frequently studied for its interaction with cellular aging pathways, telomere regulation, and neuroendocrine signaling mechanisms associated with the pineal gland.\u003c\/p\u003e\n\u003cp data-start=\"1053\" data-end=\"1337\"\u003eDue to its small molecular size (≈390 Da), Epithalon demonstrates high cellular permeability and has been observed in laboratory models to interact with intracellular targets including DNA binding motifs, histone complexes, and amino acid transport systems such as LAT1 and PEPT1.\u003c\/p\u003e\n\u003cp data-start=\"1339\" data-end=\"1519\"\u003eThese characteristics have made the peptide a subject of investigation in studies exploring epigenetic regulation, cellular longevity pathways, and circadian signaling systems.\u003c\/p\u003e\n\u003cp data-start=\"1649\" data-end=\"1813\"\u003eEpithalon is a short tetrapeptide capable of entering cells and interacting with nuclear regulatory elements involved in gene expression and chromatin organization.\u003c\/p\u003e\n\u003cp data-start=\"1815\" data-end=\"2040\"\u003eExperimental models have suggested that the peptide may interact with specific DNA binding motifs, including sequences such as ATTTC and CAG, potentially influencing transcriptional regulation and chromatin accessibility.\u003c\/p\u003e\n\u003ch3 data-section-id=\"10gl7hx\" data-start=\"2047\" data-end=\"2093\"\u003eCellular Mechanisms Investigated in Research\u003c\/h3\u003e\n\u003cp data-start=\"2095\" data-end=\"2222\"\u003eMultiple studies in human cell cultures and in vitro systems have explored several biological pathways influenced by Epithalon.\u003c\/p\u003e\n\u003ch3 data-section-id=\"hkl10f\" data-start=\"2224\" data-end=\"2273\"\u003eTelomerase Activation and Telomere Regulation\u003c\/h3\u003e\n\u003cp data-start=\"2275\" data-end=\"2521\"\u003eIn laboratory studies involving telomerase-negative human fibroblasts, Epithalon exposure has been associated with increased expression of the hTERT catalytic subunit, along with measurable telomerase enzymatic activity using TRAP assays.\u003c\/p\u003e\n\u003cp data-start=\"2523\" data-end=\"2725\"\u003eThese findings were accompanied by measurable changes in telomere length and cellular replicative lifespan, suggesting that the peptide may influence mechanisms associated with telomere maintenance.\u003c\/p\u003e\n\u003cp data-start=\"2727\" data-end=\"2955\"\u003eSimilar observations have been reported in lymphocyte models and additional human cell lines, where Epithalon exposure was associated with activation of telomerase-related pathways or alternative telomere lengthening mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"2957\" data-end=\"3101\"\u003eThese findings have positioned Epithalon as a compound frequently examined in research focused on cellular senescence and genomic stability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1vk4t1c\" data-start=\"3108\" data-end=\"3153\"\u003ePineal Signaling and Circadian Regulation\u003c\/h3\u003e\n\u003cp data-start=\"3155\" data-end=\"3250\"\u003eThe peptide has also been studied for its interaction with pineal gland signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3252\" data-end=\"3474\"\u003eExperimental research indicates that Epithalon may influence biochemical pathways associated with serotonin, N-acetylserotonin, and melatonin synthesis, molecules that play central roles in circadian rhythm regulation.\u003c\/p\u003e\n\u003cp data-start=\"3476\" data-end=\"3668\"\u003eAnimal models have reported restoration of melatonin rhythmicity and circadian hormone patterns in aged organisms following exposure to pineal peptides including Epithalon and epithalamin.\u003c\/p\u003e\n\u003cp data-start=\"3670\" data-end=\"3820\"\u003eHuman studies exploring pineal signaling have also observed increased melatonin-related markers and modulation of circadian clock gene expression.\u003c\/p\u003e\n\u003cp data-start=\"3822\" data-end=\"3948\"\u003eThese findings have led to interest in Epithalon within studies examining circadian biology and neuroendocrine regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6dtfz0\" data-start=\"3955\" data-end=\"4000\"\u003eAntioxidant and Cellular Stress Signaling\u003c\/h3\u003e\n\u003cp data-start=\"4002\" data-end=\"4089\"\u003eEpithalon has been investigated in research models examining oxidative stress pathways.\u003c\/p\u003e\n\u003cp data-start=\"4091\" data-end=\"4146\"\u003eExperimental findings have associated the peptide with:\u003c\/p\u003e\n\u003cul data-start=\"4148\" data-end=\"4361\"\u003e\n\u003cli data-section-id=\"fzci8c\" data-start=\"4148\" data-end=\"4201\"\u003e\n\u003cp data-start=\"4150\" data-end=\"4201\"\u003ereduced levels of reactive oxygen species (ROS)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1d5dk6f\" data-start=\"4202\" data-end=\"4240\"\u003e\n\u003cp data-start=\"4204\" data-end=\"4240\"\u003edecreased lipid peroxidation markers\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"f8zrky\" data-start=\"4241\" data-end=\"4361\"\u003e\n\u003cp data-start=\"4243\" data-end=\"4361\"\u003eactivation of cellular antioxidant systems including Nrf2, superoxide dismutase (SOD), catalase, and ceruloplasmin\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4363\" data-end=\"4522\"\u003eSeveral studies have also examined the peptide’s influence on p53-related signaling, a pathway involved in genomic stability and cellular stress responses.\u003c\/p\u003e\n\u003ch3 data-section-id=\"5luq3p\" data-start=\"4529\" data-end=\"4565\"\u003eImmune and Epigenetic Regulation\u003c\/h3\u003e\n\u003cp data-start=\"4567\" data-end=\"4728\"\u003eResearch exploring immune signaling has suggested that Epithalon may influence thymic signaling pathways and T-lymphocyte maturation in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"4730\" data-end=\"4975\"\u003eAt the chromatin level, studies have reported changes in heterochromatin condensation states, suggesting that Epithalon may influence gene expression by altering chromatin accessibility and reactivating genes that become suppressed with age.\u003c\/p\u003e\n\u003cp data-start=\"4977\" data-end=\"5127\"\u003eThese epigenetic observations have led to increased interest in Epithalon in research investigating cellular aging and transcriptional regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1nisyld\" data-start=\"5134\" data-end=\"5165\"\u003ePreclinical Research Findings\u003c\/h3\u003e\n\u003cp data-start=\"5167\" data-end=\"5313\"\u003eExtensive experimental work has investigated Epithalon in a variety of biological models including mice, rats, primates, and invertebrate systems.\u003c\/p\u003e\n\u003cp data-start=\"5315\" data-end=\"5374\"\u003eResearch has explored several biological domains including:\u003c\/p\u003e\n\u003ch3 data-section-id=\"nipbeu\" data-start=\"5376\" data-end=\"5415\"\u003eLongevity and Cellular Aging Models\u003c\/h3\u003e\n\u003cp data-start=\"5417\" data-end=\"5562\"\u003eAnimal studies have reported measurable changes in lifespan markers and age-associated biological parameters following exposure to Epithalon.\u003c\/p\u003e\n\u003cp data-start=\"5564\" data-end=\"5747\"\u003eFor example, experiments in Drosophila and rodent models reported increases in mean and maximal lifespan, along with delayed onset of certain age-associated physiological changes.\u003c\/p\u003e\n\u003cp data-start=\"5749\" data-end=\"5869\"\u003eAdditional studies have observed reductions in chromosomal abnormalities and preservation of cellular genomic stability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1itszh3\" data-start=\"5876\" data-end=\"5902\"\u003eTumor Biology Research\u003c\/h3\u003e\n\u003cp data-start=\"5904\" data-end=\"5995\"\u003ePreclinical research has examined Epithalon in models of chemically induced carcinogenesis.\u003c\/p\u003e\n\u003cp data-start=\"5997\" data-end=\"6234\"\u003eIn certain experimental systems, Epithalon exposure was associated with changes in tumor incidence, tumor multiplicity, and gene expression markers linked to tumor signaling pathways, including HER-2 related transcriptional activity.\u003c\/p\u003e\n\u003cp data-start=\"6236\" data-end=\"6361\"\u003eThese studies are frequently cited in research exploring cellular stress responses, genomic stability, and tumor biology.\u003c\/p\u003e\n\u003ch3 data-section-id=\"jbg307\" data-start=\"6368\" data-end=\"6404\"\u003eAntioxidant and Immune Signaling\u003c\/h3\u003e\n\u003cp data-start=\"6406\" data-end=\"6598\"\u003eExperimental investigations have reported that Epithalon may influence oxidative stress markers and immune cell populations, including T- and B-lymphocyte activity and antibody production.\u003c\/p\u003e\n\u003cp data-start=\"6600\" data-end=\"6756\"\u003eThe peptide has also been studied in models examining pineal-immune interactions and the relationship between circadian signaling and immune regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"11i1ubz\" data-start=\"6763\" data-end=\"6806\"\u003eNeural and Reproductive Research Models\u003c\/h3\u003e\n\u003cp data-start=\"6808\" data-end=\"6917\"\u003eAdditional research has explored Epithalon’s influence on neurological signaling and reproductive physiology.\u003c\/p\u003e\n\u003cp data-start=\"6919\" data-end=\"7113\"\u003eAnimal studies have reported measurable changes in learning behavior, neuronal stress resistance, mitochondrial function in reproductive cells, and chromatin activation in aging lymphocytes.\u003c\/p\u003e\n\u003cp data-start=\"7115\" data-end=\"7271\"\u003eThese findings have contributed to interest in Epithalon within studies investigating neurobiology, reproductive biology, and cellular stress responses.\u003c\/p\u003e\n\u003ch3 data-section-id=\"ep46tr\" data-start=\"7278\" data-end=\"7305\"\u003eClinical Research Context\u003c\/h3\u003e\n\u003cp data-start=\"7307\" data-end=\"7508\"\u003eClinical investigations of pineal peptides including epithalamin and Epithalon analogs have explored their influence on circadian signaling, immune markers, and age-related physiological processes.\u003c\/p\u003e\n\u003cp data-start=\"7510\" data-end=\"7722\"\u003eStudies involving elderly populations have reported measurable changes in melatonin signaling, chromatin activation in lymphocytes, and immune system markers following exposure to pineal peptide preparations.\u003c\/p\u003e\n\u003cp data-start=\"7724\" data-end=\"7909\"\u003eAdditional clinical research examining retinal disorders reported improvements in visual function parameters following administration of pineal peptides in controlled clinical settings.\u003c\/p\u003e\n\u003cp data-start=\"7911\" data-end=\"8066\"\u003eThese studies have contributed to ongoing interest in Epithalon in research focused on circadian biology, cellular aging, and pineal hormone signaling.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1yxgta6\" data-start=\"8073\" data-end=\"8112\"\u003eSafety Profile in Research Literature\u003c\/h3\u003e\n\u003cp data-start=\"8114\" data-end=\"8308\"\u003eAcross experimental and clinical research programs, Epithalon has demonstrated a favorable safety profile, with studies reporting no significant genotoxic, nephrotoxic, or mutagenic effects.\u003c\/p\u003e\n\u003cp data-start=\"8310\" data-end=\"8512\"\u003eLong-term animal studies and clinical observations have reported good tolerability, supporting continued investigation of the peptide in research exploring aging biology and cellular signaling pathways.\u003c\/p\u003e\n\u003ch3\u003eResearch context\u003c\/h3\u003e\n\u003cp\u003eEpithalon is frequently referenced in experimental models examining cellular homeostasis, telomere dynamics, and circadian signaling pathways. These research frameworks explore how gene expression, metabolic balance, and regulatory systems interact to support long-term cellular stability.\u003c\/p\u003e\n\u003cp\u003eFor a broader overview of how peptides and small molecules are studied in health maintenance and longevity-related research models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2257\" data-end=\"2280\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2283\" data-end=\"2296\"\u003eSynonyms:\u003c\/strong\u003e  Epithalon, Epithalone, UNII-O65P17785G, alanyl-glutamyl-aspartyl-glycine\u003cbr data-start=\"2382\" data-end=\"2385\"\u003e\u003cstrong data-start=\"2385\" data-end=\"2407\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003c\/span\u003e\u003csub\u003e14\u003c\/sub\u003e\u003cspan\u003eH\u003c\/span\u003e\u003csub\u003e22\u003c\/sub\u003e\u003cspan\u003eN\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003eO\u003c\/span\u003e\u003csub\u003e9\u003c\/sub\u003e\u003cbr data-start=\"2418\" data-end=\"2421\"\u003e\u003cstrong data-start=\"2421\" data-end=\"2436\"\u003eMolar Mass:\u003c\/strong\u003e 390.35 g\/mol\u003cbr data-start=\"2449\" data-end=\"2452\"\u003e\u003cstrong data-start=\"2452\" data-end=\"2467\"\u003eCAS Number:\u003c\/strong\u003e \u003cspan\u003e307297-39-8\u003c\/span\u003e\u003cbr data-start=\"2479\" data-end=\"2482\"\u003e\u003cstrong data-start=\"2482\" data-end=\"2494\"\u003ePubChem:\u003c\/strong\u003e 219042\u003cbr data-start=\"2501\" data-end=\"2504\"\u003e\u003cstrong data-start=\"2504\" data-end=\"2532\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 25 mg (1 vial)\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003eEpithalon \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Epitalon.png?v=1755244759\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/219042\" title=\"PubChem_Epithalon\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52642219196682,"sku":"epithalon25mg-1","price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52642219229450,"sku":"epithalon25mg-2","price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/epithalon_25mg_2.png?v=1773049932"},{"product_id":"retatrutide-20-mg","title":"Retatrutide – Advanced Research Peptide (20mg)","description":"\u003ch2 data-start=\"44\" data-end=\"101\"\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a next-generation triple-agonist peptide examined in metabolic and energy regulation research models. It is studied for its interaction with GLP-1, GIP, and glucagon-related signaling pathways, making it a central compound in experimental systems exploring glucose regulation, appetite signaling, and energy balance.\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRetatrutide peptide is designed to bind three critical metabolic receptors for enhanced therapeutic effect. Activating \u003cem data-start=\"135\" data-end=\"143\"\u003eGLP‑1R\u003c\/em\u003e improves insulin secretion and satiety, \u003cem data-start=\"184\" data-end=\"190\"\u003eGIPR\u003c\/em\u003e enhances insulin response and may promote healthy fat metabolism, while \u003cem data-start=\"263\" data-end=\"269\"\u003eGCGR\u003c\/em\u003e activation increases energy expenditure. As a next-generation peptide, Retatrutide represents a leap forward in metabolic pharmacotherapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRetatrutide is available in both lyophilized vial format for laboratory reconstitution (This format is typically selected for controlled preparation within research environments.) and pre-filled research pen format for immediate experimental handling. (This format allows immediate experimental handling without additional preparation steps.)\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eFor detailed storage and handling guidance, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-peptide-research\"\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003cstrong data-start=\"1005\" data-end=\"1083\"\u003eRetatrutide in Research: Stability, Storage, and Experimental Optimization\u003c\/strong\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1635\" data-end=\"1679\"\u003eMechanism Overview in Experimental Models\u003c\/h3\u003e\n\u003cp data-start=\"1681\" data-end=\"1760\"\u003eRetatrutide demonstrates activity across three interconnected receptor systems:\u003c\/p\u003e\n\u003cp data-start=\"1762\" data-end=\"2005\"\u003e• GLP-1 receptor signaling – studied in glucose and satiety pathway research\u003cbr data-start=\"1838\" data-end=\"1841\"\u003e• GIP receptor signaling – examined in insulin response models\u003cbr data-start=\"1903\" data-end=\"1906\"\u003e• Glucagon receptor signaling – explored in energy expenditure and metabolic flexibility research\u003c\/p\u003e\n\u003cp data-start=\"2007\" data-end=\"2124\"\u003eThe combined activation profile supports integrated metabolic pathway analysis rather than isolated receptor studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrimary research pairing\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn experimental research settings, Retatrutide is frequently examined alongside compounds involved in growth hormone–related signaling pathways.\u003c\/p\u003e\n\u003cp\u003e→\u003cstrong\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003eCJC-1295 – Growth hormone signaling research\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAlternative hormonal research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSome experimental models explore Retatrutide in parallel with other compounds involved in growth hormone axis modulation.\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003eIpamorelin – GHRP-related signaling research\u003c\/a\u003e \u003c\/strong\u003e \u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong\u003eTesamorelin – GH axis modulation research\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg-ipamorelin-5-mg-research-peptide-blend\"\u003e\u003cstrong\u003eTesamorelin + Ipamorelin – GH-axis research model\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic and cellular research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdditional research frameworks examine metabolic efficiency and cellular balance alongside signaling-focused studies.\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong\u003eSLU-PP-332 – Exercise-mimetic metabolic research  \u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong\u003eL-Glutathione – Redox balance and antioxidant research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"397\" data-end=\"474\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"481\" data-end=\"506\"\u003eProduct Description\u003c\/h3\u003e\n\u003cul data-start=\"507\" data-end=\"922\"\u003e\n\u003cli data-start=\"507\" data-end=\"548\"\u003e\n\u003cp data-start=\"509\" data-end=\"548\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"13\" data-is-only-node=\"\"\u003eSynonyms:\u003c\/strong\u003e Retatrutide, LY‑3437943, GLP1‑R\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"549\" data-end=\"592\"\u003e\n\u003cp data-start=\"551\" data-end=\"592\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"22\" data-is-only-node=\"\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC₂₂₁H₃₄₂N₄₆O₆₈\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"593\" data-end=\"676\"\u003e\n\u003cp data-start=\"595\" data-end=\"676\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"21\" data-is-only-node=\"\"\u003eMolecular Weight:\u003c\/strong\u003e ~\u003cspan\u003e4731.33 g\/mol\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"677\" data-end=\"760\"\u003e\n\u003cp data-start=\"679\" data-end=\"760\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"15\" data-is-only-node=\"\"\u003eCAS Number:\u003c\/strong\u003e 2381089‑83‑2\u003c\/span\u003e \u003cspan class=\"\" data-state=\"closed\"\u003e\u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"845\" data-end=\"892\"\u003e\n\u003cp data-start=\"847\" data-end=\"892\"\u003e\u003cstrong data-start=\"847\" data-end=\"875\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"893\" data-end=\"922\"\u003e\n\u003cp data-start=\"895\" data-end=\"922\"\u003e\u003cstrong data-start=\"895\" data-end=\"910\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003ca title=\"about reta peptide\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-retatrutide\" style=\"color: #ff8000;\"\u003e\u003cstrong\u003eWhat is Retatrutide? - Read More\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #000000;\"\u003eExplore how Retatrutide compares to Tirzepatide in current research →\u003cstrong\u003e \u003cspan style=\"color: #ff8000;\"\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-tirzepatide\" style=\"color: #ff8000;\"\u003eRetatrutide vs Tirzepatide.\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eRetatrutide is studied in research models involving multi-pathway metabolic signaling and energy regulation.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo explore how peptide-based compounds compare with oral approaches:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/oral-vs-injectable-metabolic-peptides-research\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 128, 0);\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/a\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 128, 0);\"\u003eOral vs Injectable Compounds (Orforglipron, Tirzepatide, Retatrutide)\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #000000;\"\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003cspan style=\"color: #000000;\"\u003eProper buffer selection is critical for peptide stability. Learn more in our\u003c\/span\u003e\u003c\/span\u003e\u003cstrong\u003e\u003cspan style=\"color: #ff8000;\"\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-end=\"1276\" data-start=\"1217\"\u003e\u003cspan style=\"color: #ff8000;\"\u003ePBS vs HBS vs bacteriostatic water reconstitution guide\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"color: #ff8000;\"\u003e.\u003c\/span\u003e\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how metabolic signaling pathways intersect with muscle preservation and adaptive regeneration research, see:\u003cbr\u003e→ \u003cspan style=\"color: #ff8000;\"\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\" style=\"color: #ff8000;\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen ( 1 )","offer_id":51899984838922,"sku":"retatrutide20mg-1","price":205.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":51899984871690,"sku":"retatrutide20mg-2","price":180.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/retatrutide20mg_12-pen.png?v=1778073877"},{"product_id":"nad-plus-1000mg","title":"NAD+ 1000mg – Research Compound","description":"\u003ch3 data-start=\"329\" data-end=\"931\"\u003e\u003cstrong data-start=\"329\" data-end=\"342\"\u003eOverview:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade compound is supplied exclusively for laboratory and experimental use. NAD⁺ is widely studied in experimental models focused on cellular energy metabolism, mitochondrial function, and longevity-related pathways. Research interest centers on its role as a core coenzyme supporting metabolic and repair processes at the cellular level.\u003cstrong data-start=\"329\" data-end=\"342\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"240\" data-start=\"192\"\u003ePrimary metabolic and redox research pairing\u003c\/h3\u003e\n\u003cp data-end=\"441\" data-start=\"242\"\u003eIn experimental and laboratory research settings, NAD+ is commonly examined alongside compounds involved in cellular energy metabolism, redox regulation, and mitochondrial signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"512\" data-start=\"443\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"462\" data-start=\"445\"\u003eL-Glutathione\u003c\/strong\u003e – redox balance and antioxidant system research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"569\" data-start=\"519\"\u003eNAD⁺ metabolism and signaling research context\u003c\/h3\u003e\n\u003cp data-end=\"732\" data-start=\"571\"\u003eSome experimental models explore NAD+ in parallel with compounds studied for NAD⁺ biosynthesis, salvage pathways, and intracellular signaling regulation.\u003c\/p\u003e\n\u003cp data-end=\"804\" data-start=\"734\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-end=\"751\" data-start=\"736\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"877\" data-start=\"811\"\u003eMitochondrial energy and metabolic efficiency research context\u003c\/h3\u003e\n\u003cp data-end=\"1052\" data-start=\"879\"\u003eAdditional research frameworks reference NAD+ alongside compounds examined for mitochondrial energy signaling, energy expenditure, and systemic metabolic regulation.\u003c\/p\u003e\n\u003cp data-end=\"1128\" data-start=\"1054\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-end=\"1070\" data-start=\"1056\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"329\" data-end=\"931\"\u003eNicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in every living cell, playing a central role in energy production, redox reactions, and cellular signaling. NAD+ supports mitochondrial efficiency, influences gene expression through sirtuin activation, and contributes to DNA repair. Research shows NAD+ levels decline with age, which may contribute to metabolic disorders, cognitive decline, and other age-related conditions. Supplementation aims to restore optimal levels, potentially improving resilience to oxidative stress and supporting overall cellular health.\u003c\/p\u003e\n\u003ch3 data-start=\"933\" data-end=\"1683\"\u003e\u003cstrong data-start=\"933\" data-end=\"946\"\u003eResearch:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"933\" data-end=\"1683\"\u003eStudies have demonstrated that NAD+ participates in critical oxidation–reduction reactions, acting as a cofactor for enzymes in glycolysis, the Krebs cycle, and oxidative phosphorylation. Beyond its metabolic role, NAD+ regulates signaling pathways involved in calcium homeostasis, inflammation, and chromatin remodeling. Declines in NAD+ during aging have been linked to increased oxidative stress, DNA damage, and mitochondrial dysfunction. This creates a cycle of metabolic decline, contributing to cellular senescence and impaired tissue function. Enhancing NAD+ availability has been shown to activate DNA repair enzymes, boost mitochondrial biogenesis, and improve metabolic performance in various models of aging and disease.\u003c\/p\u003e\n\u003cp data-start=\"933\" data-end=\"1683\"\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"1794\" data-start=\"1761\"\u003eFurther NAD⁺ Research Reading\u003c\/h3\u003e\n\u003cp data-end=\"2018\" data-start=\"1796\"\u003eFor an in-depth overview of NAD⁺ biochemistry and its role in cellular energy metabolism, see our article \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-nad-plus\"\u003e\u003cstrong data-end=\"1919\" data-start=\"1902\"\u003eWhat Is NAD⁺?\u003c\/strong\u003e\u003c\/a\u003e, which examines the molecular mechanisms underlying NAD⁺ function in experimental research models.\u003c\/p\u003e\n\u003cp data-end=\"2192\" data-start=\"2020\"\u003eTo explore how NAD⁺ is studied in the context of aging-related pathways, autophagy, and cellular renewal, refer to our research overview on \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/longevity-and-nad-plus\"\u003e\u003cstrong data-end=\"2191\" data-start=\"2160\"\u003eNAD⁺ and longevity research\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eNAD⁺ metabolism is also closely associated with NNMT-related regulatory pathways in experimental research models. Certain small-molecule research compounds are frequently examined for their role in modulating NAD⁺ availability through NNMT activity.\u003c\/p\u003e\n\u003cp\u003eFor a research-focused overview of NNMT modulation and its relationship with NAD⁺ metabolism, see:\u003cbr\u003e→\u003cstrong\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-5-amino-1mq\"\u003eWhat is 5-Amino-1MQ? – Research overview of NNMT-related metabolic pathways\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNAD⁺ is central to cellular energy production, redox balance, and metabolic regulation across multiple biological systems.\u003c\/p\u003e\n\u003cp\u003eTo explore how metabolic energy pathways and fat metabolism are investigated in research:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eExplore the role of mitochondrial bioenergetics, ATP production, and exercise-responsive cellular pathways.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1685\" data-end=\"1711\"\u003e\n\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003ch3 data-start=\"1685\" data-end=\"1711\"\u003e\n\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003eNAD+ Product Description:\u003c\/strong\u003e\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003e\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cul data-start=\"1712\" data-end=\"2015\"\u003e\n\u003cli data-start=\"1712\" data-end=\"1798\"\u003e\n\u003cp data-start=\"1714\" data-end=\"1798\"\u003e\u003cstrong data-start=\"1714\" data-end=\"1727\"\u003eSynonyms:\u003c\/strong\u003e nadide, coenzyme I, beta-NAD, beta-nicotinamide adenine dinucleotide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1799\" data-end=\"1839\"\u003e\n\u003cp data-start=\"1801\" data-end=\"1839\"\u003e\u003cstrong data-start=\"1801\" data-end=\"1823\"\u003eMolecular Formula:\u003c\/strong\u003e C21H27N7O14P2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1840\" data-end=\"1871\"\u003e\n\u003cp data-start=\"1842\" data-end=\"1871\"\u003e\u003cstrong data-start=\"1842\" data-end=\"1857\"\u003eMolar Mass:\u003c\/strong\u003e 663.4 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1872\" data-end=\"1899\"\u003e\n\u003cp data-start=\"1874\" data-end=\"1899\"\u003e\u003cstrong data-start=\"1874\" data-end=\"1889\"\u003eCAS Number:\u003c\/strong\u003e 53-84-9\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1900\" data-end=\"1921\"\u003e\n\u003cp data-start=\"1902\" data-end=\"1921\"\u003e\u003cstrong data-start=\"1902\" data-end=\"1914\"\u003ePubChem:\u003c\/strong\u003e 5892\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1922\" data-end=\"1985\"\u003e\n\u003cp data-start=\"1924\" data-end=\"1985\"\u003e\u003cstrong data-start=\"1924\" data-end=\"1966\"\u003eTotal Amount of the Active Ingredient:\u003c\/strong\u003e 1000 mg (1 vial)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1986\" data-end=\"2015\"\u003e\n\u003cp data-start=\"1988\" data-end=\"2015\"\u003e\u003cstrong data-start=\"1988\" data-end=\"2003\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eNAD+ structure: \u003c\/h3\u003e\n\u003cp\u003e\u003cimg alt=\"Chemical structure of nucleotides with labeled components\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_plus_stuctures.jpg?v=1758966119\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5419884\/\" title=\"PubMed_NAD+1000\"\u003ePubMed\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1325\" data-end=\"1363\"\u003eRelated Metabolic Research Context\u003c\/h3\u003e\n\u003cp data-start=\"1365\" data-end=\"1708\"\u003eNAD⁺ is frequently studied in experimental models alongside compounds involved in metabolic regulation and NAD⁺-dependent signaling pathways. In preclinical research, small molecules such as \u003cstrong data-start=\"1556\" data-end=\"1571\"\u003e5-Amino-1MQ\u003c\/strong\u003e are investigated for their role in pathways that influence intracellular NAD⁺ availability, metabolic flux, and cellular energy balance.\u003c\/p\u003e\n\u003cp data-start=\"1710\" data-end=\"1883\"\u003eResearchers examining NAD⁺ metabolism, redox regulation, and energy-related signaling may reference related research materials explored within these experimental frameworks.\u003c\/p\u003e\n\u003cp data-start=\"1710\" data-end=\"1883\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-start=\"1556\" data-end=\"1571\"\u003e5-Amino-1MQ\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51896117166346,"sku":"nadplus_1000mg-1","price":210.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":51896117199114,"sku":"nadplus_1000mg-2","price":235.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_1000_7-pen.png?v=1760890423"},{"product_id":"l-glutathione-3000-mg","title":"L-Glutathione – 3000mg","description":"\u003ch3\u003eOverview:\u003c\/h3\u003e\n\u003cp\u003eThis research-grade compound is supplied exclusively for laboratory and experimental use. L-Glutathione is studied in experimental systems examining antioxidant balance, cellular protection, and detoxification-related signaling. Research models often focus on how cells manage oxidative stress and maintain redox stability.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlutathione (GSH) \u003c\/strong\u003eis a tripeptide composed of glutamate, cysteine, and glycin.\u003cbr\u003eGlutathione levels decrease with aging, alcohol consumption, environmental factors,\u003cbr\u003eand sleep disturbances. Glutathione oral administration is not effective due to low\u003cbr\u003ebioavailability.\u003cbr\u003eIn mitochondria, GSH neutralizes reactive oxygen species (ROS) to prevent\u003cbr\u003emitochondrial DNA damage and collapse of the mitochondrial membrane potential\u003cbr\u003ebelow 100 mV.\u003cbr\u003eGSH, by reducing oxidative stress, can improve muscle recovery and reduce fatigue.\u003cbr\u003eGSH regenerates Vitamins C and E, protects mitochondrial membranes.\u003cbr\u003eIf you’re experimenting with mitochondrial agents like \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\" title=\"SLU-PP-332 200 mg capsules\"\u003eSLU-PP-332\u003c\/a\u003e and \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-peptide-20-mg\" title=\"SS-31 20mg vials\"\u003eSS-31\u003c\/a\u003e, GSH\u003cbr\u003ehelps you cover the ROS angle.\u003c\/p\u003e\n\u003ch3\u003eGlutathione effect boosters in clinical settings:\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003eVit-D, Selenium 25mcg, L-Glycine 3000mg, NAC 1200mg, Calcium Alpha\u003cbr\u003eCetoglutarate 300mg, Molybdenum 50 mcg\u003c\/p\u003e\n\u003ch3\u003eDetailed description:\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, GSH acts as a primary cellular antioxidant by donating\u003cbr\u003eelectrons from its thiol group (-SH) in cysteine to neutralize reactive oxygen species\u003cbr\u003e(ROS), such as hydrogen peroxide and superoxide radicals.\u003cbr\u003eThrough enzymatic catalysis by glutathione peroxidase (GPx), GSH reduces\u003cbr\u003ehydroperoxides to water or alcohols, forming oxidized glutathione (GSSG) as a\u003cbr\u003ebyproduct in the process.\u003cbr\u003eGSSG is then regenerated back to GSH by glutathione reductase (GR), which\u003cbr\u003eutilizes NADPH as a reducing equivalent, maintaining the cellular redox balance.\u003cbr\u003eGSH participates in detoxification by conjugating with xenobiotics and electrophilic\u003cbr\u003ecompounds via glutathione S-transferases (GSTs), forming glutathione S-conjugates\u003cbr\u003ethat are more water-soluble and easier to excrete.\u003c\/p\u003e\n\u003cp\u003eNon-enzymatically, GSH can directly react with electrophiles, such as lipid peroxides\u003cbr\u003eor reactive nitrogen species, to prevent oxidative damage to proteins, lipids, and\u003cbr\u003eDNA.\u003cbr\u003eIn protein glutathionylation, GSH forms mixed disulfides with protein thiols under\u003cbr\u003eoxidative stress, reversibly modifying protein function to protect against irreversible\u003cbr\u003eoxidation.\u003cbr\u003eAt the molecular level, GSH supports nutrient metabolism by facilitating the reduction\u003cbr\u003eof dehydroascorbate to ascorbate (vitamin C), thereby recycling this antioxidant.\u003cbr\u003eGSH regulates redox-sensitive transcription factors, such as NF-κB and AP-1, which\u003cbr\u003eare crucial in immune responses and inflammatory processes. Low GSH levels\u003cbr\u003einhibit T-cell proliferation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eRead about oxidative stress, mitochondrial defense systems, and the cellular benefits of exercise.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2310\" data-start=\"2061\"\u003e\u003cstrong data-end=\"2084\" data-start=\"2061\"\u003eGlutathione Product Description:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2310\" data-start=\"2061\"\u003e\u003cstrong data-end=\"2100\" data-start=\"2087\"\u003e\u003cbr\u003eSynonyms:\u003c\/strong\u003e γ-L-Glutamyl-L-cysteinylglycine, GSH\u003cbr data-end=\"2140\" data-start=\"2137\"\u003e\u003cstrong data-end=\"2155\" data-start=\"2140\"\u003eMolar Mass:\u003c\/strong\u003e 307.32 g\/mol\u003cbr data-end=\"2171\" data-start=\"2168\"\u003e\u003cstrong data-end=\"2186\" data-start=\"2171\"\u003eCAS Number:\u003c\/strong\u003e 70-18-8\u003cbr data-end=\"2197\" data-start=\"2194\"\u003e\u003cstrong data-end=\"2209\" data-start=\"2197\"\u003ePubChem:\u003c\/strong\u003e 124886\u003cbr data-end=\"2219\" data-start=\"2216\"\u003e\u003cstrong data-end=\"2261\" data-start=\"2219\"\u003eTotal Amount of the Active Ingredient:\u003c\/strong\u003e 3000mg per serving\u003cbr data-end=\"2283\" data-start=\"2280\"\u003e\u003cstrong data-end=\"2298\" data-start=\"2283\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-end=\"2310\" data-start=\"2061\"\u003eGlutathione \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Gluthatione structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Glutathione.png?v=1755187970\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eSource: \u003ca title=\"PubChem_Glutathione3000\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/124886\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51896146952458,"sku":"lglutathione_3000mg-1","price":90.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 3 )","offer_id":51896146985226,"sku":"lglutathione_3000mg-2","price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/glutathione3000mg_7-pen.png?v=1760890228"},{"product_id":"ss-31-20mg","title":"SS-31 20mg – Research Peptide","description":"\u003ch3\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. SS-31 is studied in experimental systems focused on mitochondrial stability, oxidative stress modulation, and cellular energy preservation. Research models examine its role in maintaining mitochondrial efficiency under stress conditions.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"400\" data-end=\"442\"\u003ePrimary mitochondrial research pairing\u003c\/h3\u003e\n\u003cp data-start=\"444\" data-end=\"649\"\u003eIn experimental and laboratory research settings, SS-31 (Elamipretide) is examined either as a standalone mitochondrial-targeting compound or within specific growth hormone–related research models.\u003c\/p\u003e\n\u003ch3 data-start=\"656\" data-end=\"711\"\u003eGrowth hormone–related research context\u003c\/h3\u003e\n\u003cp data-start=\"713\" data-end=\"848\"\u003eSome experimental frameworks explore SS-31 alongside compounds involved in GHRH-mediated metabolic and mitochondrial signaling.\u003c\/p\u003e\n\u003cp data-start=\"850\" data-end=\"935\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-start=\"852\" data-end=\"871\"\u003eCJC-1295 \u003c\/strong\u003e– GHRH-related metabolic and mitochondrial signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"942\" data-end=\"999\"\u003eAlternative GH-axis research context \u003c\/h3\u003e\n\u003cp data-start=\"1001\" data-end=\"1142\"\u003eOther experimental models reference SS-31 in parallel with compounds studied for GH-axis modulation without long-acting GHRH analogs.\u003c\/p\u003e\n\u003cp data-start=\"1144\" data-end=\"1271\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-start=\"1146\" data-end=\"1161\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-start=\"1205\" data-end=\"1208\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-start=\"1210\" data-end=\"1224\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1278\" data-end=\"1349\"\u003eMitochondrial and cellular energy research context \u003c\/h3\u003e\n\u003cp data-start=\"1351\" data-end=\"1559\"\u003eIn research frameworks not centered on growth hormone signaling, SS-31 is commonly examined alongside compounds involved in mitochondrial efficiency, cellular energy balance, and metabolic regulation.\u003c\/p\u003e\n\u003cp data-start=\"1561\" data-end=\"1726\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-start=\"1563\" data-end=\"1577\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic efficiency research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1733\" data-end=\"1790\"\u003eRedox balance and metabolic cofactor research context\u003c\/h3\u003e\n\u003cp data-start=\"1792\" data-end=\"1943\"\u003eSome experimental discussions reference SS-31 alongside compounds examined for oxidative stress regulation and intracellular redox homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"1945\" data-end=\"2080\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1947\" data-end=\"1964\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003cbr data-start=\"2007\" data-end=\"2010\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-start=\"2012\" data-end=\"2027\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"2087\" data-end=\"2146\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"2148\" data-end=\"2293\"\u003eIn specialized experimental models, SS-31 may be referenced alongside compounds studied for neurotrophic signaling and synaptic function.\u003c\/p\u003e\n\u003cp data-start=\"2295\" data-end=\"2356\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"2297\" data-end=\"2307\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"2363\" data-end=\"2410\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"2412\" data-end=\"2576\"\u003eCertain research discussions reference SS-31 alongside alternative peptide formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-start=\"2578\" data-end=\"2642\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"2580\" data-end=\"2602\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eSS-31 Peptide, also known as elamipretide, MTP-131, or Bendavia, is a synthetic tetrapeptide that selectively targets and penetrates the inner mitochondrial membrane. Its unique structure allows it to bind cardiolipin, a critical phospholipid involved in maintaining mitochondrial structure and function. Research suggests that SS-31 pepptide can reduce mitochondrial oxidative damage, improve ATP production, and stabilize electron transport chain efficiency.\u003c\/p\u003e\n\u003cp\u003eStudies have investigated SS-31 peptide in the context of age-related mitochondrial decline, cardiovascular dysfunction, neurodegeneration, and metabolic disorders, making it a promising compound in longevity and cellular health research.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMitochondrial Protection:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBinds and stabilizes cardiolipin to maintain mitochondrial cristae structure.\u003c\/li\u003e\n\u003cli\u003eReduces production of reactive oxygen species (ROS), limiting oxidative damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eEnergy Metabolism:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEnhances efficiency of oxidative phosphorylation, increasing ATP synthesis.\u003c\/li\u003e\n\u003cli\u003eRestores mitochondrial membrane potential in models of mitochondrial dysfunction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCardiovascular Studies:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eImproves cardiac bioenergetics and function in preclinical models of ischemia-reperfusion injury and heart failure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNeuroprotection:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePreserves mitochondrial function in neuronal cells, with potential benefits in neurodegenerative disease models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic Health:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInvestigated for reversing age-associated declines in mitochondrial performance, potentially improving muscle endurance and metabolic flexibility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e D-Arg-Tyr(2,6-diMe)-Lys-Phe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₄₉N₉O₅\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 639.8 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePubChem CID:\u003c\/strong\u003e 11764719\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 736992-21-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynonyms:\u003c\/strong\u003e elamipretide, MTP-131, Bendavia\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eScientific background and research context:\u003c\/strong\u003e\u003cbr data-end=\"1271\" data-start=\"1268\"\u003e\u003cstrong\u003e→ \u003ca title=\"ss 31 research background\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ss-31-peptide\"\u003eSS-31 (Elamipretide): Mitochondrial function and energy research overview\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eDiscover how mitochondrial protection, oxidative stress regulation, and exercise influence long-term cellular resilience.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Elamipretide.png?v=1755186474\" alt=\"ss-31 structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003c\/strong\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11764719\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cstrong\u003ePubChem\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-end=\"620\" data-start=\"589\"\u003eRelated research compounds:\u003c\/strong\u003e\u003cbr data-end=\"623\" data-start=\"620\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cstrong data-end=\"695\" data-start=\"625\"\u003eNAD⁺ – Research-Grade Compound for mitochondrial energy metabolism\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51900001288458,"sku":"ss31_20mg-1","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ss-31_20mg_7-pen.png?v=1760890079"},{"product_id":"bpc-157-500mcg","title":"BPC-157 Capsules – High Purity Research Peptide (500mcg per capsule)","description":"\u003ch2 data-end=\"598\" data-start=\"573\"\u003eBPC 157 Peptide Research Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade capsule formulation is supplied exclusively for laboratory and experimental use. BPC-157 capsules are studied in experimental models focusing on gastrointestinal integrity, systemic signaling, and tissue-supportive pathways. Research interest often examines how oral peptide exposure may influence cellular communication beyond localized tissue models.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"960\" data-start=\"600\"\u003eBPC-157 is a synthetic pentadecapeptide originally characterized in experimental studies as a stable fragment derived from gastric protective proteins. In laboratory research, it is widely examined as a \u003cstrong data-end=\"838\" data-start=\"803\"\u003emulti-pathway signaling peptide\u003c\/strong\u003e due to its interaction with cellular repair mechanisms, vascular signaling systems, and inflammatory modulation pathways.\u003c\/p\u003e\n\u003cp data-end=\"1187\" data-start=\"962\"\u003eRather than focusing on a single molecular target, BPC-157 is studied for its \u003cstrong data-end=\"1069\" data-start=\"1040\"\u003ebroad regulatory behavior\u003c\/strong\u003e across connective tissue, endothelial function, and neurochemical signaling under controlled experimental conditions.\u003c\/p\u003e\n\u003ch3 data-end=\"1232\" data-start=\"1194\"\u003eKey Molecular Research Context\u003c\/h3\u003e\n\u003cp data-end=\"1367\" data-start=\"1234\"\u003eExperimental literature describes BPC-157 as interacting with multiple intracellular and extracellular signaling pathways, including:\u003c\/p\u003e\n\u003cul data-end=\"1667\" data-start=\"1369\"\u003e\n\u003cli data-end=\"1440\" data-start=\"1369\"\u003e\n\u003cp data-end=\"1440\" data-start=\"1371\"\u003emodulation of fibroblast activity and extracellular matrix dynamics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1508\" data-start=\"1441\"\u003e\n\u003cp data-end=\"1508\" data-start=\"1443\"\u003eregulation of angiogenic signaling via VEGF-associated pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1589\" data-start=\"1509\"\u003e\n\u003cp data-end=\"1589\" data-start=\"1511\"\u003einfluence on nitric oxide–related signaling involved in vascular homeostasis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1667\" data-start=\"1590\"\u003e\n\u003cp data-end=\"1667\" data-start=\"1592\"\u003eparticipation in cellular stress response and survival signaling cascades\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1850\" data-start=\"1669\"\u003eThese characteristics make BPC-157 a commonly referenced peptide in \u003cstrong data-end=\"1849\" data-start=\"1737\"\u003elaboratory models examining tissue repair signaling, vascular adaptation, and inflammation-related processes\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"1907\" data-start=\"1857\"\u003eExperimental Models Referenced in Research\u003c\/h3\u003e\n\u003cp data-end=\"2013\" data-start=\"1909\"\u003eIn controlled laboratory environments, BPC-157 has been incorporated into experimental models exploring:\u003c\/p\u003e\n\u003cul data-end=\"2322\" data-start=\"2015\"\u003e\n\u003cli data-end=\"2091\" data-start=\"2015\"\u003e\n\u003cp data-end=\"2091\" data-start=\"2017\"\u003e\u003cstrong data-end=\"2048\" data-start=\"2017\"\u003econnective tissue signaling\u003c\/strong\u003e in tendon, ligament, and muscle research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2164\" data-start=\"2092\"\u003e\n\u003cp data-end=\"2164\" data-start=\"2094\"\u003e\u003cstrong data-end=\"2129\" data-start=\"2094\"\u003egastrointestinal cytoprotection\u003c\/strong\u003e and endothelial stability models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2232\" data-start=\"2165\"\u003e\n\u003cp data-end=\"2232\" data-start=\"2167\"\u003e\u003cstrong data-end=\"2206\" data-start=\"2167\"\u003evascular integrity and angiogenesis\u003c\/strong\u003e under stress conditions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2322\" data-start=\"2233\"\u003e\n\u003cp data-end=\"2322\" data-start=\"2235\"\u003e\u003cstrong data-end=\"2271\" data-start=\"2235\"\u003eneurochemical signaling pathways\u003c\/strong\u003e, including serotonergic and dopaminergic systems\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2502\" data-start=\"2324\"\u003eThese studies focus on \u003cstrong data-end=\"2374\" data-start=\"2347\"\u003emechanistic observation\u003c\/strong\u003e, not therapeutic application, and are designed to explore how peptide-mediated signaling influences complex biological systems.\u003c\/p\u003e\n\u003ch3 data-end=\"2552\" data-start=\"2509\"\u003eCapsule Format in Research Settings\u003c\/h3\u003e\n\u003cp data-end=\"2806\" data-start=\"2554\"\u003eThe capsule format of BPC-157 is commonly referenced in research discussions comparing \u003cstrong data-end=\"2682\" data-start=\"2641\"\u003edifferent laboratory delivery formats\u003c\/strong\u003e, allowing investigators to evaluate stability, handling characteristics, and experimental consistency across study designs.\u003c\/p\u003e\n\u003cp data-end=\"2924\" data-start=\"2808\"\u003eFor a comprehensive scientific background on BPC-157, including its origin and broader research classification, see:\u003c\/p\u003e\n\u003cp data-end=\"3027\" data-start=\"2926\"\u003e➝ \u003cstrong data-end=\"2968\" data-start=\"2928\"\u003eWhat is BPC-157? – \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-bpc-157\"\u003eResearch Overview\u003c\/a\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e➝ \u003cstrong data-end=\"3027\" data-start=\"2973\"\u003eBPC-157: Oral vs Injection – \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-oral-versus-injection-best-method\"\u003eResearch Perspectives\u003c\/a\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor an overview of experimental research examining muscle and tendon recovery mechanisms, including regenerative signaling and tissue repair models, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle and Tendon Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"3027\" data-start=\"2926\"\u003e \u003c\/p\u003e\n\u003ch3\u003eProduct Description:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSynonyms: Body Protection Compound 15, Bepecin, L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-\u003c\/li\u003e\n\u003cli\u003eMolar Mass: 1419.5 g\/mol\u003c\/li\u003e\n\u003cli\u003eCAS Number: 137525-51-0\u003c\/li\u003e\n\u003cli\u003ePubChem: 994195\u003c\/li\u003e\n\u003cli\u003eTotal Active Ingredient: 60000mcg (500mcg per capsule)\u003c\/li\u003e\n\u003cli\u003eShelf Life: 36 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBPC-157 Structures:\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Bpc-157.png?v=1755163863\" alt=\"BPC-157 Structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eSources \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\" title=\"PubChem_12\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51621457461514,"sku":"bpc157_500mcg","price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/BPC-157_500mcg_14_1_cb81f0f1-b504-4c7c-b219-fafcfd8d9938.png?v=1768032218"},{"product_id":"dihexa-20mg","title":"Dihexa – High Purity Cognitive Research Molecule (20mg)","description":"\u003ch2 data-start=\"489\" data-end=\"939\"\u003e\u003cstrong data-start=\"489\" data-end=\"513\"\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. Dihexa is examined in experimental models investigating neurotrophic signaling, synaptic plasticity, and advanced cognitive pathway modulation. Research interest centers on its role in cellular communication related to learning and neural adaptation.\u003cstrong data-start=\"489\" data-end=\"513\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"489\" data-end=\"939\"\u003eDihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a nootropic peptide originally developed at Washington State University as a potential treatment for neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Unlike many cognitive enhancers that work by temporarily boosting neurotransmitter levels, Dihexa promotes \u003cstrong data-start=\"886\" data-end=\"923\"\u003elong-term structural improvements\u003c\/strong\u003e in the brain.\u003c\/p\u003e\n\u003cp data-start=\"941\" data-end=\"1334\"\u003eIts mechanism involves acting as a potent \u003cstrong data-start=\"983\" data-end=\"1025\"\u003ehepatocyte growth factor (HGF) mimetic\u003c\/strong\u003e, binding to and activating the c-Met receptor. This signaling pathway plays a critical role in neuronal survival, differentiation, and synaptic plasticity. By enhancing HGF\/c-Met activity, Dihexa facilitates \u003cstrong data-start=\"1234\" data-end=\"1252\"\u003esynaptogenesis\u003c\/strong\u003e, effectively increasing the number and strength of connections between neurons.\u003c\/p\u003e\n\u003cp data-start=\"1336\" data-end=\"1402\"\u003ePreclinical studies in animal models have shown that Dihexa can:\u003c\/p\u003e\n\u003cul data-start=\"1403\" data-end=\"1701\"\u003e\n\u003cli data-start=\"1403\" data-end=\"1484\"\u003e\n\u003cp data-start=\"1405\" data-end=\"1484\"\u003eImprove learning and memory performance, even in models of cognitive decline,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1485\" data-end=\"1544\"\u003e\n\u003cp data-start=\"1487\" data-end=\"1544\"\u003eReverse cognitive deficits caused by disease or injury,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1545\" data-end=\"1605\"\u003e\n\u003cp data-start=\"1547\" data-end=\"1605\"\u003ePromote neuronal repair and structural brain plasticity,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1606\" data-end=\"1701\"\u003e\n\u003cp data-start=\"1608\" data-end=\"1701\"\u003eExhibit extremely high potency (active in the picomolar range) without measurable toxicity. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1758\" data-end=\"1781\"\u003e\u003cstrong data-start=\"1758\" data-end=\"1779\"\u003eDihexa Product Description:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1782\" data-end=\"2088\"\u003e\n\u003cli data-start=\"1782\" data-end=\"1904\"\u003e\n\u003cp data-start=\"1784\" data-end=\"1904\"\u003e\u003cstrong data-start=\"1784\" data-end=\"1797\"\u003eSynonyms:\u003c\/strong\u003e Dihexa, 1401708-83-5, UNII-9WYX65A5C2, L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1905\" data-end=\"1936\"\u003e\n\u003cp data-start=\"1907\" data-end=\"1936\"\u003e\u003cstrong data-start=\"1907\" data-end=\"1922\"\u003eMolar Mass:\u003c\/strong\u003e 504.7 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1937\" data-end=\"1969\"\u003e\n\u003cp data-start=\"1939\" data-end=\"1969\"\u003e\u003cstrong data-start=\"1939\" data-end=\"1954\"\u003eCAS Number:\u003c\/strong\u003e 1401708-83-5\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1970\" data-end=\"1999\"\u003e\n\u003cp data-start=\"1972\" data-end=\"1999\"\u003e\u003cstrong data-start=\"1972\" data-end=\"1987\"\u003ePubChem ID:\u003c\/strong\u003e 129010512\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2000\" data-end=\"2058\"\u003e\n\u003cp data-start=\"2002\" data-end=\"2058\"\u003e\u003cstrong data-start=\"2002\" data-end=\"2030\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 600mg (20mg per capsule)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2059\" data-end=\"2088\"\u003e\n\u003cp data-start=\"2061\" data-end=\"2088\"\u003e\u003cstrong data-start=\"2061\" data-end=\"2076\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-end=\"489\" data-start=\"458\"\u003e\u003cstrong\u003eResearch background and further reading:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"489\" data-start=\"458\"\u003eFor a detailed, research-focused overview of Dihexa, including its role in neurotrophic signaling and synaptic plasticity models, see: → \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-does-dihexa-do\"\u003eWhat does Dihexa do? – Research overview\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"489\" data-start=\"458\"\u003e\u003cstrong\u003eComparative research context:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"489\" data-start=\"458\"\u003eFor a broader comparison of neuropeptide and neurotrophic research compounds, including Dihexa, Semax, and Selank, see: \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003e\u003cstrong\u003e→ Semax vs Selank vs Dihexa – Key research differences\u003c\/strong\u003e\u003c\/a\u003e\u003cbr data-end=\"576\" data-start=\"573\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003e\u003cstrong\u003eOCD Circuit-Level Neurobiology Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDihexa Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Dihexa.png?v=1755162451\" alt=\"dihexa structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSources \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/129010512\" title=\"PubChem_10\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1703\" data-end=\"1957\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51621457592586,"sku":"dihexa20mg","price":160.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/dihexa_20mg_10_1.png?v=1768032685"},{"product_id":"o-304","title":"O-304 (ATX-304, OS-01) - High Purity Research Molecule (150 MG)","description":"\u003ch2\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade capsule formulation is supplied exclusively for laboratory and experimental use. O-304 is studied in experimental metabolic models examining energy utilization, insulin-independent glucose handling, and lipid metabolism signaling pathways. Research interest centers on its role in metabolic flexibility and endurance-related cellular adaptation.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"313\" data-start=\"275\"\u003ePrimary metabolic research pairing\u003c\/h3\u003e\n\u003cp data-end=\"511\" data-start=\"315\"\u003eIn experimental and laboratory research settings, O-304 is commonly examined in studies focused on metabolic regulation, insulin sensitivity, and energy balance–related signaling pathways.\u003c\/p\u003e\n\u003ch3 data-end=\"573\" data-start=\"518\"\u003eGrowth hormone–related research context\u003c\/h3\u003e\n\u003cp data-end=\"713\" data-start=\"575\"\u003eSome experimental frameworks explore O-304 alongside compounds involved in GHRH-mediated metabolic and systemic energy regulation.\u003c\/p\u003e\n\u003cp data-end=\"779\" data-start=\"715\"\u003e→\u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e \u003cstrong data-end=\"729\" data-start=\"717\"\u003eCJC-1295\u003c\/strong\u003e – GHRH-related metabolic and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"843\" data-start=\"786\"\u003eAlternative GH-axis research context \u003c\/h3\u003e\n\u003cp data-end=\"994\" data-start=\"845\"\u003eOther research models reference O-304 in parallel with compounds studied for growth hormone axis modulation without long-acting GHRH analogs.\u003c\/p\u003e\n\u003cp data-end=\"1123\" data-start=\"996\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-end=\"1013\" data-start=\"998\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-end=\"1060\" data-start=\"1057\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-end=\"1076\" data-start=\"1062\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1201\" data-start=\"1130\"\u003eMitochondrial and cellular energy research context (GH-independent)\u003c\/h3\u003e\n\u003cp data-end=\"1408\" data-start=\"1203\"\u003eIn research frameworks not centered on growth hormone signaling, O-304 is often examined alongside compounds involved in mitochondrial efficiency, cellular energy balance, and metabolic adaptation.\u003c\/p\u003e\n\u003cp data-end=\"1575\" data-start=\"1410\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-50mg-per-vial\"\u003e\u003cstrong data-end=\"1436\" data-start=\"1412\"\u003eSS-31 (Elamipretide)\u003c\/strong\u003e – mitochondrial stabilization and bioenergetics research\u003c\/a\u003e\u003cbr data-end=\"1496\" data-start=\"1493\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/mots-c-peptide-20-mg-research-grade\"\u003e\u003cstrong data-end=\"1508\" data-start=\"1498\"\u003eMOTS-c\u003c\/strong\u003e – mitochondrial-derived peptide and metabolic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1637\" data-start=\"1582\"\u003eIntegrated metabolic and signaling research context\u003c\/h3\u003e\n\u003cp data-end=\"1810\" data-start=\"1639\"\u003eIn broader experimental discussions, O-304 may also be referenced alongside compounds studied for systemic metabolic regulation and multi-pathway energy signaling.\u003c\/p\u003e\n\u003cp data-end=\"1888\" data-start=\"1812\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/retatrutide-20-mg\"\u003e\u003cstrong data-end=\"1829\" data-start=\"1814\"\u003eRetatrutide\u003c\/strong\u003e – multi-receptor metabolic and energy signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eDue to its unique in vitro and in vivo regulation of AMPK, it is positioned not only for metabolic improvement but also for cardiovascular protection, exercise physiology, and aging research. It is considered a potential \u003cstrong\u003eO-304\u003c\/strong\u003e is a first-in-class, orally available pan- AMPK  activator, which increases  AMPK  activity by suppressing the dephosphorylation of pAMPK. O-304 exhibits a great potential as an agent to treat type 2 diabetes (T2D) and associated cardiovascular complications. Studies have found that aged mice fed it showed significantly improved cardiac function indicators, such as cardiac output, ejection fraction, and infarct volume, compared to the control group. This improvement was also accompanied by a reduction in insulin resistance and hyperinsulinemia, reflecting its potential to promote cardiac metabolism, energy utilization, and overall metabolic homeostasis. AMPK Activator O-304 protects against kidney aging through promoting energy metabolism and autophagy. O-304 reduces whole-body fat mass and lowers blood cholesterol levels in models of nonalcoholic steatohepatitis.\u003cbr\u003e\u003cbr\u003eO-304 increases glucose uptake in skeletal muscle, reduces β-cell stress, and promotes β-cell rest in diet-induced obese mice. O-304 reduces fasting plasma glucose levels. In a Phase IIa clinical trial in patients with T2D, it not only improved glucose homeostasis but also significantly enhanced peripheral microcirculatory function, including skin microvascular perfusion, which is a common mechanism leading to the severe consequences of T2D.\u003cbr\u003e\u003cbr\u003eThe small molecule pan-AMPK activator prevents dephosphorylation of AMPK at threonine-172. Muscle glucose uptake increases without needing insulin. Fat oxidation ramps up while fat synthesis is suppressed. \u003cstrong\u003eO-304\u003c\/strong\u003e has also been observed to promote autophagy and alleviate mitochondrial dysfunction. For example, in a model of oxidative stress, it significantly increased the formation of LC3B-positive autophagosomes, promoting autophagic flux, and restoring the expression of key factors involved in mitochondrial biogenesis (such as PGC-1α and TFAM), reducing ROS production, and restoring mitochondrial ultrastructure, suggesting a protective role in maintaining cellular quality control and energy metabolism. Improves blood flow via nitric oxide signaling. It also acts as a mild mitochondrial uncoupler, increasing basal oxygen consumption and calorie burn by ~38% in cell models. O-304 also does not reduce cellular ATP levels, distinguishing it from indirect AMPK activators (metformin) that alter energy status. This behavior mimics the protective effect of ADP, unlike classic AMPK activators, which rely on reduced ATP or increased AMP levels for activation. (PP2C dephosphorylation experiments have shown that it can stabilize p-T172 AMPK even in the presence of high ATP levels.). Notably, this mechanism renders it a more gentle and sustained AMPK activation tool, thereby preventing cellular errors or damage caused by energy depletion.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eO-304 is investigated in research exploring metabolic regulation, energy balance, and cellular adaptation mechanisms.\u003c\/p\u003e\n\u003cp\u003eTo learn how metabolic energy pathways and fat metabolism are studied in experimental systems:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how metabolic efficiency and endurance-related signaling pathways intersect with muscle performance research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eLearn how AMPK activation and mitochondrial efficiency relate to exercise-induced metabolic improvements.\u003cbr\u003e\u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"168\" data-start=\"130\"\u003eProduct Description – O-304\u003c\/h3\u003e\n\u003cp data-end=\"434\" data-start=\"170\"\u003e\u003cstrong data-end=\"183\" data-start=\"170\"\u003eSynonyms:\u003c\/strong\u003e 4-chloro-N-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide\u003cbr\u003e\u003cstrong\u003eMolecular Formula: \u003c\/strong\u003e\u003cspan\u003eC\u003csub\u003e16\u003c\/sub\u003eH\u003csub\u003e11\u003c\/sub\u003eCl\u003csub\u003e2\u003c\/sub\u003eN\u003csub\u003e3\u003c\/sub\u003eO\u003csub\u003e2\u003c\/sub\u003eS\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003cstrong data-end=\"255\" data-start=\"240\"\u003eMolecular Weight:\u003c\/strong\u003e \u003cspan\u003e380.2\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003eg\/mol\u003c\/span\u003e\u003cbr data-end=\"271\" data-start=\"268\"\u003e\u003cstrong data-end=\"286\" data-start=\"271\"\u003eCAS Number:\u003c\/strong\u003e 1261289-04-6\u003cbr\u003e\u003cstrong data-end=\"316\" data-start=\"301\"\u003ePubChem ID:\u003c\/strong\u003e \u003cspan\u003e50923806\u003c\/span\u003e\u003cbr data-end=\"327\" data-start=\"324\"\u003e\u003cstrong data-end=\"355\" data-start=\"327\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 4500 mg per container (150 mg per capsule)\u003cbr data-end=\"407\" data-start=\"404\"\u003e\u003cstrong data-end=\"422\" data-start=\"407\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eO-304 Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"float: none;\" alt=\"O-304 structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/O-304.png?v=1756893623\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSource: \u003c\/strong\u003e\u003ca title=\"O-304 structure\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/50923806\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51621458346250,"sku":null,"price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/os-304_150mg_10_1.png?v=1768032795"},{"product_id":"slu-pp-332-200mg","title":"SLU-PP-332 – High Purity Research Molecule (200mg per capsule)","description":"\u003ch2 data-start=\"139\" data-end=\"604\"\u003e\u003cstrong data-start=\"139\" data-end=\"162\"\u003eOverview\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. SLU-PP-332 is examined in experimental models focused on metabolic efficiency, mitochondrial activation, and exercise-mimetic signaling pathways. Research interest centers on how cells adapt to increased energy demand without physical stress.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"139\" data-end=\"162\"\u003e\u003c\/strong\u003e\u003cstrong data-start=\"139\" data-end=\"162\"\u003e\u003c\/strong\u003eSLU-PP-332 capsules are widely recognized for their potential to improve overall health and vitality. These capsules are formulated to enhance mood, help defend against chronic diseases, and may contribute to slowing some aspects of aging. Scientific studies have repeatedly shown that using SLU-PP-332 capsules could assist in preventing heart disease, supporting better cognitive function, and increasing general well-being. Traditionally, the benefits offered by physical exercise were hard to replicate using pharmaceuticals. Now, with the introduction of SLU-PP-332 capsules, a new opportunity is emerging for people and researchers who want to pursue the physiological advantages associated with exercise.\u003c\/p\u003e\n\u003ch3 data-start=\"168\" data-end=\"206\"\u003ePrimary metabolic research pairing\u003c\/h3\u003e\n\u003cp data-start=\"208\" data-end=\"424\"\u003eIn experimental and laboratory research settings, SLU-PP-332 is commonly examined alongside compounds involved in mitochondrial energy signaling, metabolic efficiency, and systemic energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"426\" data-end=\"624\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-start=\"428\" data-end=\"440\"\u003eCJC-1295\u003c\/strong\u003e – growth hormone–related metabolic signaling research\u003c\/a\u003e\u003cbr data-start=\"494\" data-end=\"497\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-start=\"499\" data-end=\"514\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-start=\"558\" data-end=\"561\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-start=\"563\" data-end=\"577\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"631\" data-end=\"685\"\u003eMitochondrial and cellular energy research context\u003c\/h3\u003e\n\u003cp data-start=\"687\" data-end=\"852\"\u003eSome experimental frameworks explore SLU-PP-332 in parallel with compounds studied for mitochondrial function, bioenergetics, and cellular stress adaptation.\u003c\/p\u003e\n\u003cp data-start=\"854\" data-end=\"1017\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-50mg-per-vial\"\u003e\u003cstrong data-start=\"856\" data-end=\"880\"\u003eSS-31 (Elamipretide)\u003c\/strong\u003e – mitochondrial stabilization and respiration research\u003c\/a\u003e\u003cbr data-start=\"935\" data-end=\"938\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/mots-c-peptide-10-mg-research-grade\"\u003e\u003cstrong data-start=\"940\" data-end=\"950\"\u003eMOTS-c\u003c\/strong\u003e – mitochondrial-derived peptide and metabolic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1024\" data-end=\"1080\"\u003eRedox balance and metabolic support research context\u003c\/h3\u003e\n\u003cp data-start=\"1082\" data-end=\"1239\"\u003eAdditional research models reference SLU-PP-332 alongside compounds examined for redox balance, cellular resilience, and metabolic cofactor pathways.\u003c\/p\u003e\n\u003cp data-start=\"1241\" data-end=\"1384\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cstrong data-start=\"1243\" data-end=\"1251\"\u003eNAD+\u003c\/strong\u003e – cellular energy metabolism and redox signaling research\u003c\/a\u003e\u003cbr data-start=\"1309\" data-end=\"1312\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1314\" data-end=\"1331\"\u003eL-Glutathione\u003c\/strong\u003e – oxidative stress and antioxidant system research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"606\" data-end=\"840\"\u003eSlu pp 332 represents a genuine advancement in this category. It is an estrogen-related receptor (ERR) agonist designed to target specific ERR alpha and gamma subtypes. In laboratory research, Slu pp 332 has demonstrated several promising effects:\u003c\/p\u003e\n\u003cul data-start=\"842\" data-end=\"1011\"\u003e\n\u003cli data-start=\"842\" data-end=\"879\"\u003e\n\u003cp data-start=\"844\" data-end=\"879\"\u003eEnhance muscular endurance during exercise\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"880\" data-end=\"908\"\u003e\n\u003cp data-start=\"882\" data-end=\"908\"\u003eAssist with weight management\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"909\" data-end=\"947\"\u003e\n\u003cp data-start=\"911\" data-end=\"947\"\u003eBoost cardiovascular system performance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"948\" data-end=\"1011\"\u003e\n\u003cp data-start=\"950\" data-end=\"1011\"\u003eHelp protect the central nervous system during aging\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1013\" data-end=\"1301\"\u003eBy supporting similar metabolic pathways to those activated by regular exercise, Slu pp 332 creates excitement in the scientific community. Researchers focusing on longevity, energy metabolism, and human performance optimization have found particular interest here. These effects may lead to more options for those who seek improved metabolic health and a higher quality of life.\u003c\/p\u003e\n\u003ch3 data-start=\"130\" data-end=\"168\"\u003eProduct Description – SLU-PP-332 Capsules\u003c\/h3\u003e\n\u003cp data-start=\"170\" data-end=\"434\"\u003e\u003cstrong data-start=\"170\" data-end=\"183\"\u003eSynonyms:\u003c\/strong\u003e 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide\u003cbr data-start=\"237\" data-end=\"240\"\u003e\u003cstrong data-start=\"240\" data-end=\"255\"\u003eMolar Mass:\u003c\/strong\u003e 290.32 g\/mol\u003cbr data-start=\"268\" data-end=\"271\"\u003e\u003cstrong data-start=\"271\" data-end=\"286\"\u003eCAS Number:\u003c\/strong\u003e 303760-60-3\u003cbr data-start=\"298\" data-end=\"301\"\u003e\u003cstrong data-start=\"301\" data-end=\"316\"\u003ePubChem ID:\u003c\/strong\u003e 5338394\u003cbr data-start=\"324\" data-end=\"327\"\u003e\u003cstrong data-start=\"327\" data-end=\"355\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 12,000 mg per container (200 mg per capsule)\u003cbr data-start=\"404\" data-end=\"407\"\u003e\u003cstrong data-start=\"407\" data-end=\"422\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003cp data-start=\"170\" data-end=\"434\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"170\" data-end=\"434\"\u003eFurther research reading:\u003c\/h3\u003e\n\u003cp data-start=\"170\" data-end=\"434\"\u003eTo learn more about the scientific background, molecular mechanisms, and experimental research context of SLU-PP-332, see our in-depth article: \u003cbr data-end=\"280\" data-start=\"277\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-slu-pp-332\"\u003e\u003cstrong data-end=\"350\" data-start=\"282\"\u003eWhat is SLU-PP-332? – Research overview and experimental context\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eSLU-PP is studied in experimental models focused on mitochondrial function, energy expenditure, and metabolic efficiency.\u003c\/p\u003e\n\u003cp\u003eTo better understand the broader framework of metabolic energy systems in research:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"170\" data-end=\"434\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"170\" data-end=\"434\"\u003e\u003cstrong\u003eStructures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Slu-PP-332.png?v=1755158769\" alt=\"slu-pp-332 structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSources \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5338394\" title=\"PubChem_3\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"264\" data-end=\"299\"\u003e\u003cstrong data-start=\"264\" data-end=\"297\"\u003e\u003cbr\u003eResearch Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"301\" data-end=\"680\"\u003eIt has long been established that regular exercise improves quality of life and health outcomes. Cardiovascular fitness, improved metabolic profiles, reduced risk of cognitive decline, and better weight management are often cited as gains. For decades, scientists attempted to mirror these effects with chemical compounds, but most solutions provided limited results. However, Slu pp 332, classified as an \u003cstrong data-start=\"634\" data-end=\"677\"\u003eestrogen-related receptor (ERR) agonist\u003c\/strong\u003e, alters the field. Its selective activity for specific ERR subtypes makes it a focal point for today's research on healthspan and metabolism.\u003c\/p\u003e\n\u003cp data-start=\"682\" data-end=\"957\"\u003eEstrogen-related receptors are nuclear receptors. They help manage gene expression for energy metabolism, fat oxidation, and the vital operations of mitochondria. Slu pp 332 uniquely targets ERRα and ERRγ, which are fundamental for exercise tolerance. Verified research has shown that activating these receptors can help:\u003c\/p\u003e\n\u003cul data-start=\"959\" data-end=\"1188\"\u003e\n\u003cli data-start=\"959\" data-end=\"1023\"\u003e\n\u003cp data-start=\"961\" data-end=\"1023\"\u003eIncrease muscle stamina and performance capability,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1024\" data-end=\"1077\"\u003e\n\u003cp data-start=\"1026\" data-end=\"1077\"\u003ePromote fat loss without dietary restriction,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1078\" data-end=\"1131\"\u003e\n\u003cp data-start=\"1080\" data-end=\"1131\"\u003eEncourage cardiovascular health and optimal lipid levels,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1132\" data-end=\"1188\"\u003e\n\u003cp data-start=\"1134\" data-end=\"1188\"\u003eOffer safeguarding for the nervous system as it ages.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1190\" data-end=\"1609\"\u003e\u003cstrong data-start=\"1190\" data-end=\"1207\"\u003eHow ERRs Work\u003c\/strong\u003e\u003cbr data-start=\"1207\" data-end=\"1210\"\u003eERRα is heavily involved with gluconeogenesis, lipid metabolism, and brown fat thermogenesis. Through these actions, it impacts blood glucose, cholesterol, and triglyceride regulation. ERRγ boosts mitochondrial activity and helps control energy consumption. Its actions connect to metabolic syndrome prevention and possibly neuroprotection against Parkinson’s disease. ERRβ likely plays a part in stem cell transitions and tissue repair.\u003c\/p\u003e\n\u003ch3\u003ePotential Benefits of SLU-PP-332 Capsules for Research\u003c\/h3\u003e\n\u003cp\u003eStudies in animals reveal that SLU-PP-332 capsules can mimic vital elements of exercise. Key effects include increased energy expenditure, mostly due to fat utilization, growth in mitochondrial number and capacity, as well as improvements in sustained energy output. These properties highlight why SLU-PP-332 capsules are being explored as an alternative strategy for those who cannot regularly exercise or want added support for metabolic function.\u003c\/p\u003e\n\u003cp\u003eDespite the name, activity at these receptors is \u003cstrong data-start=\"1954\" data-end=\"1983\"\u003enot regulated by estrogen\u003c\/strong\u003e. They only share a structural likeness to estrogen receptors, without the hormonal effects. The function and advantages of SLU-PP-332 capsules are generated by this unique receptor activity. This product may provide one of the closest parallels to exercise currently known, which has gained it strong interest in fields investigating obesity, metabolic disease, heart health, and reduced neurodegenerative risk.\u003c\/p\u003e\n\u003cp\u003eSLU-PP-332 capsules could soon play a significant role in further research for aging, performance, and chronic disease. With their special ERR agonist activity and promising safety profile, many scientists see SLU-PP-332 capsules as a critical component of future health technology and metabolic innovation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"976\" data-end=\"1005\"\u003eRelated research context:\u003c\/strong\u003e\u003cbr data-start=\"1005\" data-end=\"1008\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1010\" data-end=\"1092\"\u003eGlutathione (GSH) in mitochondrial redox balance and oxidative stress research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51621460902154,"sku":"slupp332_200mg","price":290.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/slu-pp332_200mg_9_2.png?v=1768032762"},{"product_id":"5-amino-1mq-50mg","title":"5-Amino-1MQ – High Purity Research Molecule (50mg)","description":"\u003ch2\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. 5-Amino-1MQ is studied in experimental models exploring NNMT-related metabolic pathways and cellular energy regulation. Research interest includes how NAD⁺ availability and metabolic signaling intersect in energy balance and aging-related research.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"1077\" data-start=\"574\"\u003e5-Amino-1MQ is a small-molecule compound that inhibits the enzyme nicotinamide N-methyltransferase (NNMT), a key regulator of cellular energy balance and metabolic pathways, with notable activity in adipose tissue. Inhibition of NNMT has been associated with increased availability of nicotinamide adenine dinucleotide (NAD⁺), an essential cofactor in cellular metabolism, which may influence mitochondrial activity and support NAD⁺-dependent signaling processes, including sirtuin-1 (SIRT1) activation.\u003c\/p\u003e\n\u003cp data-end=\"1648\" data-start=\"1079\"\u003eSIRT1, often studied in the context of metabolic regulation and cellular stress response, has been linked in research literature to pathways relevant to metabolic health, lipid metabolism, and age-associated cellular function. In preclinical research models, modulation of NNMT activity has been examined for its potential effects on adipocyte metabolism and energy utilization under controlled experimental conditions. These findings suggest that altered NNMT signaling may influence fat cell biology and metabolic efficiency without directly affecting caloric intake.\u003c\/p\u003e\n\u003ch3 data-start=\"106\" data-end=\"175\"\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"177\" data-end=\"460\"\u003e\u003cstrong data-start=\"177\" data-end=\"190\"\u003eSynonyms:\u003c\/strong\u003e 5-amino-1-methylquinolinium, SCHEMBL6403148, CHEMBL4116828, ZINC552049, STL196667\u003cbr data-start=\"272\" data-end=\"275\"\u003e\u003cstrong data-start=\"275\" data-end=\"290\"\u003eMolar Mass:\u003c\/strong\u003e 159.21 g\/mol\u003cbr data-start=\"303\" data-end=\"306\"\u003e\u003cstrong data-start=\"306\" data-end=\"321\"\u003eCAS Number:\u003c\/strong\u003e 42464-96-0\u003cbr data-start=\"332\" data-end=\"335\"\u003e\u003cstrong data-start=\"335\" data-end=\"350\"\u003ePubChem ID:\u003c\/strong\u003e 950107\u003cbr data-start=\"357\" data-end=\"360\"\u003e\u003cstrong data-start=\"360\" data-end=\"388\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 6000 mg per container (50 mg per capsule) 2 x 60 capsules\u003cbr data-start=\"430\" data-end=\"433\" data-is-only-node=\"\"\u003e\u003cstrong data-start=\"433\" data-end=\"448\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-start=\"177\" data-end=\"460\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003eResearch context:\u003c\/h3\u003e\n\u003cp\u003e5-Amino-1MQ is commonly referenced in experimental studies investigating NNMT activity, metabolic regulation, and NAD⁺-associated cellular pathways. For a detailed research-focused overview of its mechanisms and experimental context, see:\u003c\/p\u003e\n\u003cp\u003e→\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-5-amino-1mq\"\u003e \u003cstrong\u003eWhat is 5-Amino-1MQ? – Research overview of NNMT-related metabolic pathways\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/nad-metabolism-5-amino-1mq-vs-1-mna\"\u003e5-Amino-1MQ vs 1-MNA in NAD+ metabolism\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e5-Amino-1MQ is frequently studied in the context of metabolic regulation, particularly within research models exploring energy utilization, lipid metabolism, and cellular efficiency.\u003c\/p\u003e\n\u003cp\u003eTo understand how metabolic energy systems and fat metabolism pathways are examined in experimental research:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eLearn how exercise-associated metabolic pathways influence mitochondrial efficiency and cellular energy regulation.\u003cbr\u003e\u003cspan\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"177\" data-end=\"460\"\u003e\u003cstrong\u003e5-Amino-1MQ Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"5-Amino-1MQ structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/5-Amino-1-methylquinolinium.png?v=1755157132\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSources \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5-Amino-1-methylquinolinium\" title=\"PubChem\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1552\" data-end=\"1576\"\u003e\u003cstrong data-start=\"1556\" data-end=\"1576\"\u003eResearch Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1578\" data-end=\"1973\"\u003eNicotinamide N-methyltransferase (NNMT) has been widely studied as a regulator of cellular metabolism and energy balance, with particular relevance in adipose tissue and metabolic signaling pathways. NNMT activity influences the flux of nicotinamide and S-adenosylmethionine (SAM) within the NAD⁺ salvage pathway and methionine cycle, positioning it as an important enzyme in metabolic research.\u003c\/p\u003e\n\u003cp data-start=\"1975\" data-end=\"2385\"\u003eIn laboratory investigations, small-molecule NNMT inhibitors have been evaluated for membrane permeability, selectivity, and biochemical activity. In vitro studies have demonstrated that NNMT inhibition can reduce intracellular levels of 1-methylnicotinamide (1-MNA), while increasing NAD⁺ and SAM availability and modulating lipogenic signaling in cultured adipocytes under controlled experimental conditions.\u003c\/p\u003e\n\u003cp data-start=\"2387\" data-end=\"2784\"\u003ePreclinical research models have further explored the metabolic effects of NNMT modulation, highlighting its role in adipocyte function, lipid metabolism, and systemic energy regulation. These findings have established NNMT inhibition as an active area of investigation in metabolic and cellular energy research, particularly in studies examining NAD⁺-dependent pathways and metabolic homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"2786\" data-end=\"2881\"\u003e\u003cstrong data-start=\"2786\" data-end=\"2813\"\u003eRelated research focus:\u003c\/strong\u003e\u003cbr data-start=\"2813\" data-end=\"2816\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cem data-start=\"2818\" data-end=\"2881\"\u003eNAD⁺ – Research-Grade Compound for cellular energy metabolism\u003c\/em\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-end=\"1501\" data-start=\"1060\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_metabolic_diagram.jpg?v=1758966221\" alt=\"Diagram of metabolic pathways with various chemicals and their interactions on a white background.\" width=\"1590\" height=\"831\"\u003e\u003c\/p\u003e\n\u003cp data-end=\"1537\" data-start=\"1508\"\u003eSource: \u003ca title=\"ScienceDirect_1\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006295217306718\"\u003eScienceDirect\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"3338\" data-start=\"2903\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52963575365898,"sku":"5amino1mq-1","price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52963575398666,"sku":"5amino1mq-2","price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen","offer_id":52963575431434,"sku":"5amino1mq-3","price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/5amino_cap_vial_1.png?v=1777626095"},{"product_id":"bacteriostatic-water-20-ml","title":"Bacteriostatic Water - 20 ml","description":"\u003ch2 data-start=\"525\" data-end=\"609\"\u003e\u003cstrong data-start=\"529\" data-end=\"609\"\u003eBacteriostatic Water (BAC) for Laboratory Reconstitution Workflows\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"611\" data-end=\"989\"\u003eBacteriostatic Water (BAC) is a sterile, laboratory-grade water preparation containing 0.9% benzyl alcohol, a compound that helps inhibit bacterial proliferation inside multi-use vials. Because of this stabilizing effect, BAC is widely used across research laboratories that require reliable reconstitution fluids for peptides, small molecules, and various investigative agents.\u003c\/p\u003e\n\u003cp data-start=\"991\" data-end=\"1355\"\u003eUnlike single-use sterile water, bacteriostatic water maintains its integrity over multiple entries, allowing researchers to withdraw aliquots at different points in an experiment without compromising the remaining volume. This characteristic makes BAC particularly useful in studies where repeated dilution, reagent preparation, or multi-phase setup is necessary.\u003c\/p\u003e\n\u003ch3 data-start=\"1362\" data-end=\"1426\"\u003e\u003cstrong data-start=\"1366\" data-end=\"1426\"\u003eRole in Research Reconstitution and Solution Preparation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1428\" data-end=\"1498\"\u003eIn controlled laboratory environments, BAC is frequently selected for:\u003c\/p\u003e\n\u003cul data-start=\"1500\" data-end=\"1733\"\u003e\n\u003cli data-start=\"1500\" data-end=\"1559\"\u003e\n\u003cp data-start=\"1502\" data-end=\"1559\"\u003ereconstituting peptides and other lyophilized materials\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1560\" data-end=\"1607\"\u003e\n\u003cp data-start=\"1562\" data-end=\"1607\"\u003epreparing dilutions for experimental assays\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1608\" data-end=\"1666\"\u003e\n\u003cp data-start=\"1610\" data-end=\"1666\"\u003esupporting workflows that involve repeated vial access\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1667\" data-end=\"1733\"\u003e\n\u003cp data-start=\"1669\" data-end=\"1733\"\u003emaintaining sterility during multi-step experimental timelines\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1735\" data-end=\"2053\"\u003eIts composition is designed to preserve solution stability, minimize contamination risk, and support reproducibility across multiple experimental runs. Because BAC contains no sodium or buffering components, it provides a neutral base that does not interfere with biochemical signaling pathways or analytical readouts.\u003c\/p\u003e\n\u003ch3 data-start=\"2060\" data-end=\"2111\"\u003e\u003cstrong data-start=\"2064\" data-end=\"2111\"\u003eWhy Researchers Prefer Bacteriostatic Water\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2113\" data-end=\"2233\"\u003eLaboratories working with peptide studies, molecular biology, or metabolic models often rely on BAC because it provides:\u003c\/p\u003e\n\u003cul data-start=\"2235\" data-end=\"2523\"\u003e\n\u003cli data-start=\"2235\" data-end=\"2298\"\u003e\n\u003cp data-start=\"2237\" data-end=\"2298\"\u003e\u003cstrong data-start=\"2237\" data-end=\"2280\"\u003eextended usability within a single vial\u003c\/strong\u003e, reducing waste\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2299\" data-end=\"2363\"\u003e\n\u003cp data-start=\"2301\" data-end=\"2363\"\u003e\u003cstrong data-start=\"2301\" data-end=\"2325\"\u003econsistent sterility\u003c\/strong\u003e, even during multi-access workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2364\" data-end=\"2426\"\u003e\n\u003cp data-start=\"2366\" data-end=\"2426\"\u003e\u003cstrong data-start=\"2366\" data-end=\"2424\"\u003ecompatibility with a broad range of research compounds\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2427\" data-end=\"2523\"\u003e\n\u003cp data-start=\"2429\" data-end=\"2523\"\u003e\u003cstrong data-start=\"2429\" data-end=\"2469\"\u003ea clear, predictable solvent profile\u003c\/strong\u003e that integrates smoothly into established protocols\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2525\" data-end=\"2714\"\u003eThese properties help reduce preparation variability, a critical factor in studies where experimental accuracy depends on maintaining uniform solution conditions from one trial to the next.\u003c\/p\u003e\n\u003ch3 data-start=\"2721\" data-end=\"2772\"\u003e\u003cstrong data-start=\"2725\" data-end=\"2772\"\u003eLaboratory Handling and Application Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2774\" data-end=\"3142\"\u003eAs with all reconstitution materials intended for scientific investigation, bacteriostatic water should be handled according to standard laboratory aseptic techniques. Researchers typically incorporate BAC into workflows involving lyophilized peptides, reference standards, or small-molecule models, ensuring precise concentration control during experimental planning.\u003c\/p\u003e\n\u003cp data-start=\"3144\" data-end=\"3357\"\u003eBAC’s predictable performance and multi-use stability have made it a staple reagent across peptide facilities, molecular research teams, and biochemical laboratories seeking reliability in their preparation steps.\u003c\/p\u003e\n\u003cp data-start=\"3402\" data-end=\"3595\"\u003eTo support a wider range of laboratory workflows, researchers can also explore additional reconstitution materials such as PBS and HBS, along with other ready-to-use solutions available in our Liquid Formulas Collection.\u003c\/p\u003e\n\u003cp data-start=\"3402\" data-end=\"3595\"\u003eLearn \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003ehow bacteriostatic water compares to PBS and HBS in peptide preparation.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51729853284618,"sku":null,"price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/BACwater5.png?v=1760888733"},{"product_id":"phosphate-buffer-pbs-20-ml","title":"Phosphate Buffered Saline (PBS) - 20 ml","description":"\u003ch3 data-start=\"117\" data-end=\"177\"\u003e\u003cstrong data-start=\"121\" data-end=\"175\"\u003eOverview: Phosphate Buffered Saline (PBS)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"179\" data-end=\"470\"\u003ePhosphate Buffered Saline is one of the most commonly used solutions for peptide or small molecule reconstitution in laboratory research. By maintaining a constant pH and osmolarity, PBS provides a controlled environment that preserves the structure and function of biological samples.\u003c\/p\u003e\n\u003cp data-start=\"472\" data-end=\"901\"\u003eIn \u003cstrong data-start=\"475\" data-end=\"500\"\u003ecell culture research\u003c\/strong\u003e, PBS is essential for washing and resuspending cells without causing osmotic stress. In \u003cstrong data-start=\"589\" data-end=\"630\"\u003eprotein and molecular biology studies\u003c\/strong\u003e, it serves as a reliable diluent that minimizes interference in downstream assays. Because of its compatibility with \u003cstrong data-start=\"748\" data-end=\"790\"\u003eenzymes, antibodies, and nucleic acids\u003c\/strong\u003e, PBS is a standard reagent in fields ranging from immunology and biochemistry to microscopy and diagnostics.\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eResearch has consistently demonstrated that PBS’s isotonic properties support reproducibility and reduce variability across experiments, making it an indispensable tool in modern laboratories.\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eSee other buffered saline solution:  \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/histidine-buffered-saline-hbs\"\u003eHistidine Buffered Saline (HBS) - 20 ml\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eNot sure which buffer to use? Explore how \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-start=\"1356\" data-end=\"1424\"\u003ebacteriostatic water compares to PBS and HBS in peptide research\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51729970135306,"sku":null,"price":18.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Phosphate5.png?v=1760888824"},{"product_id":"histidine-buffered-saline-hbs","title":"Histidine Buffered Saline (HBS) - 20 ml","description":"\u003ch3 data-start=\"1130\" data-end=\"1189\"\u003e\u003cstrong data-start=\"1133\" data-end=\"1187\"\u003eOverview: Histidine Buffered Saline (HBS)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1191\" data-end=\"1545\"\u003eHistidine Buffered Saline has become increasingly important in pharmaceutical and protein research and is one of the most commonly used solutions for peptide or small molecule reconstitution because of its effective buffering capacity in the slightly acidic to neutral range. Histidine’s imidazole side chain allows precise pH regulation, making HBS a preferred choice in studies where \u003cstrong data-start=\"1479\" data-end=\"1524\"\u003eprotein stability and biological activity\u003c\/strong\u003e must be preserved.\u003c\/p\u003e\n\u003cp data-start=\"1547\" data-end=\"1861\"\u003eIn \u003cstrong data-start=\"1550\" data-end=\"1583\"\u003epeptide and antibody research\u003c\/strong\u003e, HBS helps maintain molecular integrity by reducing denaturation and aggregation, which can occur in less stable buffers. It has also been applied in \u003cstrong data-start=\"1734\" data-end=\"1757\"\u003eformulation studies\u003c\/strong\u003e, where maintaining consistent conditions is crucial for reproducibility and accurate data collection.\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eComparative research has shown that histidine buffers may outperform phosphate buffers in scenarios involving \u003cstrong data-start=\"1973\" data-end=\"1999\"\u003esensitive biomolecules\u003c\/strong\u003e, particularly when phosphate interference could alter experimental outcomes. For this reason, HBS is widely used in \u003cstrong data-start=\"2116\" data-end=\"2175\"\u003ebiotechnology, immunology, and biochemical laboratories\u003c\/strong\u003e as a reliable, research-grade buffer solution.\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eSee other bufferes saline solution products: \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/phosphate-buffer-pbs-20-ml\"\u003ePhosphate Buffered Saline (PBS) - 20 ml\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eFor guidance on peptide reconstitution and buffer selection, see our detailed comparison of \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-end=\"1092\" data-start=\"1054\"\u003ePBS vs HBS vs bacteriostatic water\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51730117722378,"sku":null,"price":18.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/histide5.png?v=1760888775"},{"product_id":"thymosin-alpha-1-10mg","title":"Thymosin Alpha-1 – High Purity Research Peptide (10mg per vial)","description":"\u003ch3 data-start=\"385\" data-end=\"402\"\u003e\u003cstrong data-start=\"388\" data-end=\"400\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Thymosin Alpha-1 is commonly studied in research models examining immune signaling, inflammatory balance, and cellular resilience under physiological stress, including contexts related to tissue recovery and regeneration-supportive processes.\u003cstrong data-start=\"388\" data-end=\"400\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"403\" data-end=\"853\"\u003eThymosin Alpha-1 is a synthetic version of a naturally occurring thymic peptide that plays a critical role in immune regulation. It works by stimulating T-cell production and activity, enhancing the body’s ability to respond to pathogens and modulate inflammatory processes. Preclinical and clinical research has investigated its potential in managing immune deficiencies, chronic infections, cancer immunotherapy, and vaccine response enhancement.\u003c\/p\u003e\n\u003cp data-start=\"855\" data-end=\"1019\"\u003eBeyond its immune functions, emerging research suggests Tα1 may also impact neurodevelopment and cognitive performance through immune–nervous system interactions.\u003c\/p\u003e\n\u003ch3 data-start=\"268\" data-end=\"296\"\u003ePrimary research pairing\u003c\/h3\u003e\n\u003cp data-start=\"298\" data-end=\"506\"\u003eIn experimental and laboratory research settings, \u003cstrong data-start=\"348\" data-end=\"368\"\u003eThymosin Alpha 1\u003c\/strong\u003e is frequently examined alongside peptides involved in \u003cstrong data-start=\"423\" data-end=\"505\"\u003eimmune signaling, cellular regulation, and tissue-associated response pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"508\" data-end=\"676\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-10mg-per-vial\"\u003e\u003cstrong data-start=\"510\" data-end=\"528\"\u003eBPC-157 (vial)\u003c\/strong\u003e – peptide-mediated cellular signaling and tissue-related research\u003c\/a\u003e\u003cbr data-start=\"594\" data-end=\"597\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"599\" data-end=\"616\"\u003eTB-500 (vial)\u003c\/strong\u003e – cytoskeletal regulation and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"683\" data-end=\"740\"\u003eNeuroimmune and regulatory signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"742\" data-end=\"920\"\u003eSome experimental models explore \u003cstrong data-start=\"775\" data-end=\"795\"\u003eThymosin Alpha 1\u003c\/strong\u003e in parallel with compounds studied for \u003cstrong data-start=\"835\" data-end=\"919\"\u003eneuroimmune signaling, stress-response pathways, and regulatory peptide activity\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"922\" data-end=\"994\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/selank-peptide-25-mg\"\u003e\u003cstrong data-start=\"924\" data-end=\"934\"\u003eSelank\u003c\/strong\u003e – regulatory peptide and neurochemical signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1001\" data-end=\"1048\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1050\" data-end=\"1225\"\u003eCertain research discussions reference \u003cstrong data-start=\"1089\" data-end=\"1109\"\u003eThymosin Alpha 1\u003c\/strong\u003e alongside alternative peptide formats when evaluating \u003cstrong data-start=\"1164\" data-end=\"1224\"\u003edelivery considerations and experimental exposure models\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1227\" data-end=\"1291\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1229\" data-end=\"1251\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1026\" data-end=\"1043\"\u003e\u003cstrong data-start=\"1029\" data-end=\"1041\"\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1044\" data-end=\"1209\"\u003eAnimal studies have demonstrated that peripheral administration of Thymosin Alpha-1 can improve cognitive abilities early in life. In neonatal mice, Tα1 treatment:\u003c\/p\u003e\n\u003cul data-start=\"1211\" data-end=\"1865\"\u003e\n\u003cli data-start=\"1211\" data-end=\"1387\"\u003e\n\u003cp data-start=\"1213\" data-end=\"1387\"\u003e\u003cstrong data-start=\"1213\" data-end=\"1239\"\u003ePromoted Neurogenesis:\u003c\/strong\u003e Increased populations of hippocampal neural progenitors and differentiated neurons (BrdU+, nestin+, Tbr2+, BrdU+\/DCX+, BrdU+\/Iba1+, BrdU+\/NeuN+).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1388\" data-end=\"1545\"\u003e\n\u003cp data-start=\"1390\" data-end=\"1545\"\u003e\u003cstrong data-start=\"1390\" data-end=\"1423\"\u003eBoosted Neurotrophic Factors:\u003c\/strong\u003e Elevated brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and insulin-like growth factor-1 (IGF-1).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1546\" data-end=\"1643\"\u003e\n\u003cp data-start=\"1548\" data-end=\"1643\"\u003e\u003cstrong data-start=\"1548\" data-end=\"1573\"\u003eReduced Inflammation:\u003c\/strong\u003e Lowered IL-6 and TNF-α, while increasing IL-4 and interferon-gamma.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1644\" data-end=\"1748\"\u003e\n\u003cp data-start=\"1646\" data-end=\"1748\"\u003e\u003cstrong data-start=\"1646\" data-end=\"1674\"\u003eInduced Th1 Immune Bias:\u003c\/strong\u003e Positive link between neurotrophic factor expression and Th1\/Th2 ratio.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1749\" data-end=\"1865\"\u003e\n\u003cp data-start=\"1751\" data-end=\"1865\"\u003e\u003cstrong data-start=\"1751\" data-end=\"1780\"\u003eProvided Neuroprotection:\u003c\/strong\u003e Prevented lipopolysaccharide (LPS)-induced disruption of hippocampal neurogenesis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003eThese findings indicate that Tα1 may exert neuroprotective and cognitive benefits by modulating systemic immunity and enhancing neuronal growth factors.\u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e\u003cem data-start=\"269\" data-end=\"380\"\u003eLearn more about the scientific background and research applications of Thymosin Alpha-1 in our full article. \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/thymosin-alpha-1-mechanisms\" title=\"thymosin alpha1 benefits\"\u003e➜ \u003c\/a\u003e\u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/thymosin-alpha-1-mechanisms\" title=\"thymosin alpha1 benefits\"\u003e\u003cstrong data-start=\"400\" data-end=\"478\"\u003eThymosin Alpha-1: Mechanisms, Immune Modulation, and Research Applications\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on immune signaling, cellular balance, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRecent research explores how Thymosin α1 may influence iron regulation pathways, including hepcidin signaling and dopamine-related mechanisms in neurodevelopmental conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/adhd-iron-dysregulation-hepcidin-dopamine\"\u003e\u003cstrong\u003eRead the ADHD iron dysregulation research article\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eThymosin Alpha-1 in Immune and Gut Signaling Research\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThymosin Alpha-1 is studied in research models focused on immune signaling, cytokine regulation, and system-level coordination. Within gut-associated environments, it is examined in relation to how immune responses align with local cellular conditions.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo explore how TA1 is positioned alongside KPV and BPC-157 in gut and inflammation research:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"97\" data-end=\"149\"\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003eThymosin Alpha-1 10mg – Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"150\" data-end=\"336\"\u003e\u003cstrong data-start=\"150\" data-end=\"163\"\u003eSynonyms:\u003c\/strong\u003e Thymalfasin\u003cbr data-start=\"175\" data-end=\"178\"\u003e\u003cstrong data-start=\"178\" data-end=\"193\"\u003eMolar Mass:\u003c\/strong\u003e 3108.28 g\/mol\u003cbr data-start=\"207\" data-end=\"210\"\u003e\u003cstrong data-start=\"210\" data-end=\"225\"\u003eCAS Number:\u003c\/strong\u003e 62304-98-7\u003cbr data-start=\"236\" data-end=\"239\"\u003e\u003cstrong data-start=\"239\" data-end=\"251\"\u003ePubChem:\u003c\/strong\u003e 16130571\u003cbr data-start=\"260\" data-end=\"263\"\u003e\u003cstrong data-start=\"263\" data-end=\"291\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-start=\"306\" data-end=\"309\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"97\" data-end=\"149\"\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003eThymosin Alpha-1 \u003cspan\u003eStructures:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Thymalfasin.png?v=1755185016\" alt=\"Thymosin Alpha-1 Structures\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/16130571\" title=\"PubChem_Thymosin Alpha 1\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52192218677514,"sku":"thymosinalpha1_10mg-1","price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52192218710282,"sku":"thymosinalpha1_10mg-2","price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/thymosinalpha-1_10mg.png?v=1764412645"},{"product_id":"ss-31-50mg-per-vial","title":"SS-31 50mg – Research Peptide","description":"\u003ch2 data-start=\"338\" data-end=\"354\"\u003e\u003cstrong data-start=\"342\" data-end=\"354\"\u003eOverview\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. SS-31 is studied in experimental systems focused on mitochondrial stability, oxidative stress modulation, and cellular energy preservation. Research models examine its role in maintaining mitochondrial efficiency under stress conditions.\u003cstrong data-start=\"342\" data-end=\"354\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"442\" data-start=\"400\"\u003ePrimary mitochondrial research pairing\u003c\/h3\u003e\n\u003cp data-end=\"649\" data-start=\"444\"\u003eIn experimental and laboratory research settings, SS-31 (Elamipretide) is examined either as a standalone mitochondrial-targeting compound or within specific growth hormone–related research models.\u003c\/p\u003e\n\u003ch3 data-end=\"711\" data-start=\"656\"\u003eGrowth hormone–related research context\u003c\/h3\u003e\n\u003cp data-end=\"848\" data-start=\"713\"\u003eSome experimental frameworks explore SS-31 alongside compounds involved in GHRH-mediated metabolic and mitochondrial signaling.\u003c\/p\u003e\n\u003cp data-end=\"935\" data-start=\"850\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-end=\"871\" data-start=\"852\"\u003eCJC-1295\u003c\/strong\u003e – GHRH-related metabolic and mitochondrial signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"999\" data-start=\"942\"\u003eAlternative GH-axis research context \u003c\/h3\u003e\n\u003cp data-end=\"1142\" data-start=\"1001\"\u003eOther experimental models reference SS-31 in parallel with compounds studied for GH-axis modulation without long-acting GHRH analogs.\u003c\/p\u003e\n\u003cp data-end=\"1271\" data-start=\"1144\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-end=\"1161\" data-start=\"1146\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-end=\"1208\" data-start=\"1205\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-end=\"1224\" data-start=\"1210\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1349\" data-start=\"1278\"\u003eMitochondrial and cellular energy research context \u003c\/h3\u003e\n\u003cp data-end=\"1559\" data-start=\"1351\"\u003eIn research frameworks not centered on growth hormone signaling, SS-31 is commonly examined alongside compounds involved in mitochondrial efficiency, cellular energy balance, and metabolic regulation.\u003c\/p\u003e\n\u003cp data-end=\"1726\" data-start=\"1561\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-end=\"1577\" data-start=\"1563\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic efficiency research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1790\" data-start=\"1733\"\u003eRedox balance and metabolic cofactor research context\u003c\/h3\u003e\n\u003cp data-end=\"1943\" data-start=\"1792\"\u003eSome experimental discussions reference SS-31 alongside compounds examined for oxidative stress regulation and intracellular redox homeostasis.\u003c\/p\u003e\n\u003cp data-end=\"2080\" data-start=\"1945\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"1964\" data-start=\"1947\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003cbr data-end=\"2010\" data-start=\"2007\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-end=\"2027\" data-start=\"2012\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2146\" data-start=\"2087\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-end=\"2293\" data-start=\"2148\"\u003eIn specialized experimental models, SS-31 may be referenced alongside compounds studied for neurotrophic signaling and synaptic function.\u003c\/p\u003e\n\u003cp data-end=\"2356\" data-start=\"2295\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-end=\"2307\" data-start=\"2297\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2410\" data-start=\"2363\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-end=\"2576\" data-start=\"2412\"\u003eCertain research discussions reference SS-31 alongside alternative peptide formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-end=\"2642\" data-start=\"2578\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-end=\"2602\" data-start=\"2580\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"356\" data-end=\"715\"\u003eSS-31 peptide has been FDA-approved in 2025 for treating Barth syndrome, a rare mitochondrial disorder, by improving cardiac function and exercise tolerance in affected patients.\u003cbr data-start=\"526\" data-end=\"529\"\u003eIn clinical trials, SS-31 peptide demonstrates potential to alleviate symptoms of primary mitochondrial diseases, including fatigue and muscle weakness, by enhancing mitochondrial bioenergetics.\u003c\/p\u003e\n\u003ch3 data-start=\"722\" data-end=\"769\"\u003e\u003cstrong data-start=\"726\" data-end=\"769\"\u003eClinical Research Settings and Benefits\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"771\" data-end=\"947\"\u003eFor patients with heart failure, SS-31 shows promise in reducing cardiac ischemia-reperfusion injury and improving overall heart function through mitochondrial stabilization.\u003c\/p\u003e\n\u003cp data-start=\"949\" data-end=\"1117\"\u003eSS-31 may benefit individuals with renal diseases by protecting against kidney ischemia-reperfusion damage, potentially slowing progression of chronic kidney disease.\u003c\/p\u003e\n\u003cp data-start=\"1119\" data-end=\"1313\"\u003eIn neurodegenerative conditions like Alzheimer’s and Parkinson’s, preclinical and early clinical data suggest SS-31 could mitigate neuronal damage by reducing oxidative stress in mitochondria.\u003c\/p\u003e\n\u003cp data-start=\"1315\" data-end=\"1466\"\u003eAging-related frailty may be addressed by SS-31, as studies indicate it improves skeletal muscle function and reduces inflammation in elderly models.\u003c\/p\u003e\n\u003cp data-start=\"1468\" data-end=\"1777\"\u003eSS-31 holds potential for treating orphan cardiomyopathies, where it supports mitochondrial integrity to enhance cardiac output and patient quality of life. Clinical trials have demonstrated that elamipretide can improve myocardial ischemia-reperfusion injury and reduce complications after cardiac surgery.\u003c\/p\u003e\n\u003cp data-start=\"1779\" data-end=\"2355\"\u003eFor cognitive decline associated with aging, SS-31’s ability to restore mitochondrial health may improve brain function and memory in clinical settings.\u003cbr data-start=\"1931\" data-end=\"1934\"\u003eSS-31 not only protects mitochondrial function but also plays a role in regulating the apoptotic process. It promotes cell survival by inhibiting endogenous apoptotic signals and delaying cell apoptosis. This property makes Elamipretide show potential in the study of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease because these diseases are often accompanied by abnormal cell apoptosis.\u003c\/p\u003e\n\u003cp data-start=\"2357\" data-end=\"2903\"\u003eIn models of dry age-related macular degeneration, SS-31 has shown efficacy in preserving retinal function by targeting mitochondrial dysfunction in ocular cells.\u003cbr data-start=\"2519\" data-end=\"2522\"\u003eSlow photoreceptor degeneration by preserving EZ (Ellipsoid Zone) integrity. Improve low-luminance vision and reduce GA (Geographic Atrophy) progression (though not statistically significant in Phase 2 primaries). Mitigate oxidative stress and apoptosis in RPE cells (Retinal Pigment Epithelium Cell), potentially delaying vision loss. Offer neuroprotection without cytotoxicity.\u003c\/p\u003e\n\u003cp data-start=\"2905\" data-end=\"3086\"\u003eOverall, SS-31’s broad therapeutic potential extends to metabolic disorders, where it could enhance energy production and insulin sensitivity by optimizing mitochondrial efficiency.\u003c\/p\u003e\n\u003ch3 data-start=\"3093\" data-end=\"3130\"\u003e\u003cstrong data-start=\"3097\" data-end=\"3130\"\u003eMolecular Mechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3132\" data-end=\"3527\"\u003eSS-31 peptide, a synthetic tetrapeptide, selectively targets mitochondria by binding to cardiolipin in the inner mitochondrial membrane through hydrophobic interactions with acyl chains and electrostatic interactions with phosphate head groups.\u003cbr data-start=\"3368\" data-end=\"3371\"\u003eThis binding concentrates SS-31 in the inner membrane, stabilizing cristae morphology and optimizing the organization of respiratory chain supercomplexes.\u003c\/p\u003e\n\u003cp data-start=\"3529\" data-end=\"3840\"\u003eSS-31 peptide interacts with subunits of oxidative phosphorylation complexes, such as complex III (QCR2 and QCR6), complex IV (NDUA4), and complex V (ATPA and ATPB), near their cardiolipin-binding sites. These interactions enhance electron transport efficiency and reduce hydrogen peroxide production in mitochondria.\u003c\/p\u003e\n\u003cp data-start=\"3842\" data-end=\"4010\"\u003eBy binding to ADP\/ATP translocase (ADT1) in its matrix-open state, SS-31 prevents proton leak through charge repulsion while improving ADP sensitivity and ATP export.\u003c\/p\u003e\n\u003cp data-start=\"4012\" data-end=\"4175\"\u003eSS-31 also binds to creatine kinase S-type near cardiolipin-binding residues, supporting mitochondrial structural integrity and phosphocreatine energy buffering.\u003c\/p\u003e\n\u003cp data-start=\"4177\" data-end=\"4340\"\u003eIn fatty acid β-oxidation, SS-31 interacts with the trifunctional enzyme subunit ECHA near its active site, potentially rescuing proton leak in deficient models.\u003c\/p\u003e\n\u003cp data-start=\"4342\" data-end=\"4678\"\u003eFor 2-oxoglutarate metabolism, SS-31 binds to isocitrate dehydrogenase at sites that may regulate enzymatic activity and NADPH production via electrostatic effects.\u003cbr data-start=\"4506\" data-end=\"4509\"\u003eAdditional interactions with 2-oxoglutarate dehydrogenase complex subunits and aspartate aminotransferase suggest SS-31 modulates TCA cycle flux and redox homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"4680\" data-end=\"4846\"\u003eOverall, these molecular interactions reduce reactive oxygen species, improve bioenergetics, and mitigate mitochondrial dysfunction at the protein and membrane level.\u003c\/p\u003e\n\u003ch3 data-start=\"1976\" data-end=\"2004\"\u003e\u003cstrong data-start=\"1979\" data-end=\"2002\"\u003eSS-31 Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"2005\" data-end=\"2315\"\u003e\n\u003cli data-start=\"2005\" data-end=\"2050\"\u003e\n\u003cp data-start=\"2007\" data-end=\"2050\"\u003e\u003cstrong data-start=\"2007\" data-end=\"2020\"\u003eSequence:\u003c\/strong\u003e D-Arg-Tyr(2,6-diMe)-Lys-Phe\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2051\" data-end=\"2088\"\u003e\n\u003cp data-start=\"2053\" data-end=\"2088\"\u003e\u003cstrong data-start=\"2053\" data-end=\"2075\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₄₉N₉O₅\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2089\" data-end=\"2126\"\u003e\n\u003cp data-start=\"2091\" data-end=\"2126\"\u003e\u003cstrong data-start=\"2091\" data-end=\"2112\"\u003eMolecular Weight:\u003c\/strong\u003e 639.8 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2127\" data-end=\"2156\"\u003e\n\u003cp data-start=\"2129\" data-end=\"2156\"\u003e\u003cstrong data-start=\"2129\" data-end=\"2145\"\u003ePubChem CID:\u003c\/strong\u003e 11764719\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2157\" data-end=\"2188\"\u003e\n\u003cp data-start=\"2159\" data-end=\"2188\"\u003e\u003cstrong data-start=\"2159\" data-end=\"2174\"\u003eCAS Number:\u003c\/strong\u003e 736992-21-5\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2189\" data-end=\"2238\"\u003e\n\u003cp data-start=\"2191\" data-end=\"2238\"\u003e\u003cstrong data-start=\"2191\" data-end=\"2204\"\u003eSynonyms:\u003c\/strong\u003e elamipretide, MTP-131, Bendavia\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2239\" data-end=\"2285\"\u003e\n\u003cp data-start=\"2241\" data-end=\"2285\"\u003e\u003cstrong data-start=\"2241\" data-end=\"2269\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 50 mg per vial\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eResearch background \u0026amp; scientific overview:\u003c\/strong\u003e\u003cbr data-start=\"749\" data-end=\"752\"\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ss-31-peptide\" title=\"ss 31 research article\"\u003eSS-31 (Elamipretide): Mitochondrial research mechanisms and study background\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"ss-31 50 mg strucutre\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Elamipretide.png?v=1755186474\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11764719\" title=\"PubChem_SS-31\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1754\" data-end=\"2029\"\u003e\u003cstrong data-start=\"104\" data-end=\"174\"\u003e \u003c\/strong\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51972266721546,"sku":"ss31_50mg-1","price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ss-31_50mg_7_pen.png?v=1760890668"},{"product_id":"epithalon-50mg","title":"Epithalon 50mg – High Purity Longevity Research Peptide","description":"\u003ch3 data-start=\"408\" data-end=\"892\"\u003e\u003cstrong data-start=\"408\" data-end=\"420\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"408\" data-end=\"892\"\u003e\u003cbr data-start=\"420\" data-end=\"423\"\u003eEpithalon (Ala-Glu-Asp-Gly) is a laboratory-synthesized analogue of epithalamin, a naturally occurring peptide secreted by the pineal gland. It has been studied for its unique ability to stimulate telomerase activity, an enzyme that rebuilds telomeres — protective caps at the ends of chromosomes that naturally shorten with age. By supporting telomere maintenance, Epithalon may help delay cellular senescence, contributing to healthier aging at the molecular level.\u003c\/p\u003e\n\u003cp data-start=\"894\" data-end=\"1203\"\u003eBeyond telomere regulation, research suggests Epithalon can enhance antioxidant activity, normalize circadian rhythm regulation, and promote optimal immune and endocrine function. These combined effects make it a compound of interest in the fields of anti-aging, regenerative medicine, and metabolic health.\u003c\/p\u003e\n\u003ch3 data-start=\"1210\" data-end=\"1695\"\u003e\u003cstrong data-start=\"1210\" data-end=\"1222\"\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1210\" data-end=\"1695\"\u003e\u003cbr data-start=\"1222\" data-end=\"1225\"\u003eOver several decades, both preclinical and limited clinical studies have investigated Epithalon’s biological effects. Laboratory research has demonstrated that it can activate telomerase and maintain telomere length in cultured cells, potentially reversing some age-related cellular changes. In animal models, Epithalon administration has been associated with increased lifespan, improved immune system responsiveness, and normalization of hormonal secretion patterns.\u003c\/p\u003e\n\u003cp data-start=\"1697\" data-end=\"2250\"\u003eStudies also indicate its antioxidant properties, including the ability to reduce lipid peroxidation and oxidative stress markers. These benefits may result from improved mitochondrial efficiency and gene expression modulation linked to stress resistance and longevity. Furthermore, Epithalon has been explored for its potential role in restoring circadian rhythms and regulating melatonin secretion, both of which decline with age. While these results are promising, larger-scale human trials are needed to fully confirm its therapeutic applications.\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2257\" data-end=\"2280\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2283\" data-end=\"2296\"\u003eSynonyms:\u003c\/strong\u003e 307297-39-8, Epithalon, Epithalone, UNII-O65P17785G, alanyl-glutamyl-aspartyl-glycine\u003cbr data-start=\"2382\" data-end=\"2385\"\u003e\u003cstrong data-start=\"2385\" data-end=\"2407\"\u003eMolecular Formula:\u003c\/strong\u003e C14H22N4O9\u003cbr data-start=\"2418\" data-end=\"2421\"\u003e\u003cstrong data-start=\"2421\" data-end=\"2436\"\u003eMolar Mass:\u003c\/strong\u003e 390.35 g\/mol\u003cbr data-start=\"2449\" data-end=\"2452\"\u003e\u003cstrong data-start=\"2452\" data-end=\"2467\"\u003eCAS Number:\u003c\/strong\u003e 307297-40-1\u003cbr data-start=\"2479\" data-end=\"2482\"\u003e\u003cstrong data-start=\"2482\" data-end=\"2494\"\u003ePubChem:\u003c\/strong\u003e 219042\u003cbr data-start=\"2501\" data-end=\"2504\"\u003e\u003cstrong data-start=\"2504\" data-end=\"2532\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 50 mg (1 vial)\u003cbr data-start=\"2547\" data-end=\"2550\"\u003e\u003cstrong data-start=\"2550\" data-end=\"2565\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003eEpithalon \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Epitalon.png?v=1755244759\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/219042\" title=\"PubChem_Epithalon\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000856568074,"sku":"epithalon50mg-1","price":215.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000856600842,"sku":"epithalon50mg-2","price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/epithalon_50mg_4.png?v=1778072674"},{"product_id":"bpc-157-tb-500-blend","title":"BPC-157 + TB-500  – Blend ( 10mg + 10mg )","description":"\u003ch3\u003e\u003cstrong\u003eGlow Blend Overview: \u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The BPC-157 and TB-500 combination is studied in experimental systems exploring complementary tissue signaling, cellular migration, and recovery-adjacent pathways. Research models often examine how these peptides interact within broader regeneration frameworks.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157 (10mg)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA synthetic pentadecapeptide with 15 amino acids, derived from a naturally occurring protein in gastric juice. Known in research for its potential to accelerate healing, promote angiogenesis, and support gastrointestinal and musculoskeletal recovery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500 (10mg)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA synthetic fragment of the naturally occurring thymosin beta-4 protein. Studied for its role in promoting tissue repair, reducing inflammation, and aiding recovery from injuries by enhancing cell migration and blood vessel formation.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e has demonstrated healing benefits in animal studies by modulating VEGFR2 activity, activating FAK–paxillin signaling, and enhancing nitric oxide pathways, leading to improved angiogenesis, fibroblast migration, and epithelial repair. Preclinical results show accelerated recovery in muscle, tendon, ligament, and intestinal injuries.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e acts as a potent regulator of cell movement by binding to actin, facilitating tissue regeneration through VEGF upregulation and reduced inflammatory cytokines. It has been investigated for applications ranging from cardiac repair to dermal wound closure, particularly in chronic or slow-healing injuries.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eLearn more about combined peptide recovery mechanisms - \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of why these peptides are often studied together, see:\u003cstrong\u003e\u003cbr data-end=\"886\" data-start=\"883\"\u003e\u003ca title=\"bpc-157-tb-500-together\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\"\u003e\u003cstrong data-end=\"956\" data-start=\"888\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eProduct Description: \u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3\u003e\n\u003cstrong\u003eName:\u003c\/strong\u003e \u003cstrong\u003eBPC-157 + TB-500  Blend (10mg + 10mg)\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e:\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 137525-51-0\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolar Mass:\u003c\/strong\u003e 1419.556 g\/mol\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C62H98N16O22\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e:\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 77591-33-4\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolar Mass:\u003c\/strong\u003e 4963.44 g\/mol\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C212H350N56O78S\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251892941066,"sku":"bpc157_tb500_10mg-1","price":170.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251892973834,"sku":"bpc157_tb500_10mg-2","price":195.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/bpc157_tb500_10_10_1.png?v=1765457237"},{"product_id":"bpc-157-10mg-per-vial","title":"BPC-157 10mg – High Purity Research Peptide","description":"\u003ch3 data-end=\"806\" data-start=\"789\"\u003e\u003cstrong data-end=\"804\" data-start=\"792\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. BPC-157 is widely studied in experimental models focused on tissue signaling, structural integrity, and recovery-related cellular pathways. It is commonly examined in research exploring how biological systems respond to injury and regeneration signals.\u003cstrong data-end=\"804\" data-start=\"792\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"176\" data-end=\"221\"\u003ePrimary tissue-signaling research pairing\u003c\/h3\u003e\n\u003cp data-start=\"223\" data-end=\"440\"\u003eIn experimental and laboratory research settings, BPC-157 is frequently examined alongside peptides involved in cellular signaling, extracellular matrix interactions, and tissue-associated regulatory pathways.\u003c\/p\u003e\n\u003cp data-start=\"442\" data-end=\"616\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ghk-cu-50-mg\"\u003e\u003cstrong data-start=\"444\" data-end=\"454\"\u003eGHK-Cu\u003c\/strong\u003e – copper peptide research focused on cellular communication and matrix-related signaling\u003c\/a\u003e\u003cbr data-start=\"543\" data-end=\"546\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"548\" data-end=\"558\"\u003eTB-500\u003c\/strong\u003e – cytoskeletal dynamics and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"623\" data-end=\"674\"\u003eImmune and cellular regulation research context\u003c\/h3\u003e\n\u003cp data-start=\"676\" data-end=\"837\"\u003eSome experimental models explore BPC-157 in parallel with compounds studied for immune modulation, cellular resilience, and regulatory peptide signaling.\u003c\/p\u003e\n\u003cp data-start=\"839\" data-end=\"914\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/thymosin-alpha-1-10mg\"\u003e\u003cstrong data-start=\"841\" data-end=\"861\"\u003eThymosin Alpha 1\u003c\/strong\u003e – immune-related and regulatory signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"921\" data-end=\"980\"\u003eRedox balance and cellular environment research context\u003c\/h3\u003e\n\u003cp data-start=\"982\" data-end=\"1132\"\u003eAdditional research frameworks reference BPC-157 alongside compounds examined for oxidative stress regulation and intracellular redox balance.\u003c\/p\u003e\n\u003cp data-start=\"1134\" data-end=\"1198\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1136\" data-end=\"1153\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1205\" data-end=\"1264\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"1266\" data-end=\"1446\"\u003eIn specialized experimental discussions, BPC-157 may be referenced alongside compounds studied for neurotrophic signaling and higher-order molecular communication pathways.\u003c\/p\u003e\n\u003cp data-start=\"1448\" data-end=\"1509\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"1450\" data-end=\"1460\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1516\" data-end=\"1563\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1565\" data-end=\"1723\"\u003eCertain research discussions reference BPC-157 alongside alternative formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-start=\"1725\" data-end=\"1789\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1727\" data-end=\"1749\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"390\" data-start=\"50\"\u003eBPC-157, short for Body Protection Compound-157, is a peptide fragment derived from a naturally occurring body protection compound (BPC) found in human gastric juice. This protein plays an important role in safeguarding the gastrointestinal lining from damage, supporting tissue repair, and stimulating the formation of new blood vessels.\u003c\/p\u003e\n\u003cp data-end=\"634\" data-start=\"392\"\u003eSynthetic BPC-157 is a pentadecapeptide made up of 15 amino acids, isolated from the larger parent BPC protein. Research indicates that it retains many of the parent compound’s regenerative properties. Studies suggest BPC-157 may influence:\u003c\/p\u003e\n\u003cul data-end=\"905\" data-start=\"636\"\u003e\n\u003cli data-end=\"677\" data-start=\"636\"\u003e\n\u003cp data-end=\"677\" data-start=\"638\"\u003eWound healing and tissue regeneration\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"719\" data-start=\"678\"\u003e\n\u003cp data-end=\"719\" data-start=\"680\"\u003eAngiogenesis (blood vessel formation)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"747\" data-start=\"720\"\u003e\n\u003cp data-end=\"747\" data-start=\"722\"\u003eThe coagulation process\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"775\" data-start=\"748\"\u003e\n\u003cp data-end=\"775\" data-start=\"750\"\u003eNitric oxide production\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"804\" data-start=\"776\"\u003e\n\u003cp data-end=\"804\" data-start=\"778\"\u003eImmune system modulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"824\" data-start=\"805\"\u003e\n\u003cp data-end=\"824\" data-start=\"807\"\u003eGene expression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"905\" data-start=\"825\"\u003e\n\u003cp data-end=\"905\" data-start=\"827\"\u003eHormonal regulation, particularly within the gastrointestinal nervous system\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"1479\" data-start=\"1462\"\u003e\u003cstrong data-end=\"1477\" data-start=\"1465\"\u003eBPC-157 Peptide Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1531\" data-start=\"1480\"\u003ePreclinical animal studies on BPC-157 have shown:\u003c\/p\u003e\n\u003cul data-end=\"2446\" data-start=\"1532\"\u003e\n\u003cli data-end=\"1692\" data-start=\"1532\"\u003e\n\u003cp data-end=\"1692\" data-start=\"1534\"\u003e\u003cstrong data-end=\"1558\" data-start=\"1534\"\u003eAccelerated Healing:\u003c\/strong\u003e Enhanced repair of muscle, tendon, ligament, bone, and skin injuries, including burns, via increased blood flow to damaged tissues.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1910\" data-start=\"1693\"\u003e\n\u003cp data-end=\"1910\" data-start=\"1695\"\u003e\u003cstrong data-end=\"1727\" data-start=\"1695\"\u003eGastrointestinal Protection:\u003c\/strong\u003e Prevention and reversal of gastric ulcers, protection against NSAID-induced damage, and improvement in inflammatory bowel conditions such as Crohn’s disease and ulcerative colitis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2085\" data-start=\"1911\"\u003e\n\u003cp data-end=\"2085\" data-start=\"1913\"\u003e\u003cstrong data-end=\"1951\" data-start=\"1913\"\u003eAngiogenesis \u0026amp; Collagen Synthesis:\u003c\/strong\u003e Significant upregulation of angiogenic factors and stimulation of fibroblasts and macrophages, leading to robust tissue remodeling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2252\" data-start=\"2086\"\u003e\n\u003cp data-end=\"2252\" data-start=\"2088\"\u003e\u003cstrong data-end=\"2108\" data-start=\"2088\"\u003eNeuroprotection:\u003c\/strong\u003e Evidence of protective effects against certain types of nervous system injury, including potential benefits in traumatic brain injury models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2446\" data-start=\"2253\"\u003e\n\u003cp data-end=\"2446\" data-start=\"2255\"\u003e\u003cstrong data-end=\"2275\" data-start=\"2255\"\u003eSystemic Action:\u003c\/strong\u003e Unlike many peptides, BPC-157 appears to exert benefits both locally and systemically, including the modulation of nitric oxide pathways and oxidative stress responses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003eThese findings highlight BPC-157’s potential as a versatile regenerative peptide with wide-ranging applications in injury recovery and organ protection. Further human studies are needed to confirm its efficacy and safety in clinical settings.\u003c\/p\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"418\" data-end=\"447\"\u003eFurther research reading:\u003c\/h3\u003e\n\u003cp data-start=\"449\" data-end=\"677\"\u003eCurious to explore the research background of BPC-157 beyond the product specifications?\u003cbr data-start=\"537\" data-end=\"540\"\u003eOur \u003cstrong data-start=\"544\" data-end=\"566\"\u003e“What Is BPC-157?”\u003c\/strong\u003e article provides an overview of its origin, molecular characteristics, and commonly studied research contexts.\u003c\/p\u003e\n\u003cp data-start=\"679\" data-end=\"721\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-bpc-157\"\u003e\u003cstrong data-start=\"681\" data-end=\"721\"\u003eWhat Is BPC-157? – Research Overview\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"723\" data-end=\"933\"\u003eResearchers comparing different laboratory formats may also find value in our analysis of \u003cstrong data-start=\"813\" data-end=\"863\"\u003eoral versus injectable BPC-157 research models\u003c\/strong\u003e, outlining how these formats are referenced in experimental settings.\u003c\/p\u003e\n\u003cp data-start=\"935\" data-end=\"991\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-oral-versus-injection-best-method\"\u003e\u003cstrong data-start=\"937\" data-end=\"991\"\u003eBPC-157: Oral vs Injection – Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003cstrong data-start=\"937\" data-end=\"991\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"935\" data-end=\"991\"\u003eLearn more about how BPC-157 is studied alongside other peptides in \u003cstrong\u003emuscle and tendon recovery research\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003e➝ \u003ca title=\"peptides for muscle recovery\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle and Tendon Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"1001\" data-start=\"809\"\u003eResearchers interested in how BPC-157 is evaluated in comparative peptide research may also find value in our overview of its relationship with other regenerative peptides, including TB-500.\u003c\/p\u003e\n\u003cp data-end=\"1078\" data-start=\"1008\"\u003e→ \u003ca title=\"bpc 157 peptide and tb 500\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\"\u003e\u003cstrong data-end=\"1078\" data-start=\"1010\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBPC-157 is commonly studied in experimental models involving angiogenesis, vascular signaling, and soft tissue repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo understand how it compares with matrix-focused peptides, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-vs-bpc-157\"\u003eGHK-Cu vs BPC-157: Tissue Repair, Angiogenesis, and Peptide Signaling\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eExplore BPC-157 in Gut Research Context\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eBPC-157 is frequently referenced in experimental research exploring tissue response, structural signaling, and epithelial integrity. In gut-associated models, it is studied in relation to cellular organization and how tissues adapt within dynamic signaling environments.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo understand how BPC-157 fits into broader gut and immune-related research systems:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"222\" data-start=\"178\"\u003e\u003cstrong data-end=\"220\" data-start=\"181\"\u003eBPC-157 10 mg – Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cstrong data-end=\"236\" data-start=\"223\"\u003eSynonyms:\u003c\/strong\u003e PL 14736\u003cbr data-end=\"248\" data-start=\"245\"\u003e\u003cstrong data-end=\"263\" data-start=\"248\"\u003eMolar Mass:\u003c\/strong\u003e 1419.5 g\/mol\u003cbr data-end=\"279\" data-start=\"276\"\u003e\u003cstrong data-end=\"294\" data-start=\"279\"\u003eCAS Number:\u003c\/strong\u003e 137525-51-0\u003cbr data-end=\"309\" data-start=\"306\"\u003e\u003cstrong data-end=\"321\" data-start=\"309\"\u003ePubChem:\u003c\/strong\u003e 9941957\u003cbr data-end=\"332\" data-start=\"329\"\u003e\u003cstrong data-end=\"370\" data-start=\"332\"\u003eTotal Amount of Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-end=\"388\" data-start=\"385\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"415\" data-start=\"223\"\u003e\u003cstrong\u003eBPC-157 Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cspan\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Bpc-157_5dcbe81f-689b-4577-a465-7f1a0d14f9f2.png?v=1755183632\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Chemical structure diagram of bpc-157 peptide\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Bpc-157.png?v=1755163863\"\u003e\u003c\/div\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cspan\u003eSource \u003ca title=\"PubChem_BPC-157\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\"\u003e\u003c\/a\u003e\u003ca title=\"bpc 157 structure\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251950022922,"sku":"bpc157_10mg-1","price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251950055690,"sku":"bpc157_10mg-2","price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/bpc-157_10mg_2.png?v=1765457082"},{"product_id":"tb-500-10-mg","title":"TB-500 10 mg - Peptide for Regeneration \u0026 Healing","description":"\u003ch3 data-end=\"108\" data-start=\"91\"\u003eOverview\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. TB-500 is studied in laboratory models examining cellular migration, actin regulation, and tissue remodeling processes. Research interest often relates to how cells coordinate movement and repair signaling after structural stress.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eIntroduction to TB-500 (Thymosin Beta-4) TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found in most eukaryotic cells. It is primarily known for sequestering G-actin (monomeric actin) and preventing its polymerization into F-actin filaments, thereby regulating cytoskeletal dynamics. At the molecular level, Tβ4 influences cell migration, proliferation, differentiation, and survival through pathways including PI3K\/Akt and HIF-1α, and through interactions with proteins such as PINCH-1 and ILK. It promotes tissue repair, angiogenesis, and anti-inflammatory\u003cbr\u003eeffects; however, it is not FDA-approved for human use and is primarily studied in research contexts.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003eNF-κB Modulation\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 acts as an NF-κB modulator by inhibiting its activation. It interferes with TNF-α-mediated NF-κB signaling, thereby reducing downstream IL-8 gene transcription and inflammation. This occurs via suppression of NF-κB nuclear translocation and phosphorylation, as shown in corneal and endothelial cell studies. In pathogen-induced inflammation, this modulation enhances resolution by activating pro-resolving pathways.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003eCytoskeleton Movement and Mitochondrial Shape\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 binds G-actin, thereby buffering the G-actin pool and regulating F-actin assembly, facilitating cytoskeletal reorganization, cell motility, and lamellipodia formation. It influences mitochondrial shape by promoting mitochondrial transfer via tunneling nanotubes (TNTs) via Rac\/F-actin pathways, maintaining the mitochondrial membrane potential (Δψm) under oxidative stress, and preventing cristae disruption in damaged cells.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003e\n\u003cbr\u003eCell Differentiation and Neonatal Gene Activation\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 promotes stem cell differentiation, particularly in cardiac and endothelial lineages, by upregulating embryonic genes like those in the epicardium. This is considered a primary effect, as it reactivates neonatal-like regenerative programs in adult tissues, enhancing organ repair via Wnt and Notch signaling. In thymocytes, it aids differentiation through cytoskeletal rearrangement and mitochondrial transfer in thymic epithelial cells.\u003c\/p\u003e\n\u003ch3\u003eStroke Effect Reduction\u003c\/h3\u003e\n\u003cp\u003eTβ4 reduces stroke effects by providing neuroprotection and neurorestoration. It decreases infarct volume, promotes oligodendrogenesis, and enhances axonal remodeling in embolic stroke models. Mechanisms include stabilizing hypoxia-induced brain microvascular barriers and improving neurological outcomes via actin sequestration and vascular repair, though effects vary in aged models.\u003c\/p\u003e\n\u003ch3\u003eEnhancement of Antibiotics\u003c\/h3\u003e\n\u003cp\u003eTβ4 synergistically enhances antibiotic effects, such as ciprofloxacin against Pseudomonas aeruginosa in keratitis models, by promoting bacterial clearance, wound healing, and inflammation resolution without direct antibacterial action at neutral pH. It boosts host defense via pro-resolving mediators.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eActin Level Increase\u003c\/h3\u003e\n\u003cp\u003eTβ4 increases actin levels indirectly by sequestering G-actin, regulating its availability for polymerization into F-actin. This elevates overall actin dynamics, supporting cell structure, migration, and repair processes.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eCell Migration to Injured Areas\u003c\/h3\u003e\n\u003cp\u003eTβ4 facilitates cell migration to injured sites by binding actin and promoting the mobilization of stem\/progenitor cells. It enhances endothelial and epithelial migration via integrin-linked kinase (ILK) activation and cytoskeletal remodeling, which are crucial for wound healing and tissue remodeling.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eAngiogenesis\u003c\/h3\u003e\n\u003cp\u003eTβ4 induces angiogenesis by upregulating angiogenic factors like angiopoietin-1 and von Willebrand factor. It promotes endothelial cell proliferation and vascular growth via PI3K\/Akt\/eNOS signaling, thereby improving blood flow in ischemic tissues, such as the sciatic nerve, in diabetic models.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eAnti-Inflammatory Effects\u003c\/h3\u003e\n\u003cp\u003eTβ4 is anti-inflammatory, suppressing NF-κB and Toll-like receptor pathways to reduce cytokine production (e.g., IL-8, TNF-α). It limits inflammation in models like keratitis and liver fibrosis by activating autophagy and pro-resolving mediators.\u003c\/p\u003e\n\u003ch3\u003eDAPK1 Pathway Activation; Apoptosis and Autophagy Regulation\u003c\/h3\u003e\n\u003cp\u003eTβ4 activates the DAPK1 pathway, promoting LC3-associated phagocytosis (LAP) for inflammation resolution. It regulates apoptosis by inhibiting TGF-β\/Smad signaling and autophagy via HIF-1α stabilization, protecting cells from stress-induced death while enhancing repair in tissues like the cornea and colon.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eEffects in Pathogen-Caused Inflammation: Direct Anti-Microbial Effect\u003c\/h3\u003e\n\u003cp\u003eTβ4 excels in pathogen-induced inflammation (e.g., bacterial keratitis) by enhancing host defense and resolution without strong direct anti-microbial activity at neutral pH. Its antimicrobial effects are pH-dependent, increasing at alkaline conditions (pH\u0026gt;7.0), where it inhibits bacteria such as S. aureus and E. coli, likely due to structural changes that enhance efficacy.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eTransforming Growth Factor Beta (TGF-β) Activation\u003c\/h3\u003e\n\u003cp\u003eTβ4 activates TGF-β signaling pathways in certain contexts, such as tumor progression via TGF-β\/MMP-2 signaling during metastasis. However, it often inhibits TGF-β activity, thereby suppressing Smad activation and reducing fibrosis and apoptosis in models such as renal injury and hepatic stellate cells.\u003c\/p\u003e\n\u003ch3\u003ePTEN Suppression for Muscle Repair in Diabetes\u003c\/h3\u003e\n\u003cp\u003eTβ4 suppresses PTEN activity, thereby enhancing PI3K\/Akt signaling and improving endothelial cell viability, proliferation, and senescence in diabetic models. This enhances reparative capacity, vascular density, and muscle repair, thereby alleviating hyperglycemia and insulin resistance in type II diabetes. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003eTB-500 is frequently referenced in \u003cstrong data-start=\"2640\" data-end=\"2680\"\u003etendon and soft tissue repair models\u003c\/strong\u003e, including comparative peptide research.\u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\" title=\"peptides for muscle recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle and Tendon Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003e\u003cem data-start=\"586\" data-end=\"693\"\u003eFor a research-focused explanation of how TB-500 is evaluated alongside other regenerative peptides, see:\u003c\/em\u003e\u003cbr data-start=\"693\" data-end=\"696\"\u003e\u003cstrong data-start=\"698\" data-end=\"766\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\" title=\"tb 500 peptide and bpc 157\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong data-end=\"147\" data-start=\"124\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"543\" data-start=\"151\"\u003e\n\u003cli data-end=\"197\" data-start=\"151\"\u003e\n\u003cp data-end=\"197\" data-start=\"153\"\u003e\u003cstrong data-end=\"169\" data-start=\"153\"\u003eProduct Name\u003c\/strong\u003e: TB-500 (Thymosin Beta-4)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"228\" data-start=\"198\"\u003e\n\u003cp data-end=\"228\" data-start=\"200\"\u003e\u003cstrong data-end=\"214\" data-start=\"200\"\u003eCAS Number\u003c\/strong\u003e: 77591-33-4\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"274\" data-start=\"229\"\u003e\n\u003cp data-end=\"274\" data-start=\"231\"\u003e\u003cstrong data-end=\"243\" data-start=\"231\"\u003eSynonyms\u003c\/strong\u003e: Thymosin Beta-4, Tβ4, TB500\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"321\" data-start=\"275\"\u003e\n\u003cp data-end=\"321\" data-start=\"277\"\u003e\u003cstrong data-end=\"298\" data-start=\"277\"\u003eMolecular Formula\u003c\/strong\u003e: \u003cstrong data-end=\"319\" data-start=\"300\"\u003eC₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"354\" data-start=\"322\"\u003e\n\u003cp data-end=\"354\" data-start=\"324\"\u003e\u003cstrong data-end=\"338\" data-start=\"324\"\u003eMolar Mass\u003c\/strong\u003e: 4963.5 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"383\" data-start=\"355\"\u003e\n\u003cp data-end=\"383\" data-start=\"357\"\u003e\u003cstrong data-end=\"371\" data-start=\"357\"\u003ePubChem ID\u003c\/strong\u003e: 16132397\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"485\" data-start=\"423\"\u003e\n\u003cp data-end=\"485\" data-start=\"425\"\u003e\u003cstrong data-end=\"466\" data-start=\"425\"\u003eTotal Amount of the Active Ingredient\u003c\/strong\u003e: 10 mg (per vial)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\n\u003cspan class=\"flex-1\"\u003eStructures\u003c\/span\u003e\u003cstrong\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Timbetasin.png?v=1757427968\"\u003e\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003ca title=\"TB-500 structures\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/16132341\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251953070346,"sku":null,"price":125.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251953103114,"sku":null,"price":150.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tb-500_10mg_2_1.png?v=1765456935"},{"product_id":"ghk-cu-50-mg","title":"GHK-Cu 50 mg – High-Purity Copper Peptide","description":"\u003ch3\u003eResearch context overview\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. GHK-Cu is studied in laboratory models focusing on tissue remodeling, cellular communication, and extracellular matrix–related repair mechanisms.\u003c\/p\u003e\n\u003ch3 data-start=\"213\" data-end=\"241\"\u003ePrimary research pairing\u003c\/h3\u003e\n\u003cp data-start=\"243\" data-end=\"451\"\u003eIn experimental and laboratory research settings, \u003cstrong data-start=\"293\" data-end=\"303\"\u003eGHK-Cu\u003c\/strong\u003e is frequently examined alongside peptides involved in \u003cstrong data-start=\"358\" data-end=\"450\"\u003etissue-associated signaling, extracellular matrix dynamics, and cellular repair pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"453\" data-end=\"589\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-10mg-per-vial\"\u003e\u003cstrong data-start=\"455\" data-end=\"473\"\u003eBPC-157 (vial)\u003c\/strong\u003e – peptide-mediated tissue signaling research\u003c\/a\u003e\u003cbr data-start=\"518\" data-end=\"521\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"523\" data-end=\"540\"\u003eTB-500 (vial)\u003c\/strong\u003e – cytoskeletal and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"596\" data-end=\"643\"\u003eRedox and cellular balance research context\u003c\/h3\u003e\n\u003cp data-start=\"645\" data-end=\"818\"\u003eSome experimental frameworks explore \u003cstrong data-start=\"682\" data-end=\"692\"\u003eGHK-Cu\u003c\/strong\u003e in parallel with compounds studied for \u003cstrong data-start=\"732\" data-end=\"817\"\u003eredox regulation, oxidative stress balance, and intracellular signaling stability\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"820\" data-end=\"882\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"822\" data-end=\"839\"\u003eL-Glutathione\u003c\/strong\u003e – redox balance and antioxidant research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"889\" data-end=\"948\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"950\" data-end=\"1130\"\u003eIn more specialized experimental models, \u003cstrong data-start=\"991\" data-end=\"1001\"\u003eGHK-Cu\u003c\/strong\u003e may be referenced alongside compounds examined for \u003cstrong data-start=\"1053\" data-end=\"1129\"\u003eneurotrophic signaling and higher-order molecular communication pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1132\" data-end=\"1193\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"1134\" data-end=\"1144\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1200\" data-end=\"1247\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1249\" data-end=\"1414\"\u003eCertain research discussions reference \u003cstrong data-start=\"1288\" data-end=\"1298\"\u003eGHK-Cu\u003c\/strong\u003e alongside alternative peptide formats when evaluating \u003cstrong data-start=\"1353\" data-end=\"1413\"\u003edelivery considerations and experimental exposure models\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1416\" data-end=\"1480\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1418\" data-end=\"1440\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"148\" data-end=\"165\"\u003e\n\u003cspan class=\"s2\"\u003eGHK-Cu\u003c\/span\u003e Overview\u003c\/h3\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex)\u003c\/span\u003e\u003cspan\u003e is \u003c\/span\u003e\u003cspan\u003ean endogenous peptide found in human plasma, saliva, and urine. \u003c\/span\u003e\u003cspan\u003eGHK-Cu\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003estructures \u003c\/span\u003e\u003cspan\u003eenable safe copper transport into cells, modulating regenerative, antioxidant, and anti-inflammatory processes at nanomolar to micromolar concentrations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eFibroblast Stimulation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu activates dermal fibroblasts (connective tissue cells that produce extracellular matrix), enhancing extracellular matrix (ECM) remodeling. It upregulates mRNA (messenger RNA) for collagen type I, elastin, and glycosaminoglycans (GAGs; e.g., dermatan sulfate, chondroitin sulfate, decorin) via the TGF-β (transforming growth factor beta) signaling pathway, increasing integrin β1 expression and restoring fibroblast function in damaged tissues (e.g., COPD (chronic obstructive pulmonary disease) lungs). \u003c\/span\u003e\u003cspan\u003eIt \u003c\/span\u003e\u003cspan\u003eboosts collagen synthesis by 70–230% in wound models and elevates matrix metalloproteinases (MMPs; MMP1, MMP2) while balancing their tissue inhibitors (TIMPs; TIMP1, TIMP2) to prevent excessive ECM degradation. Evidence: In vitro fibroblast studies and rat wound models show up to 9-fold collagen increase; gene profiling confirms TGF-β pathway activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eAntioxidant and Anti-Inflammatory Effects\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu mimics superoxide dismutase (SOD) by supplying bioavailable Cu²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e for Cu,Zn-SOD1 (copper-zinc superoxide dismutase 1), reducing reactive oxygen species (ROS) such as superoxide and hydroxyl radicals. It blocks Fe²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e (iron(II) ion) release from ferritin (87% inhibition), \u003c\/span\u003e\u003cspan\u003edecreases\u003c\/span\u003e\u003cspan\u003e lipid peroxidation byproducts (e.g., 4-hydroxynonenal, acrolein), and inhibits Cu²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e-dependent LDL oxidation (full protection vs. 20% for SOD1 alone). Anti-inflammatory actions involve suppression of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) p65 and p38 MAPK (mitogen-activated protein \u003c\/span\u003e\u003cspan\u003ekinase), lowering TNF-α\u003c\/span\u003e\u003cspan\u003e, I\u003c\/span\u003e\u003cspan\u003eL-6\u003c\/span\u003e\u003cspan\u003e,\u003c\/span\u003e\u003cspan\u003e and fibrinogen. In lung injury models, it elevates SOD activity and curbs ROS-induced inflammation. Evidence: Keratinocyte UV protection assays and fibroblast cultures show cytokine reduction; animal models confirm ROS scavenging and anti-inflammatory gene modulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eEnhancement of Angiogenesis\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu promotes new blood vessel formation (angiogenesis) by upregulating vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF, also known as FGF2) secretion from mesenchymal stem cells (MSCs) and fibroblasts. Released from SPARC (secreted protein acidic and rich in cysteine) protein during tissue injury, it stimulates endothelial cell proliferation and vessel growth in early wound phases, while inhibiting excess later via SPARC restoration. Gene data show +487% expression of ANGPT1 (angiopoietin 1). Evidence: Rabbit wound studies demonstrate enhanced granulation tissue and vessels; in vitro MSC assays confirm VEGF\/bFGF increases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eGene Expression Modulation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu alters \u003c\/span\u003e\u003cspan\u003ethe \u003c\/span\u003e\u003cspan\u003eexpression of over 1,000 genes (e.g., 1,569 upregulated, 583 downregulated at ≥50% change), acting as an epigenetic modifier by inhibiting histone deacetylases (HDACs) to reverse gene silencing. It activates regenerative pathways (e.g., TGF-β, integrins, p63 (tumor protein p63)) and suppresses cancer-related genes (70% of 54 metastatic colon cancer genes). In neurons, it upregulates 408 genes (e.g., OPRM1 (opioid receptor mu 1) +1,294%) for development and pain relief. Evidence: Microarray analyses (e.g., Connectivity Map database) show broad impacts; COPD gene reversal (127 genes) and ubiquitin-proteasome system (UPS) pathway activation (41 genes upregulated) support tissue repair roles. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompound background and research mechanisms\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of GHK-Cu, including its role in cellular communication, extracellular matrix remodeling, and antioxidant regulation, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ghk-cu\"\u003eWhat is GHK-Cu? – Research overview\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo explore GHK-Cu in hair loss–related research, including hair follicle signaling and extracellular matrix remodeling, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-hair-loss-research\"\u003e\u003cstrong\u003eGHK-Cu and Hair Follicle Research: Copper Peptides and Tissue Remodeling\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eGHK-Cu is frequently examined in research related to extracellular matrix signaling and dermal remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a broader comparison with repair-focused peptides, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-vs-bpc-157\"\u003eGHK-Cu vs BPC-157: Tissue Repair, Angiogenesis, and Peptide Signaling\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1567\" data-end=\"1595\"\u003e\u003cstrong data-start=\"1570\" data-end=\"1593\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli data-start=\"1599\" data-end=\"1645\"\u003eProduct Name: GHK-Cu (Copper Tripeptide)\u003c\/li\u003e\n\u003cli data-start=\"1599\" data-end=\"1645\"\u003eMolecular Formula: C₁₄H₂₃CuN₆O₄\u003c\/li\u003e\n\u003cli\u003eSynonyms : \u003cspan class=\"value\"\u003ePrezatide \u003c\/span\u003e\u003cspan class=\"value\"\u003ecopper, Copper peptide, BCP32687, SY253680, GHK copper; CG-copper peptide; [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003eMolar Mass : \u003cspan class=\"value\"\u003e401.91 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003eCAS Number : \u003cspan class=\"value\"\u003e89030-95-5\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003ePubChem : \u003cspan class=\"value\"\u003e78122578\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1895\" data-end=\"1990\"\u003eTotal Amount of the Active Ingredient: 50 mg \/ vial \u003c\/li\u003e\n\u003c\/ul\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52417639153930,"sku":null,"price":160.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52417639186698,"sku":null,"price":185.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/GHK-Cu_50mg_4.png?v=1768894375"},{"product_id":"ipamorelin-5-mg","title":"Ipamorelin 5 mg – Selective GH Secretagogue Peptide","description":"\u003ch3 data-start=\"163\" data-end=\"178\"\u003e\u003cstrong data-start=\"166\" data-end=\"178\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Ipamorelin is examined in experimental systems focused on growth hormone secretagogue signaling and metabolic adaptation. Research models often explore its role in pulsatile hormonal communication pathways.\u003c\/p\u003e\n\u003cp\u003eIpamorelin is a synthetic pentapeptide (C₃₈H₄₉N₉O₅; MW 711.9 Da) developed in the 1990s as the first selective growth hormone secretagogue (GHS). It mimics ghrelin to stimulate pulsatile growth hormone (GH) release with high specificity, without affecting other hormones. Studies show its potency in vitro (EC₅₀ 1.3 nmol\/L) and in vivo (ED₅₀ 80 nmol\/kg in rats, 2 nmol\/kg in swine). It has a 2-hour half-life, with peak GH effects at 0.67 hours post-dose, suitable for IV, SC, or intranasal administration. Blends with CJC-1295 or tesamorelin enhance synergistic GH pulses for recovery and optimization.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003eAs a GHS-R1a agonist, ipamorelin binds ghrelin receptors in the pituitary and hypothalamus, activating phospholipase C to raise intracellular calcium and trigger GH secretion from somatotrophs. It inhibits somatostatin, which limits GH release, while boosting IGF-1 levels. Unlike non-selective GHSs, it spares ACTH, cortisol, PRL, FSH, LH, TSH, aldosterone, and acetylcholine, even at high doses. It mimics ghrelin to increase hunger but maintains selectivity. Administration before sleep can induce GH secretion within 20 minutes.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003ePotential Applications\u003c\/h3\u003e\n\u003cp\u003eIpamorelin supports hormonal balance, particularly in women, by restoring fertility, menstrual cycles, and alleviating menopausal symptoms like fatigue, low libido, and weight gain. It increases uterine size and pregnancy rates in infertility cases, and improves thyroid\/adrenal function for better energy and mood. For body composition, it reduces fat storage, promotes lean muscle via protein synthesis and satellite cell activation, and enhances strength in aging populations. Anti-aging benefits include collagen production (up to 860% increase), cell repair for skin issues (wrinkles, sagging), and wound healing.\u003cbr\u003eIt bolsters bone and joint health by elevating bone mineral content and velocity, countering glucocorticoid-induced loss (e.g., restoring periosteal formation four-fold in rat models). Injury recovery accelerates through tissue repair and reduced inflammation. Metabolic applications involve fat loss via lipolysis, improved insulin sensitivity for blood sugar control, and energy metabolism. It enhances sleep quality (slow-wave sleep), immune function (thymus\/T-cell development), brain health (dopamine for Parkinson's), heart function (cardiac output), gastrointestinal motility (for ileus), and sexual health (nitric oxide, testosterone\/estrogen boost). In fitness and performance, it's ranked highly among GH peptides for muscle building and recovery, often cycled with other agents such as MK-677 or HGH. \u003c\/p\u003e\n\u003cp\u003e\u003cem data-start=\"516\" data-end=\"657\"\u003eFor a deeper scientific overview of how GHRP peptides like Ipamorelin differ from GHRH compounds, see our GHRH vs GHRP research comparison. - \u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong data-start=\"675\" data-end=\"711\"\u003eGHRH vs GHRP research comparison\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eOur research article on \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003emuscle preservation\u003c\/a\u003e\u003c\/strong\u003e during GLP-1\/GIP therapy provides additional context on how growth hormone signaling pathways are studied in relation to lean muscle maintenance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Description – Ipamorelin 5 mg\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"1610\" data-end=\"1623\"\u003eSynonyms:\u003c\/strong\u003e Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr data-start=\"1689\" data-end=\"1692\"\u003e\u003cstrong data-start=\"1692\" data-end=\"1714\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₈H₄₉N₉O₅\u003cbr data-start=\"1725\" data-end=\"1728\"\u003e\u003cstrong data-start=\"1728\" data-end=\"1743\"\u003eMolar Mass:\u003c\/strong\u003e ~711.87 g\/mol\u003cbr data-start=\"1757\" data-end=\"1760\"\u003e\u003cstrong data-start=\"1760\" data-end=\"1775\"\u003eCAS Number:\u003c\/strong\u003e 170851-70-4\u003cbr\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e: 9831659\u003cbr\u003e\u003cstrong data-start=\"1790\" data-end=\"1818\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Ipamorelin_1.png?v=1757839513\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9831659\" title=\"Ipamorelin stuctures\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251945566474,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251945599242,"sku":null,"price":115.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ipamorelin_3_1.png?v=1765456716"},{"product_id":"tesamorelin-10-mg","title":"Tesamorelin 10 mg – High-Purity GHRH Analog Peptide","description":"\u003ch3 data-end=\"161\" data-start=\"146\"\u003e\u003cstrong data-end=\"161\" data-start=\"149\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Tesamorelin is studied in experimental models investigating growth hormone axis modulation and body composition–related signaling. Research interest includes how endocrine signaling influences metabolic and structural adaptation.\u003cstrong data-end=\"161\" data-start=\"149\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoyl group for enhanced stability and potency. Originally developed as an orphan drug (branded as Egrifta), it received FDA approval in 2010 for reducing excess visceral adipose tissue (VAT) in HIV-infected adults with lipodystrophy associated with antiretroviral therapy. It has since gained attention in anti-aging, body composition optimization, metabolic health, performance enhancement, and cognitive support.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003eTesamorelin selectively binds to GHRH receptors on pituitary somatotroph cells, stimulating pulsatile release of endogenous growth hormone (GH) while preserving natural feedback regulation and avoiding receptor desensitization. The resulting GH surge prompts hepatic production of insulin-like growth factor-1 (IGF-1), which promotes lipolysis, protein synthesis, and metabolic efficiency. With a short half-life (8–120 minutes), it mimics physiological GH pulses without significantly affecting cortisol, prolactin, TSH, LH, FSH, or ACTH. It enhances mitochondrial biogenesis, fatty acid beta-oxidation, autophagy, and key signaling pathways including PI3K\/AKT\/mTOR and AMPK, supporting cellular energy efficiency, myogenesis, and preferential fat utilization. It synergizes effectively with testosterone and other GH secretagogues to amplify anabolism, improve glucose disposal, promote deep sleep, and reduce triglycerides without promoting insulin resistance.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eBenefits and Potential Applications\u003c\/h3\u003e\n\u003cp\u003eClinical data demonstrate 12–20% reductions in visceral adipose tissue, 1.3–1.8 cm decreases in waist circumference, and improvements in liver enzymes (reduced ALT\/AST) in non-alcoholic fatty liver disease. Lipid profiles improve with significant drops in triglycerides (up to ~150 mg\/dL), total cholesterol, and LDL, alongside cardiovascular benefits such as reduced carotid intima-media thickness. Cognitive effects include enhanced executive function, verbal memory, and visual recall, particularly in aging populations or those with mild impairment after 20 weeks of use. For physique and performance, it supports indirect muscle gains through elevated GH, accelerated recovery, increased stamina, and fat loss—most pronounced in caloric surplus (12–20% above maintenance) with optimized testosterone levels. It aids nerve repair, activates satellite cells for myogenesis and angiogenesis, reduces fibrosis during training stress, and improves sleep architecture. Off-label applications include general obesity management, menopausal hormone optimization, immune modulation, sexual function, sleep quality, and athletic performance. Exploratory studies examine its role in age-related abdominal fat accumulation, though long-term safety data remain limited outside the approved indication.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eTo better understand how Tesamorelin functions within growth hormone research, explore our detailed guide on the differences between GHRH and GHRP peptides - \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong\u003eDifferences Between GHRH and GHRP peptides\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how growth hormone–related peptide research is examined in the context of muscle preservation during GLP-1\/GIP–associated weight loss, see our related research article on \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003e\u003cstrong\u003emuscle preservation mechanisms.\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eProduct Description – Tesamorelin 10 mg\u003c\/h3\u003e\n\u003cp data-end=\"418\" data-start=\"266\"\u003e\u003cstrong data-end=\"288\" data-start=\"266\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003csub\u003e223\u003c\/sub\u003eH\u003csub\u003e370\u003c\/sub\u003eN\u003csub\u003e72\u003c\/sub\u003eO\u003csub\u003e69\u003c\/sub\u003eS\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"418\" data-start=\"266\"\u003e\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-end=\"360\" data-start=\"345\"\u003eMolar Mass:\u003c\/strong\u003e ~ 5196 g\/mol\u003c\/p\u003e\n\u003cp data-end=\"487\" data-start=\"420\"\u003e\u003cstrong data-end=\"435\" data-start=\"420\"\u003eCAS Number:\u003c\/strong\u003e 901758-09-6\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"553\" data-start=\"489\"\u003e\u003cstrong data-end=\"504\" data-start=\"489\"\u003ePubChem ID:\u003c\/strong\u003e 44147413\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003e\u003cstrong data-end=\"583\" data-start=\"555\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Tesamorelin.png?v=1757839048\"\u003e\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003eSource: \u003ca title=\"Tesamorelin structures\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/44147413\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251944190218,"sku":null,"price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251944222986,"sku":null,"price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tesamorelin_10mg_3.png?v=1765456463"},{"product_id":"cjc-1295-10mg","title":"CJC-1295 ( No DAC ) 10 mg – High-Purity GHRH Analog Peptide","description":"\u003ch2 data-start=\"122\" data-end=\"137\"\u003eCJC- 1295 Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. CJC-1295 is studied in experimental models examining growth hormone–related signaling and anabolic regulation pathways. Research interest includes its role in long-term hormonal signaling dynamics.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eCJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous growth hormone (GH) production from the pituitary gland. It is available in two main forms: with Drug Affinity Complex (DAC), which significantly extends its half-life, and without DAC, which provides shorter, more pulsatile effects. It is frequently combined with other peptides, such as Ipamorelin, to enhance GH release, improve body composition, support recovery, and promote overall vitality.\u003c\/p\u003e\n\u003ch3 data-start=\"1487\" data-end=\"1711\"\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eCJC-1295 acts as a GHRH receptor agonist, binding to somatotroph cells in the anterior pituitary. This activates G-protein-coupled signaling that elevates intracellular cyclic AMP (cAMP), leading to calcium influx, GH vesicle exocytosis, and increased GH synthesis through transcription factors such as CREB. The result is amplified pulsatile or sustained GH secretion, followed by hepatic production of insulin-like growth factor-1 (IGF-1).\u003cbr\u003eThe DAC-conjugated version binds reversibly to albumin, prolonging plasma half-life to approximately 6–8 days. This produces sustained GH elevations (2–10-fold) and IGF-1 increases (1.5–3-fold) that can persist for up to 11 days after a single dose. In contrast, non-DAC CJC-1295 has a shorter half-life (~30 minutes), generating more physiological, pulsatile GH release patterns similar to those seen in younger individuals. Both forms stimulate the GH\/IGF-1 axis without introducing exogenous hormones, promoting protein synthesis, lipolysis, collagen production, and cellular repair while preserving natural feedback regulation when dosed appropriately.\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003ePotential Applications\u003cbr\u003eCJC-1295 is primarily used in research and optimization protocols for:\u003cbr\u003eBody composition improvement: Increased lean muscle mass, accelerated fat loss (particularly visceral fat), and enhanced metabolic rate. Recovery and performance: Faster healing from training or injury, improved sleep quality, and greater exercise capacity. Anti-aging and longevity: Counteracting age-related GH decline, supporting connective tissue integrity, reducing inflammation, improving insulin sensitivity, and promoting cardiovascular health. Regenerative therapy: Applications in musculoskeletal repair, metabolic optimization, and addressing conditions associated with low GH\/IGF-1, such as sarcopenia or chronic fatigue.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003e\u003cem data-end=\"898\" data-start=\"773\"\u003eLearn more about the role of GHRH analogs such as CJC-1295 in growth hormone research by reading our GHRH vs GHRP overview. - \u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong data-end=\"941\" data-start=\"916\"\u003eGHRH vs GHRP overview\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eFor a broader research discussion on muscle loss during GLP-1\/GIP therapy and the role of growth hormone signaling pathways, refer to our detailed\u003cstrong data-end=\"941\" data-start=\"916\"\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003eresearch article on muscle preservation.\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Description:\u003cstrong\u003e \u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cdiv class=\"p-2 sm:table-row pc-gray-border-t sm:border-0\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 pb-1 pl-2 sm:align-middle\"\u003e\n\u003cp\u003e\u003cstrong data-start=\"284\" data-end=\"306\"\u003eMolecular Formula:\u003c\/strong\u003e C₁₅₂H₂₅₂N₄₄O₄₂\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"364\" data-end=\"412\"\u003e\u003cstrong data-start=\"364\" data-end=\"379\"\u003eMolar Mass:\u003c\/strong\u003e ~ 3367.9 g\/mol\u003c\/p\u003e\n\u003cp data-start=\"414\" data-end=\"443\"\u003e\u003cstrong data-start=\"414\" data-end=\"429\"\u003eCAS Number:\u003c\/strong\u003e 863288-34-0\u003c\/p\u003e\n\u003cp data-start=\"445\" data-end=\"470\"\u003e\u003cstrong data-start=\"445\" data-end=\"460\"\u003ePubChem ID:\u003c\/strong\u003e 56841945\u003c\/p\u003e\n\u003cp data-start=\"472\" data-end=\"553\"\u003e\u003cstrong data-start=\"472\" data-end=\"500\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/CJC1295_Without_DAC.png?v=1757838270\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/CJC1295-Without-DAC?utm_source=chatgpt.com\" title=\"CJC-1295 structures\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251942093066,"sku":null,"price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251942125834,"sku":null,"price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/CJC-1295_4.png?v=1765456298"},{"product_id":"cjc-1295-ipamorelin-10mg-5mg","title":"CJC-1295 No DAC (10 mg) + Ipamorelin (5 mg) Research Peptide Blend","description":"\u003ch2 data-start=\"468\" data-end=\"492\"\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The CJC-1295 and Ipamorelin combination is studied in experimental models focused on coordinated growth hormone release and anabolic signaling dynamics. Research interest includes how multiple secretagogue pathways influence long-term endocrine communication.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"494\" data-end=\"1024\"\u003e\u003cstrong data-start=\"494\" data-end=\"519\"\u003eCJC-1295 + Ipamorelin\u003c\/strong\u003e is a dual-peptide blend commonly utilized in controlled experimental settings to investigate coordinated interactions within growth hormone–related signaling pathways. CJC-1295 is a synthetic tetrasubstituted peptide analog of GHRH, designed to support prolonged receptor engagement through increased stability. Ipamorelin is a selective GHSR (growth hormone secretagogue receptor) agonist frequently explored for its high receptor specificity and minimal off-target binding profile in laboratory assays.\u003c\/p\u003e\n\u003cp data-start=\"1026\" data-end=\"1384\"\u003eCombined in a 10 mg (CJC-1295) + 5 mg (Ipamorelin) format, the blend enables researchers to examine multi-pathway activation dynamics involving both GHRH-mediated and ghrelin-mimetic mechanisms, offering a complementary model for studying pulsatile GH release patterns, receptor synergy, and peptide pharmacokinetics under controlled experimental conditions.\u003c\/p\u003e\n\u003ch3 data-start=\"1446\" data-end=\"1476\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"1446\" data-end=\"1476\"\u003eScientific Description\u003c\/h3\u003e\n\u003cp data-start=\"1478\" data-end=\"1853\"\u003eCJC-1295 is a modified peptide incorporating Drug Affinity Complex (DAC) technology in some research variants, enhancing its plasma stability and receptor interaction time frame. It engages GHRH receptors (GHRH-R), influencing intracellular signaling cascades such as cAMP–PKA, CREB activation, and downstream transcriptional pathways related to somatotropic axis modulation.\u003c\/p\u003e\n\u003cp data-start=\"1855\" data-end=\"2323\"\u003eIpamorelin, a pentapeptide secretagogue, selectively binds GHSR-1a and exhibits high specificity for this receptor compared to earlier GHRP-class compounds. In vitro studies frequently evaluate its selective suppression of off-target hormones while maintaining preserved ghrelin-receptor binding kinetics. The combined blend allows investigation of synchronized receptor activation events, GH pulse frequency modulation, and comparative potency across peptide classes.\u003c\/p\u003e\n\u003ch3 data-start=\"2381\" data-end=\"2408\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"2381\" data-end=\"2408\"\u003eResearch Background\u003c\/h3\u003e\n\u003cp data-start=\"2410\" data-end=\"2488\"\u003eExperimental literature involving CJC-1295 and Ipamorelin commonly focuses on:\u003c\/p\u003e\n\u003cul data-start=\"2490\" data-end=\"3069\"\u003e\n\u003cli data-start=\"2490\" data-end=\"2592\"\u003e\n\u003cp data-start=\"2492\" data-end=\"2592\"\u003e\u003cstrong data-start=\"2492\" data-end=\"2521\"\u003eReceptor pathway synergy:\u003c\/strong\u003e GHRH-R and GHSR-1a co-activation and downstream signaling interplay.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2593\" data-end=\"2722\"\u003e\n\u003cp data-start=\"2595\" data-end=\"2722\"\u003e\u003cstrong data-start=\"2595\" data-end=\"2624\"\u003ePharmacokinetic modeling:\u003c\/strong\u003e comparative half-life, stability, and degradation kinetics of individual and combined peptides.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2723\" data-end=\"2840\"\u003e\n\u003cp data-start=\"2725\" data-end=\"2840\"\u003e\u003cstrong data-start=\"2725\" data-end=\"2763\"\u003ePeptide–receptor binding profiles:\u003c\/strong\u003e selectivity, receptor affinity, and influence on intracellular messengers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2841\" data-end=\"2951\"\u003e\n\u003cp data-start=\"2843\" data-end=\"2951\"\u003e\u003cstrong data-start=\"2843\" data-end=\"2878\"\u003ePulsatile secretion patterning:\u003c\/strong\u003e simulation and mapping of growth-hormone–related pulsatility in vitro.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2952\" data-end=\"3069\"\u003e\n\u003cp data-start=\"2954\" data-end=\"3069\"\u003e\u003cstrong data-start=\"2954\" data-end=\"2997\"\u003eStructure–activity relationships (SAR):\u003c\/strong\u003e how substitutions and sequence motifs influence stability and function.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3071\" data-end=\"3240\"\u003eThe blend format (10 mg + 5 mg) provides a practical ratio for comparative and combination-model research, enabling consistent experimental conditions across replicates.\u003c\/p\u003e\n\u003cp data-start=\"3242\" data-end=\"3350\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"3357\" data-end=\"3393\"\u003eSpecifications \u0026amp; Identifiers\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCJC-1295 - 10 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂\u003cbr\u003eMolar Mass: ~ 3367.9 g\/mol\u003cbr\u003eCAS Number: 863288-34-0\u003cbr\u003ePubChem ID: 56841945\u003cbr\u003eTotal Active Ingredient: 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin 5 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSynonyms: Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr\u003eMolecular Formula: C₃₈H₄₉N₉O₅\u003cbr\u003eMolar Mass: ~711.87 g\/mol\u003cbr\u003eCAS Number: 170851-70-4\u003cbr\u003ePubChem CID: 9831659\u003cbr\u003eTotal Active Ingredient: 5 mg lyophilised peptide per vial\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52252210233610,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52252210266378,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/cjc_ipa_10_5_1.png?v=1765456033"},{"product_id":"tesamorelin-10-mg-ipamorelin-5-mg-research-peptide-blend","title":"Tesamorelin (10 mg) + Ipamorelin (5 mg) Research Peptide Blend","description":"\u003ch2 data-start=\"492\" data-end=\"517\"\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The Ipamorelin and Tesamorelin combination is studied in experimental systems examining complementary growth hormone–related signaling pathways. Research models explore how pulsatile and regulatory endocrine signals interact within metabolic and structural adaptation frameworks.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"519\" data-end=\"1084\"\u003eThe \u003cstrong data-start=\"523\" data-end=\"589\"\u003eTesamorelin (10 mg) + Ipamorelin (5 mg) Research Peptide Blend\u003c\/strong\u003e is a dual-component formulation designed for controlled laboratory investigations into growth hormone–related signaling pathways. Tesamorelin is a stabilized growth hormone–releasing hormone (GHRH) analog featuring enhanced structural resistance to enzymatic degradation, allowing extended receptor interaction in vitro. Ipamorelin is a selective agonist of the ghrelin receptor (GHSR-1a), known for its high receptor specificity and minimal off-target binding profile in experimental settings.\u003c\/p\u003e\n\u003cp data-start=\"1086\" data-end=\"1395\"\u003eIn combined format, this blend enables researchers to explore synergistic or comparative activation patterns involving \u003cstrong data-start=\"1205\" data-end=\"1215\"\u003eGHRH-R\u003c\/strong\u003e and \u003cstrong data-start=\"1220\" data-end=\"1231\"\u003eGHSR-1a\u003c\/strong\u003e pathways, providing a versatile model for studying intracellular signaling events, pulsatile GH modulation, peptide pharmacokinetics, and receptor-ligand dynamics.\u003c\/p\u003e\n\u003cp data-start=\"1397\" data-end=\"1461\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"1468\" data-end=\"1499\"\u003eScientific Description\u003c\/h3\u003e\n\u003cp data-start=\"1501\" data-end=\"1845\"\u003eTesamorelin is a synthetic, stabilized peptide analog of human GHRH incorporating modifications that increase half-life and promote sustained interaction with its receptor. Experimental models often assess its ability to modulate cAMP-dependent intracellular pathways, CREB-associated transcription factors, and somatotropic signaling cascades.\u003c\/p\u003e\n\u003cp data-start=\"1847\" data-end=\"2139\"\u003eIpamorelin, a pentapeptide secretagogue, selectively targets the GHSR-1a receptor without engaging secondary hormonal pathways. Its binding profile allows for the evaluation of ghrelin-mimetic receptor dynamics with minimized confounding cross-interactions seen in older GHRP-class compounds.\u003c\/p\u003e\n\u003cp data-start=\"2141\" data-end=\"2378\"\u003eTogether, Tesamorelin and Ipamorelin form a complementary dual-peptide system that supports advanced studies on coordinated receptor activation, downstream signal propagation, and peptide stability under controlled laboratory conditions.\u003c\/p\u003e\n\u003cp data-start=\"2380\" data-end=\"2457\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"2464\" data-end=\"2492\"\u003eResearch Background\u003c\/h3\u003e\n\u003cp data-start=\"2494\" data-end=\"2575\"\u003eScientific literature examining Tesamorelin and Ipamorelin frequently focuses on:\u003c\/p\u003e\n\u003cul data-start=\"2577\" data-end=\"3128\"\u003e\n\u003cli data-start=\"2577\" data-end=\"2676\"\u003e\n\u003cp data-start=\"2579\" data-end=\"2676\"\u003e\u003cstrong data-start=\"2579\" data-end=\"2607\"\u003eReceptor synergy models:\u003c\/strong\u003e comparative and combined activation of GHRH-R and GHSR-1a pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2677\" data-end=\"2784\"\u003e\n\u003cp data-start=\"2679\" data-end=\"2784\"\u003e\u003cstrong data-start=\"2679\" data-end=\"2708\"\u003ePharmacokinetic analysis:\u003c\/strong\u003e stability, degradation kinetics, and extended plasma interaction modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2785\" data-end=\"2884\"\u003e\n\u003cp data-start=\"2787\" data-end=\"2884\"\u003e\u003cstrong data-start=\"2787\" data-end=\"2820\"\u003eIntracellular signal mapping:\u003c\/strong\u003e cAMP-PKA, CREB, PLC, and calcium-dependent messenger pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2885\" data-end=\"2993\"\u003e\n\u003cp data-start=\"2887\" data-end=\"2993\"\u003e\u003cstrong data-start=\"2887\" data-end=\"2930\"\u003eGrowth hormone pulsatility simulations:\u003c\/strong\u003e rhythm modulation and receptor-driven pulse-pattern modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2994\" data-end=\"3128\"\u003e\n\u003cp data-start=\"2996\" data-end=\"3128\"\u003e\u003cstrong data-start=\"2996\" data-end=\"3039\"\u003eStructure–activity relationships (SAR):\u003c\/strong\u003e amino acid modifications and their impact on receptor affinity and functional behavior\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3130\" data-end=\"3283\"\u003eThe 10 mg + 5 mg ratio is widely utilized in experimental settings due to its consistency and suitability for parallel or synergistic pathway evaluation.\u003c\/p\u003e\n\u003ch3 data-start=\"3366\" data-end=\"3403\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"3366\" data-end=\"3403\"\u003eSpecifications \u0026amp; Identifiers\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin 10 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C223H370N72O69S\u003cbr\u003eMolar Mass: ~ 5196 g\/mol\u003cbr\u003eCAS Number: 901758-09-6\u003cbr\u003ePubChem ID: 44147413\u003cbr\u003eTotal Active Ingredient: 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin 5 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSynonyms: Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr\u003eMolecular Formula: C₃₈H₄₉N₉O₅\u003cbr\u003eMolar Mass: ~711.87 g\/mol\u003cbr\u003eCAS Number: 170851-70-4\u003cbr\u003ePubChem CID: 9831659\u003cbr\u003eTotal Active Ingredient: 5 mg lyophilised peptide per vial\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52252227272970,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52252227305738,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tesa_ipa_10_5_1.png?v=1765455838"},{"product_id":"motsc-10mg-research-grade","title":"MOTS-c 10 mg - Mitochondrial Peptide (Research Grade)","description":"\u003ch3\u003eIntroduction to MOTS-c\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. MOTS-C is examined in experimental models investigating mitochondrial signaling, cellular energy regulation, and metabolic adaptation. Research interest centers on how cells respond to energetic stress and efficiency-related signals.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded by the mitochondrial genome (mtDNA). Discovered in 2015, it functions as a mitochondrial-derived peptide (MDP) with systemic regulatory roles. Unlike traditional mitochondrial proteins, MOTS-c translocates from mitochondria to the nucleus, influencing gene expression and metabolic pathways. Its molecular-level mechanism of action (MoA) centers on modulating cellular energy homeostasis, primarily through AMPK activation and purine metabolism interference. Recent studies (2025-2026) highlight its potential in metabolic disorders, aging, and neurodegeneration, with applications as an exercise mimetic. Structurally distinct from other MDPs like Humanin (a 24-amino acid peptide), MOTS-c shares cytoprotective effects but targets different pathways, making it promising for neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/mots_c_product_480x480.png?v=1768894662\" alt=\"mots-c peptide mechanism\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eCore Molecular Mechanism\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, MOTS-c regulates metabolism by inhibiting the folate\/methionine cycle in the nucleus. It binds to nuclear factors, reducing de novo purine biosynthesis, which leads to accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR is a potent activator of AMP-activated protein kinase (AMPK), mimicking energy stress and triggering catabolic pathways.\u003cbr\u003e\u003cbr\u003e - \u003cstrong\u003eGlycolysis Enhancement and AICAR Buildup:\u003c\/strong\u003e MOTS-c promotes glycolysis by shifting cellular reliance from oxidative phosphorylation (OXPHOS) to glycolytic flux under stress. This is achieved via AICAR-mediated AMPK activation, which phosphorylates targets like ACC (acetyl-CoA carboxylase), inhibiting fatty acid synthesis and favoring glucose uptake.\u003cbr\u003eRecent studies (e.g., 2025 Nature article) confirm MOTS-c's role in pancreatic islets, where it boosts glycolytic enzymes like PFK1, preventing senescence.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eNAD+ Improvement and AMPK Synergy:\u003c\/strong\u003e MOTS-c elevates NAD+ levels by enhancing NAD+ salvage pathways and mitochondrial biogenesis via PGC-1α upregulation. Although AMPK activation typically depletes NAD+ in acute states, MOTS-c's chronic effects parallel NAD+ boosting (e.g., via SIRT1 activation), resolving the apparent paradox. This dual action supports mitochondrial repair and energy efficiency, as seen in 2025 NIH studies\u003cbr\u003eshowing restored OXPHOS and reduced ATP hydrolysis in damaged mitochondria.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003ep53 Upregulation and NF-κB Downregulation:\u003c\/strong\u003e MOTS-c translocates to the nucleus, interacting with transcription factors to increase p53 expression, promoting DNA repair and apoptosis in stressed cells. Conversely, it suppresses NF-κB signaling, reducing pro-inflammatory cytokines like TNF-α and CRP. This anti-inflammatory profile is key for metabolic health, without elevating homocysteine or other markers, despite increased methylation (via methionine cycle modulation).\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMitochondrial Damage Repair:\u003c\/strong\u003e MOTS-c improves mitochondrial function by increasing ROS in a controlled manner ( hormesis), enhancing OXPHOS capacity, and mitigating damage from aging or diabetes. 2025 Springer studies on diabetic cardiomyopathy show MOTS-c restores membrane potential and biogenesis, acting as a mitohormetic agent.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMetabolic and Physiological Benefits\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c's MoA extends to systemic effects, positioning it as a therapeutic for obesity, insulin resistance, and muscle health.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eObesity Prevention and Body Recomposition:\u003c\/strong\u003e By activating AMPK, MOTS-c inhibits lipogenesis and promotes fat oxidation, preventing weight gain and liver fat accumulation (2025 Taylor \u0026amp; Francis study). It aids body recomposition by enhancing lean mass through myostatin inhibition, reducing muscle atrophy signals. This is particularly beneficial for age-related sarcopenia, where MOTS-c mimics exercise-induced muscle adaptations.\u003cbr\u003e\u003cbr\u003e-\u003cstrong\u003e Insulin Resistance Improvement: \u003c\/strong\u003eMOTS-c enhances insulin sensitivity via GLUT4 translocation and IRS-1 phosphorylation, countering resistance in type 2 diabetes models. In 2025 Nature research, it protected pancreatic islets in nonobese diabetic mice, improving glucose tolerance.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eExercise Mimetic Properties:\u003c\/strong\u003e As an \"exercise in a pill\", MOTS-c replicates endurance training effects by boosting AMPK and PGC-1α, increasing mitochondrial density and aerobic capacity. 2025-2026 studies link exercise intensity to circulating MOTS-c levels, correlating with metabolic improvements.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMethylation Effects Without Inflammatory Drawbacks:\u003c\/strong\u003e MOTS-c increases global DNA methylation by altering one-carbon metabolism, supporting epigenetic stability. However, it does not elevate inflammatory markers (CRP,TNF-α) or homocysteine, avoiding risks associated with hypermethylation therapies.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSimilarities to Humanin and Applications in Neurodegeneration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c exhibits Humanin-like effects, including neuroprotection and anti-apoptotic actions, but with a distinct structure (no shared sequence motifs) and administration routes (e.g., injectable vs. oral potential). In neurodegenerative diseases, MOTS-c modulates AMPK in neurons, reducing amyloid aggregation and tau phosphorylation. 2025 studies suggest applications in Alzheimer\u0026amp;#39;s, where it preserves synaptic function and mitochondrial integrity, differing from Humanin's IGFBP-3 binding. \u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e101\u003c\/sub\u003eH\u003csub\u003e152\u003c\/sub\u003eN\u003csub\u003e28\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003e Mitochondria-derived peptide, mots-c, EX-A626, Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e2174.6 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e1627580-64-6\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e146675088\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e \u003cspan class=\"value\"\u003e10 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Mots-c.png?v=1768051802\" alt=\"Mots-c peptide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/146675088#section=2D-Structure\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52417743290634,"sku":null,"price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52417743323402,"sku":null,"price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/motsc_10mg.png?v=1768895729"},{"product_id":"mots-c-20-mg-research-grade","title":"MOTS-c 20 mg Mitochondrial Peptide (Research Grade)","description":"\u003ch3\u003eMOTS-c Peptide Introduction and Overview\u003cbr\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. MOTS-C is examined in experimental models investigating mitochondrial signaling, cellular energy regulation, and metabolic adaptation. Research interest centers on how cells respond to energetic stress and efficiency-related signals.\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded by the mitochondrial genome (mtDNA). Discovered in 2015, it functions as a mitochondrial-derived peptide (MDP) with systemic regulatory roles. Unlike traditional mitochondrial proteins, MOTS-c translocates from mitochondria to the nucleus, influencing gene expression and metabolic pathways. Its molecular-level mechanism of action (MoA) centers on modulating cellular energy homeostasis, primarily through AMPK activation and purine metabolism interference. Recent studies (2025-2026) highlight its potential in metabolic disorders, aging, and neurodegeneration, with applications as an exercise mimetic. Structurally distinct from other MDPs like Humanin (a 24-amino acid peptide), MOTS-c shares cytoprotective effects but targets different pathways, making it promising for neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCore Molecular Mechanism\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, MOTS-c regulates metabolism by inhibiting the folate\/methionine cycle in the nucleus. It binds to nuclear factors, reducing de novo purine biosynthesis, which leads to accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR is a potent activator of AMP-activated protein kinase (AMPK), mimicking energy stress and triggering catabolic pathways.\u003cbr\u003e\u003cbr\u003e - \u003cstrong\u003eGlycolysis Enhancement and AICAR Buildup:\u003c\/strong\u003e MOTS-c promotes glycolysis by shifting cellular reliance from oxidative phosphorylation (OXPHOS) to glycolytic flux under stress. This is achieved via AICAR-mediated AMPK activation, which phosphorylates targets like ACC (acetyl-CoA carboxylase), inhibiting fatty acid synthesis and favoring glucose uptake.\u003cbr\u003eRecent studies (e.g., 2025 Nature article) confirm MOTS-c's role in pancreatic islets, where it boosts glycolytic enzymes like PFK1, preventing senescence.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eNAD+ Improvement and AMPK Synergy:\u003c\/strong\u003e MOTS-c elevates NAD+ levels by enhancing NAD+ salvage pathways and mitochondrial biogenesis via PGC-1α upregulation. Although AMPK activation typically depletes NAD+ in acute states, MOTS-c's chronic effects parallel NAD+ boosting (e.g., via SIRT1 activation), resolving the apparent paradox. This dual action supports mitochondrial repair and energy efficiency, as seen in 2025 NIH studies\u003cbr\u003eshowing restored OXPHOS and reduced ATP hydrolysis in damaged mitochondria.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003ep53 Upregulation and NF-κB Downregulation:\u003c\/strong\u003e MOTS-c translocates to the nucleus, interacting with transcription factors to increase p53 expression, promoting DNA repair and apoptosis in stressed cells. Conversely, it suppresses NF-κB signaling, reducing pro-inflammatory cytokines like TNF-α and CRP. This anti-inflammatory profile is key for metabolic health, without elevating homocysteine or other markers, despite increased methylation (via methionine cycle modulation).\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMitochondrial Damage Repair:\u003c\/strong\u003e MOTS-c improves mitochondrial function by increasing ROS in a controlled manner ( hormesis), enhancing OXPHOS capacity, and mitigating damage from aging or diabetes. 2025 Springer studies on diabetic cardiomyopathy show MOTS-c restores membrane potential and biogenesis, acting as a mitohormetic agent.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMetabolic and Physiological Benefits\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c's MoA extends to systemic effects, positioning it as a therapeutic for obesity, insulin resistance, and muscle health.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eObesity Prevention and Body Recomposition:\u003c\/strong\u003e By activating AMPK, MOTS-c inhibits lipogenesis and promotes fat oxidation, preventing weight gain and liver fat accumulation (2025 Taylor \u0026amp; Francis study). It aids body recomposition by enhancing lean mass through myostatin inhibition, reducing muscle atrophy signals. This is particularly beneficial for age-related sarcopenia, where MOTS-c mimics exercise-induced muscle adaptations.\u003cbr\u003e\u003cbr\u003e-\u003cstrong\u003e Insulin Resistance Improvement: \u003c\/strong\u003eMOTS-c enhances insulin sensitivity via GLUT4 translocation and IRS-1 phosphorylation, countering resistance in type 2 diabetes models. In 2025 Nature research, it protected pancreatic islets in nonobese diabetic mice, improving glucose tolerance.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eExercise Mimetic Properties:\u003c\/strong\u003e As an \u0026amp;quot;exercise in a pill,\u0026amp;quot; MOTS-c replicates endurance training effects by boosting AMPK and PGC-1α, increasing mitochondrial density and aerobic capacity. 2025-2026 studies link exercise intensity to circulating MOTS-c levels, correlating with metabolic improvements.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMethylation Effects Without Inflammatory Drawbacks:\u003c\/strong\u003e MOTS-c increases global DNA methylation by altering one-carbon metabolism, supporting epigenetic stability. However, it does not elevate inflammatory markers (CRP,TNF-α) or homocysteine, avoiding risks associated with hypermethylation therapies.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSimilarities to Humanin and Applications in Neurodegeneration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c exhibits Humanin-like effects, including neuroprotection and anti-apoptotic actions, but with a distinct structure (no shared sequence motifs) and administration routes (e.g., injectable vs. oral potential). In neurodegenerative diseases, MOTS-c modulates AMPK in neurons, reducing amyloid aggregation and tau phosphorylation. 2025 studies suggest applications in Alzheimer\u0026amp;#39;s, where it preserves synaptic function and mitochondrial integrity, differing from Humanin's IGFBP-3 binding. \u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eRead more about mitochondrial peptides, exercise adaptation, and cellular energy signaling in our mitochondrial health deep dive.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003e \u003cstrong\u003eProduct Description: \u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e101\u003c\/sub\u003eH\u003csub\u003e152\u003c\/sub\u003eN\u003csub\u003e28\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003e Mitochondria-derived peptide, mots-c, EX-A626, Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e2174.6 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e1627580-64-6\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e146675088\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e2\u003cspan class=\"value\"\u003e0 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Mots-c_1.png?v=1768052342\" alt=\"Mots-c structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/146675088#section=2D-Structure\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52398804631818,"sku":null,"price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen (1 )","offer_id":52398804664586,"sku":null,"price":205.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/motsc_20mg.png?v=1768896003"},{"product_id":"selank-50mg","title":"Selank 50mg – Research Peptide","description":"\u003ch3\u003eIntroduction\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Selank is studied in research models exploring stress regulation, cognitive signaling, and neuroimmune communication. It is commonly examined in experimental systems focused on emotional balance, attention-related pathways, and adaptive neural responses.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of tuftsin, a natural immunomodulatory tetrapeptide derived from the heavy chain of human immunoglobulin G. Selank was created to combine anxiolytic (anti-anxiety), nootropic (cognitive-enhancing), and immunomodulatory properties. It is primarily used in Russia and Ukraine for treating generalized anxiety disorders, neurasthenia, and cognitive impairments. Unlike traditional anxiolytics like benzodiazepines, Selank reportedly lacks sedative effects, addiction potential, or withdrawal symptoms. It is administered intranasally or intravenously, subcutaneously often as a lyophilized powder reconstituted in sterile water, requiring refrigeration for stability.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eChemical Structure\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), a seven-amino-acid chain. The first four residues (Thr-Lys-Pro-Arg) mimic tuftsin, extended by Pro-Gly-Pro to enhance metabolic stability and prolong action.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMechanism of Action (Molecular Level)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, Selank acts as a positive allosteric modulator of GABA_A receptors, enhancing their affinity for gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter. This modulation inhibits central nervous system excitability, contributing to anxiolytic effects without the side effects of benzodiazepines.\u003cbr\u003e\u003cbr\u003eSelank alters gene expression in brain regions like the frontal cortex. In rat models, intranasal administration (300 μg\/kg) changes expression of 45 neurotransmission-related genes, with overlaps to GABA's effects. Key alterations include:\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA receptor subunits like Gabre (ε, ~20-fold at 1 hour) and Gabrq (θ, ~20-fold at 1 hour), reducing inhibitory tone.\u003cbr\u003e\u003cbr\u003e- Upregulation of others like Gabrb3 (β3, 1.58-fold) and Gabrg3 (γ3, 1.29-fold), enhancing receptor function.\u003cbr\u003e\u003cbr\u003e Modulation of dopamine receptors (Drd1a, Drd2, Drd3) was upregulated at 1 hour, and serotonin receptors (Htr3a, Htr1b).\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA transporters (Slc32a1, Slc6a1, Slc6a11), prolonging GABA availability.\u003cbr\u003e\u003cbr\u003e- Dramatic changes in orexin precursor (Hcrt, ~25-fold downregulation at 1 hour, 128-fold upregulation at 3 hours), aiding sleep-wake regulation.\u003cbr\u003e\u003cbr\u003e- Selank elevates brain-derived neurotrophic factor (BDNF) in the hippocampus, promoting neurogenesis, synaptic plasticity, and cognitive function. It modulates monoamine neurotransmitters: enhancing serotonin metabolism (influencing mood, sleep, and appetite) and dopamine release (improving focus and reward).\u003cbr\u003e\u003cbr\u003e- As a tuftsin analog, it stimulates interleukin-6 (IL-6) and interferon production, balancing T helper cell cytokines for immunomodulation. Enhance the phagocytic function of macrophages.\u003cbr\u003e\u003cbr\u003e- Selank inhibits enkephalin-degrading enzymes, such as carboxypeptidase H, thereby extending the effects of endogenous peptides. It maintains cortisol levels, reducing stress responses.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003ePharmacological Effects and Uses\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank exhibits anxiolytic, antidepressant, and nootropic effects in animal and human studies. It reduces anxiety and asthenia in patients with generalized anxiety disorders, improving emotional stability and cognitive performance.\u003cbr\u003e\u003cbr\u003eNootropic benefits include enhanced memory, concentration, learning, and mental endurance via BDNF upregulation and neural plasticity. It protects against alcohol-induced cognitive deficits by regulating BDNF in the hippocampus and frontal cortex.\u003cbr\u003e\u003cbr\u003eSelank, as a tuftsin analog, has neuroprotective and immunomodulatory properties that could theoretically benefit neurodegenerative conditions like ALS, Parkinson’s Disease, and Multiple Sclerosis, which involve motor neuron degeneration, inflammation, and oxidative stress.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparative research context:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader comparison of neuropeptide research compounds, including Selank, Semax, and Dihexa, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003eSemax vs Selank vs Dihexa – Key research differences\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFurther research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of Selank, including its molecular structure, neuroregulatory signaling mechanisms, and role in experimental neuroimmune models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-selank\"\u003e\u003cstrong\u003eWhat is Selank? – A Regulatory Neuropeptide in Experimental Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003e\u003cstrong\u003eOCD Circuit-Level Neurobiology Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003eThr-Lys-Pro-Arg-Pro-Gly-Pro, L-Proline, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-, Selanc, UNII-TS9JR8EP1G\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e751.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e129954-34-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e11765600\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e \u003cspan class=\"value\"\u003e50 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Selank.png?v=1768053286\" alt=\"Selank structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11765600\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52423539523850,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52423539556618,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/selank_50mg.png?v=1768901930"},{"product_id":"selank-25mg","title":"Selank 25mg – Research Peptide","description":"\u003ch3\u003eSelank Introduction\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Selank is studied in research models exploring stress regulation, cognitive signaling, and neuroimmune communication. It is commonly examined in experimental systems focused on emotional balance, attention-related pathways, and adaptive neural responses.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of tuftsin, a natural immunomodulatory tetrapeptide derived from the heavy chain of human immunoglobulin G. Selank was created to combine anxiolytic (anti-anxiety), nootropic (cognitive-enhancing), and immunomodulatory properties. It is primarily used in Russia and Ukraine for treating generalized anxiety disorders, neurasthenia, and cognitive impairments. Unlike traditional anxiolytics like benzodiazepines, Selank reportedly lacks sedative effects, addiction potential, or withdrawal symptoms. It is administered intranasally or intravenously, subcutaneously often as a lyophilized powder reconstituted in sterile water, requiring refrigeration for stability.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eChemical Structure\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), a seven-amino-acid chain. The first four residues (Thr-Lys-Pro-Arg) mimic tuftsin, extended by Pro-Gly-Pro to enhance metabolic stability and prolong action.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMechanism of Action (Molecular Level)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, Selank acts as a positive allosteric modulator of GABA_A receptors, enhancing their affinity for gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter. This modulation inhibits central nervous system excitability, contributing to anxiolytic effects without the side effects of benzodiazepines.\u003cbr\u003e\u003cbr\u003eSelank alters gene expression in brain regions like the frontal cortex. In rat models, intranasal administration (300 μg\/kg) changes expression of 45 neurotransmission-related genes, with overlaps to GABA's effects. Key alterations include:\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA receptor subunits like Gabre (ε, ~20-fold at 1 hour) and Gabrq (θ, ~20-fold at 1 hour), reducing inhibitory tone.\u003cbr\u003e\u003cbr\u003e- Upregulation of others like Gabrb3 (β3, 1.58-fold) and Gabrg3 (γ3, 1.29-fold), enhancing receptor function.\u003cbr\u003e\u003cbr\u003e Modulation of dopamine receptors (Drd1a, Drd2, Drd3) was upregulated at 1 hour, and serotonin receptors (Htr3a, Htr1b).\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA transporters (Slc32a1, Slc6a1, Slc6a11), prolonging GABA availability.\u003cbr\u003e\u003cbr\u003e- Dramatic changes in orexin precursor (Hcrt, ~25-fold downregulation at 1 hour, 128-fold upregulation at 3 hours), aiding sleep-wake regulation.\u003cbr\u003e\u003cbr\u003e- Selank elevates brain-derived neurotrophic factor (BDNF) in the hippocampus, promoting neurogenesis, synaptic plasticity, and cognitive function. It modulates monoamine neurotransmitters: enhancing serotonin metabolism (influencing mood, sleep, and appetite) and dopamine release (improving focus and reward).\u003cbr\u003e\u003cbr\u003e- As a tuftsin analog, it stimulates interleukin-6 (IL-6) and interferon production, balancing T helper cell cytokines for immunomodulation. Enhance the phagocytic function of macrophages.\u003cbr\u003e\u003cbr\u003e- Selank inhibits enkephalin-degrading enzymes, such as carboxypeptidase H, thereby extending the effects of endogenous peptides. It maintains cortisol levels, reducing stress responses.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003ePharmacological Effects and Uses\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank exhibits anxiolytic, antidepressant, and nootropic effects in animal and human studies. It reduces anxiety and asthenia in patients with generalized anxiety disorders, improving emotional stability and cognitive performance.\u003cbr\u003e\u003cbr\u003eNootropic benefits include enhanced memory, concentration, learning, and mental endurance via BDNF upregulation and neural plasticity. It protects against alcohol-induced cognitive deficits by regulating BDNF in the hippocampus and frontal cortex.\u003cbr\u003e\u003cbr\u003eSelank, as a tuftsin analog, has neuroprotective and immunomodulatory properties that could theoretically benefit neurodegenerative conditions like ALS, Parkinson’s Disease, and Multiple Sclerosis, which involve motor neuron degeneration, inflammation, and oxidative stress.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparative research context:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader comparative overview of Selank in relation to other neuropeptide research compounds, including Semax and Dihexa, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003eSemax vs Selank vs Dihexa – Key research differences\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFurther research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of Selank, including its molecular structure, neuroregulatory signaling mechanisms, and role in experimental neuroimmune models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-selank\"\u003e\u003cstrong\u003eWhat is Selank? – A Regulatory Neuropeptide in Experimental Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003e\u003cstrong\u003eOCD Circuit-Level Neurobiology Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\u003cspan\u003eChemical Formula : C\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003eThr-Lys-Pro-Arg-Pro-Gly-Pro, L-Proline, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-, Selanc, UNII-TS9JR8EP1G\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e751.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e129954-34-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e11765600\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e2\u003cspan class=\"value\"\u003e5 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Selank_1.png?v=1768053588\" alt=\"Selank peptide structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11765600\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52423541031178,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52423541063946,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/selank_25mg.png?v=1768901804"},{"product_id":"orforglipron-metabolic-signaling-capsules","title":"Orforglipron – Oral Small-Molecule for Metabolic Signaling Research","description":"\u003cp style=\"margin-bottom: 0cm;\"\u003eOrforglipron is a small-molecule compound studied in research models examining metabolic signaling pathways and incretin-related mechanisms. It is commonly referenced in experimental work focused on energy regulation, nutrient-responsive signaling, and cellular metabolic processes.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eRecommended Research Pairings\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eIn experimental research settings, orforglipron is often discussed alongside compounds studied in relation to metabolic signaling, endocrine communication, and cellular adaptation. These pairings reflect commonly explored combinations within controlled laboratory environments.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10mg\"\u003eCJC-1295\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003eCJC-1295 is examined in growth hormone–related signaling research and is sometimes referenced in studies exploring interactions between endocrine pathways and metabolic regulation.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003eTesamorelin\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003eTesamorelin is studied in research models involving GH-axis signaling and is frequently examined in contexts related to body composition and metabolic communication pathways.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003eIpamorelin\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003eIpamorelin is a selective GHRP investigated in experimental settings focused on endocrine signaling responsiveness and anabolic pathway dynamics.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003eGlutathione\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003eGlutathione is widely studied in cellular redox balance and antioxidant-related pathways and is often referenced alongside metabolic compounds in research exploring oxidative stress and signaling interactions.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003eDihexa\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003eDihexa is examined in neurotrophic and synaptic signaling research and may be included in broader experimental models investigating central signaling and metabolic cross-talk.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-section-id=\"z1pmfb\" data-start=\"0\" data-end=\"28\"\u003eOrforglipron Description\u003c\/h3\u003e\n\u003cp data-start=\"30\" data-end=\"157\"\u003eOrforglipron is an orally active small-molecule research compound studied for GLP-1 receptor signaling in metabolic regulation.\u003c\/p\u003e\n\u003cp data-start=\"159\" data-end=\"419\"\u003eIt activates the receptor for GLP-1, a hormone produced in the intestines after meals. This activation causes the pancreas to release insulin in a way that depends on blood sugar levels being elevated. It also reduces the release of glucagon from the pancreas.\u003c\/p\u003e\n\u003cp data-start=\"421\" data-end=\"585\"\u003eThe compound slows the rate at which food leaves the stomach. In the brain, it is associated with reduced appetite signaling and increased satiety-related pathways.\u003c\/p\u003e\n\u003cp data-start=\"587\" data-end=\"719\"\u003eBecause it is a small synthetic molecule rather than a large peptide, it can be absorbed effectively from the gut when taken orally.\u003c\/p\u003e\n\u003cp data-start=\"721\" data-end=\"948\"\u003eStudies conducted in animals demonstrated that it lowers blood sugar and reduces food intake. Human clinical trials have shown significant reductions in body weight and improvements in blood sugar control over extended periods.\u003c\/p\u003e\n\u003cp data-start=\"950\" data-end=\"1109\"\u003eIt has also been associated with favorable changes in cardiovascular risk-related markers such as blood pressure, cholesterol levels, and inflammatory markers.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1nplsaw\" data-start=\"1111\" data-end=\"1144\"\u003eMolecular Mechanism of Action\u003c\/h3\u003e\n\u003cp data-start=\"1146\" data-end=\"1493\"\u003eOrforglipron, also known as LY3502970, functions as a non-peptide small-molecule agonist of the glucagon-like peptide-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) characterized by its distinctive two-domain architecture consisting of a large N-terminal extracellular domain (ECD) and a seven-transmembrane (7TM) helical bundle.\u003c\/p\u003e\n\u003cp data-start=\"1495\" data-end=\"1920\"\u003eAt the molecular level, peptide-based GLP-1 receptor agonists engage the receptor through a canonical two-step mechanism: the C-terminal portion of the peptide first docks onto the ECD for high-affinity recognition, followed by insertion of the N-terminal helical segment deep into the orthosteric pocket formed by the transmembrane helices, ultimately stabilizing the active receptor conformation that couples to Gs protein.\u003c\/p\u003e\n\u003cp data-start=\"1922\" data-end=\"2236\"\u003eIn contrast, orforglipron employs a distinct, ECD-driven binding mode that positions the ligand high within the upper helical bundle, interacting exclusively with the ECD, extracellular loop 2 (ECL2), and transmembrane helices 1 (TM1), 2 (TM2), 3 (TM3), and 7 (TM7), while avoiding contacts with TM4, TM5, and TM6.\u003c\/p\u003e\n\u003cp data-start=\"2238\" data-end=\"2545\"\u003eHigh-resolution cryo-EM structures of the active-state GLP-1R complexed with orforglipron and Gs protein reveal that the molecule occupies a unique pocket where its indole-tetrahydropyran branch engages in aromatic and hydrophobic interactions with Trp33 in the ECD, effectively using this residue as a lid.\u003c\/p\u003e\n\u003cp data-start=\"2547\" data-end=\"2941\"\u003eIts 4-fluoro-1-methyl-indazole moiety slots between TM1 and TM2 with aromatic stacking against Tyr205^{2.75} and Tyr145^{1.40}; the 3,5-dimethyl-4-fluoro-phenyl ring forms hydrophobic contacts with residues on TM1 (Leu141^{1.36}, Leu144^{1.39}, Tyr148^{1.43}) and TM7 (Leu384^{7.39}, Leu388^{7.43}); and the 4H-1,2,4-oxadiazol-5-one group establishes critical hydrogen bonds with Lys197^{2.67}.\u003c\/p\u003e\n\u003cp data-start=\"2943\" data-end=\"3248\"\u003eThis binding induces specific conformational rearrangements, including an outward shift of TM7, an inward movement of TM1 toward it, and a unique kink at the extracellular end of TM1 starting at Leu141^{1.36}, alongside repositioning of TM2 farther from TM3 to accommodate the ligand's branched structure.\u003c\/p\u003e\n\u003cp data-start=\"3250\" data-end=\"3491\"\u003eThe ECD itself adopts an orientation tilted toward ECL1, with its aromatic patch (Trp39, Tyr69, Tyr88) packing directly against His212 and Trp214 in ECL1, differing markedly from the peptide-separated configuration in GLP-1-bound structures.\u003c\/p\u003e\n\u003cp data-start=\"3493\" data-end=\"3732\"\u003eThese changes stabilize an active-state receptor conformation capable of Gs coupling but with distinct dynamics in the TM6-ECL3-TM7 region, where the lack of full stabilization above Arg380^{7.35} prevents efficient β-arrestin recruitment.\u003c\/p\u003e\n\u003ch3 data-section-id=\"135auqx\" data-start=\"3734\" data-end=\"3771\"\u003eG-Protein-Biased GLP-1R Signaling\u003c\/h3\u003e\n\u003cp data-start=\"3773\" data-end=\"3974\"\u003eThis structural arrangement underpins orforglipron's pharmacological profile as a high-affinity, selective partial agonist that exhibits strong bias toward G-protein signaling over β-arrestin pathways.\u003c\/p\u003e\n\u003cp data-start=\"3976\" data-end=\"4265\"\u003eIn functional assays, it potently stimulates Gs-mediated adenylate cyclase activation, leading to robust accumulation of cyclic AMP (cAMP) comparable in potency to native GLP-1, yet with lower maximal efficacy and virtually no detectable β-arrestin recruitment or receptor internalization.\u003c\/p\u003e\n\u003cp data-start=\"4267\" data-end=\"4576\"\u003eThe biased signaling arises because orforglipron fails to fully engage the extracellular portions of TM6-ECL3-TM7 that full peptide agonists stabilize to facilitate β-arrestin docking. Instead, its interactions leave Arg380^{7.35} shifted away from TM5, a conformation associated with reduced desensitization.\u003c\/p\u003e\n\u003cp data-start=\"4578\" data-end=\"4813\"\u003eDownstream, elevated cAMP activates protein kinase A (PKA), which in pancreatic beta cells phosphorylates targets that enhance voltage-gated calcium channel activity and promote insulin granule exocytosis in a glucose-dependent manner.\u003c\/p\u003e\n\u003cp data-start=\"4815\" data-end=\"4967\"\u003eIn alpha cells, PKA-mediated pathways suppress glucagon release, thereby lowering hepatic glucose output via reduced glycogenolysis and gluconeogenesis.\u003c\/p\u003e\n\u003cp data-start=\"4969\" data-end=\"5151\"\u003ePeripherally, the signaling delays gastric emptying through vagal and direct enteric effects on smooth muscle motility, prolonging nutrient absorption and amplifying satiety signals.\u003c\/p\u003e\n\u003cp data-start=\"5153\" data-end=\"5417\"\u003eCentrally, GLP-1R activation in hypothalamic arcuate nucleus and brainstem nuclei modulates neuropeptide Y\/agouti-related peptide neurons and pro-opiomelanocortin\/cocaine- and amphetamine-regulated transcript neurons to suppress appetite and food-seeking behavior.\u003c\/p\u003e\n\u003cp data-start=\"5419\" data-end=\"5719\"\u003eThe reduced β-arrestin engagement may translate to sustained receptor responsiveness with repeated exposure, potentially offering advantages in long-term signaling durability compared to balanced agonists that promote more pronounced desensitization through internalization and lysosomal trafficking.\u003c\/p\u003e\n\u003cp data-start=\"5721\" data-end=\"5999\"\u003eAs a non-peptide, orforglipron bypasses proteolytic degradation by dipeptidyl peptidase-4 and other proteases, conferring inherent oral bioavailability and metabolic stability without the need for lipidation or other peptide modifications common in synthesized incretin analogs.\u003c\/p\u003e\n\u003ch3 data-section-id=\"pxh5eu\" data-start=\"6001\" data-end=\"6036\"\u003ePotential Research Applications\u003c\/h3\u003e\n\u003cp data-start=\"6038\" data-end=\"6201\"\u003ePotential research applications stem directly from this molecular pharmacology and the broad physiological roles of GLP-1R signaling across multiple organ systems.\u003c\/p\u003e\n\u003cp data-start=\"6203\" data-end=\"6462\"\u003eIn type 2 diabetes research, the glucose-dependent enhancement of insulin secretion combined with glucagon suppression supports investigation of incretin-related effects on postprandial and fasting glycemia while preserving beta-cell responsiveness over time.\u003c\/p\u003e\n\u003cp data-start=\"6464\" data-end=\"6656\"\u003eFor obesity and body-composition research, central appetite signaling and delayed gastric emptying are studied in relation to caloric intake, satiety pathways, and fat-mass-associated changes.\u003c\/p\u003e\n\u003cp data-start=\"6658\" data-end=\"6743\"\u003eCardiometabolic research interest arises from direct and indirect effects, including:\u003c\/p\u003e\n\u003cul data-start=\"6745\" data-end=\"7040\"\u003e\n\u003cli data-section-id=\"dxtsr4\" data-start=\"6745\" data-end=\"6827\"\u003esystolic blood pressure modulation through vasodilatory and natriuretic actions,\u003c\/li\u003e\n\u003cli data-section-id=\"dnb0es\" data-start=\"6828\" data-end=\"6953\"\u003elipid-profile changes through reduced hepatic very-low-density lipoprotein output and enhanced lipoprotein lipase activity,\u003c\/li\u003e\n\u003cli data-section-id=\"yph4ts\" data-start=\"6954\" data-end=\"7040\"\u003eand inflammatory-marker changes such as lowered high-sensitivity C-reactive protein.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"7042\" data-end=\"7361\"\u003eBroader research applications include conditions sharing metabolic dysregulation, such as obstructive sleep apnea models where body-weight and glycemic changes may influence hypoxia-driven inflammation, or hypertension models where GLP-1R-mediated endothelial nitric oxide production contributes to vascular relaxation.\u003c\/p\u003e\n\u003cp data-start=\"7363\" data-end=\"7580\"\u003eIn transition studies from injectable incretin therapies, orforglipron has been evaluated for weight-maintenance-associated outcomes through continuous receptor engagement in an oral format that may support adherence.\u003c\/p\u003e\n\u003cp data-start=\"7582\" data-end=\"7892\"\u003eIts small-molecule nature also positions it for investigation alongside other oral agents targeting complementary pathways, such as SGLT2 inhibition or DPP-4 modulation, to study additive or synergistic effects on glycemic control and weight-related parameters without overlapping peptide synthesis challenges.\u003c\/p\u003e\n\u003cp data-start=\"7894\" data-end=\"8229\"\u003eOverall, the biased agonism and oral delivery profile address key limitations of peptide-based incretin systems — manufacturing complexity, cold-chain requirements, injection burden, and variable gastrointestinal tolerability — while retaining core incretin-related signaling, making it relevant for scalable metabolic research models.\u003c\/p\u003e\n\u003ch3 data-section-id=\"jx7l6p\" data-start=\"8231\" data-end=\"8264\"\u003ePreclinical Research Findings\u003c\/h3\u003e\n\u003cp data-start=\"8266\" data-end=\"8389\"\u003ePreclinical evaluation in animal models established target engagement and efficacy consistent with the molecular mechanism.\u003c\/p\u003e\n\u003cp data-start=\"8391\" data-end=\"8623\"\u003eIn vitro, orforglipron demonstrated potent and selective activation of human GLP-1R expressed in recombinant systems, with cAMP accumulation mirroring native GLP-1 potency but partial maximal response and absent β-arrestin activity.\u003c\/p\u003e\n\u003cp data-start=\"8625\" data-end=\"8723\"\u003eFunctional glucose-dependent insulin secretion was confirmed in isolated human and primate islets.\u003c\/p\u003e\n\u003cp data-start=\"8725\" data-end=\"8933\"\u003eSpecies selectivity was evident due to the critical dependence on primate-specific Trp33 in the ECD; orforglipron showed no activity at rodent GLP-1R but robust agonism in cells expressing the human receptor.\u003c\/p\u003e\n\u003cp data-start=\"8935\" data-end=\"9291\"\u003eIn vivo, oral administration to mice engineered with human GLP-1R knocked in at the endogenous locus produced dose-responsive reductions in glucose excursion during intraperitoneal glucose tolerance tests, with efficacy comparable to subcutaneously administered exenatide and complete abrogation in GLP-1R knockout littermates, confirming on-target action.\u003c\/p\u003e\n\u003cp data-start=\"9293\" data-end=\"9582\"\u003eIn diet-induced obese rodent models sensitized to human receptor pharmacology, repeated oral exposure led to sustained reductions in food intake, body weight, and adiposity, with improvements in insulin sensitivity and hepatic lipid content paralleling those of benchmark peptide agonists.\u003c\/p\u003e\n\u003cp data-start=\"9584\" data-end=\"9943\"\u003eNon-human primate studies in cynomolgus monkeys provided the most translationally relevant data, where orforglipron stimulated glucose-dependent insulin secretion during hyperglycemic clamps and acutely reduced food consumption during ad libitum feeding periods, accompanied by lowered body weight over chronic administration without overt behavioral changes.\u003c\/p\u003e\n\u003cp data-start=\"9945\" data-end=\"10179\"\u003ePharmacokinetic profiling across species confirmed high oral bioavailability attributable to metabolic stability and favorable absorption kinetics, with central nervous system penetration sufficient for hypothalamic GLP-1R engagement.\u003c\/p\u003e\n\u003cp data-start=\"10181\" data-end=\"10502\"\u003eThese animal data collectively validated the biased partial agonism as sufficient for full physiological responses in vivo, likely due to receptor reserve in target tissues, and supported advancement by demonstrating a safety margin aligned with GLP-1 class effects, primarily transient gastrointestinal motility changes.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1e3uqux\" data-start=\"10504\" data-end=\"10540\"\u003eHuman Clinical Research Findings\u003c\/h3\u003e\n\u003cp data-start=\"10542\" data-end=\"10671\"\u003eSummary of human and animal trials underscores consistent translation of the molecular mechanism into clinical research outcomes.\u003c\/p\u003e\n\u003cp data-start=\"10673\" data-end=\"11165\"\u003ePhase 1 investigations in healthy volunteers and participants with type 2 diabetes confirmed oral bioavailability, dose-proportional pharmacokinetics with a terminal half-life supporting once-daily administration, and pharmacodynamic effects including lowered fasting glucose, delayed gastric emptying, and modest short-term body-weight reductions alongside typical class-related gastrointestinal adverse events that were predominantly mild to moderate and attenuated with continued exposure.\u003c\/p\u003e\n\u003cp data-start=\"11167\" data-end=\"11547\"\u003ePhase 2 randomized, placebo-controlled trials in adults with obesity or overweight plus weight-related comorbidities demonstrated progressive, clinically meaningful percentage reductions in body weight over 36 weeks that exceeded placebo by substantial margins, accompanied by improvements in waist circumference, systolic blood pressure, fasting lipids, and inflammatory markers.\u003c\/p\u003e\n\u003cp data-start=\"11549\" data-end=\"11888\"\u003eIn parallel phase 2 studies enrolling participants with type 2 diabetes inadequately controlled on background therapy, orforglipron produced marked declines in glycated hemoglobin alongside concurrent body-weight loss and cardiometabolic enhancements, with glycemic improvements evident within the first few weeks and sustained thereafter.\u003c\/p\u003e\n\u003cp data-start=\"11890\" data-end=\"12002\"\u003eThe safety profile mirrored that of established GLP-1 receptor agonists, with gastrointestinal events including:\u003c\/p\u003e\n\u003cul data-start=\"12004\" data-end=\"12056\"\u003e\n\u003cli data-section-id=\"1wityjy\" data-start=\"12004\" data-end=\"12013\"\u003enausea,\u003c\/li\u003e\n\u003cli data-section-id=\"qzkoju\" data-start=\"12014\" data-end=\"12025\"\u003evomiting,\u003c\/li\u003e\n\u003cli data-section-id=\"1srunr7\" data-start=\"12026\" data-end=\"12037\"\u003ediarrhea,\u003c\/li\u003e\n\u003cli data-section-id=\"1hr8wx1\" data-start=\"12038\" data-end=\"12056\"\u003eand constipation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"12058\" data-end=\"12209\"\u003erepresenting the majority of treatment-emergent adverse effects, occurring mainly during initial titration and leading to low rates of discontinuation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"jknvqc\" data-start=\"12211\" data-end=\"12240\"\u003ePhase 3 Research Programs\u003c\/h3\u003e\n\u003cp data-start=\"12242\" data-end=\"12451\"\u003ePhase 3 programs, encompassing the global ATTAIN trials in obesity with or without type 2 diabetes and the ACHIEVE trials focused on type 2 diabetes, replicated and extended these findings over 52 to 72 weeks.\u003c\/p\u003e\n\u003cp data-start=\"12453\" data-end=\"12782\"\u003eIn large-scale, double-blind, placebo-controlled studies involving thousands of participants, orforglipron achieved statistically superior body-weight reductions that continued to accrue without apparent plateau in many cohorts, with high proportions of individuals attaining categorical thresholds of 10 percent or greater loss.\u003c\/p\u003e\n\u003cp data-start=\"12784\" data-end=\"13052\"\u003eIn type 2 diabetes populations, glycated hemoglobin reductions were robust and superior in head-to-head comparisons against oral semaglutide, with accompanying weight-loss advantages and higher rates of achieving glycemic targets below 7 percent or even normal ranges.\u003c\/p\u003e\n\u003cp data-start=\"13054\" data-end=\"13124\"\u003eCardiometabolic secondary endpoints showed consistent benefits across:\u003c\/p\u003e\n\u003cul data-start=\"13126\" data-end=\"13255\"\u003e\n\u003cli data-section-id=\"89yf5b\" data-start=\"13126\" data-end=\"13152\"\u003eblood pressure lowering,\u003c\/li\u003e\n\u003cli data-section-id=\"r0edji\" data-start=\"13153\" data-end=\"13178\"\u003efavorable lipid shifts,\u003c\/li\u003e\n\u003cli data-section-id=\"1w66lge\" data-start=\"13179\" data-end=\"13213\"\u003ewaist circumference contraction,\u003c\/li\u003e\n\u003cli data-section-id=\"ixh4p1\" data-start=\"13214\" data-end=\"13255\"\u003eand reductions in inflammatory indices.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"13257\" data-end=\"13436\"\u003eMaintenance-specific trials further demonstrated the molecule's utility in preserving weight loss achieved with prior injectable incretin therapy upon switch to oral continuation.\u003c\/p\u003e\n\u003cp data-start=\"13438\" data-end=\"13699\"\u003eAcross all phases, adverse events remained predominantly gastrointestinal and transient, with pulse rate increases typical of the class but no signals of increased cardiovascular risk or other serious concerns diverging from GLP-1 receptor agonist expectations.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"13701\" data-end=\"13712\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"13714\" data-end=\"13838\"\u003eCollectively, the trial data affirm orforglipron's ability to deliver peptide-like signaling through a non-peptide scaffold.\u003c\/p\u003e\n\u003cp data-start=\"13840\" data-end=\"13875\"\u003eIts research profile is defined by:\u003c\/p\u003e\n\u003cul data-start=\"13877\" data-end=\"14105\"\u003e\n\u003cli data-section-id=\"9f3vki\" data-start=\"13877\" data-end=\"13902\"\u003eoral GLP-1R activation,\u003c\/li\u003e\n\u003cli data-section-id=\"58j115\" data-start=\"13903\" data-end=\"13932\"\u003eG-protein-biased signaling,\u003c\/li\u003e\n\u003cli data-section-id=\"1crt22n\" data-start=\"13933\" data-end=\"13971\"\u003eglucose-dependent insulin secretion,\u003c\/li\u003e\n\u003cli data-section-id=\"1xzx734\" data-start=\"13972\" data-end=\"13995\"\u003eglucagon suppression,\u003c\/li\u003e\n\u003cli data-section-id=\"19htc11\" data-start=\"13996\" data-end=\"14030\"\u003eappetite and satiety modulation,\u003c\/li\u003e\n\u003cli data-section-id=\"1byqj7p\" data-start=\"14031\" data-end=\"14062\"\u003ebody-weight-related outcomes,\u003c\/li\u003e\n\u003cli data-section-id=\"egtviv\" data-start=\"14063\" data-end=\"14105\"\u003eand cardiometabolic marker improvements.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"14107\" data-end=\"14260\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eThis positions orforglipron as a mechanistically grounded, orally bioavailable research compound that expands flexibility for metabolic disease research.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eFurther Research Reading\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eFor a deeper exploration of orforglipron’s molecular background and signaling pathways:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-orforglipron\"\u003e\u003cstrong\u003eWhat Is Orforglipron? – Metabolic Signaling Research Overview\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo understand how oral compounds compare with injectable metabolic peptides:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/oral-vs-injectable-metabolic-peptides-research\"\u003e\u003cstrong\u003eOral vs Injectable Metabolic Peptides (Retatrutide, Tirzepatide, Orforglipron)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"6 mg per capsule · 60 capsules","offer_id":52530336858378,"sku":null,"price":310.0,"currency_code":"EUR","in_stock":true},{"title":"12 mg per capsule · 60 capsules","offer_id":52530336891146,"sku":null,"price":390.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/orfo6mg_3_1_1.png?v=1770722014"},{"product_id":"1-mna-research-compound-capsules","title":"1-MNA (1-Methylnicotinamide) 60mg – Research Compound","description":"\u003cp\u003e1-MNA is a naturally occurring molecule studied in research models related to NAD⁺ metabolism, cellular energy balance, and vascular signaling. It is frequently referenced in experimental studies exploring metabolic and longevity-associated pathways.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1-Methylnicotinamide chloride powder (1-MNA or MNA)\u003c\/strong\u003e, also known as NMN-Cl, 1-MNA chloride, 3-carbamoyl-1-methyl-pyridinium chloride, or MNC, is a naturally occurring nicotinamide metabolite produced from nicotinamide through the action of N-methyltransferase (NNMT), which methylates nicotinamide (a form of vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor. Long considered an inert excretion product in urine, recent peer-reviewed research establishes 1-MNA as a signaling molecule with anti-inflammatory, antioxidant, anti-thrombotic, anti-fibrotic, and metabolic regulatory effects. It is produced in multiple tissues (liver, skeletal muscle, kidney) and shows promise as a supplement for improving exercise tolerance, reducing fatigue, and protecting cardiometabolic health.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eBiosynthesis and Role as Myokine in Energy Metabolism\u003c\/strong\u003e NNMT is the most consistently upregulated gene in human skeletal muscle after energy-deficit exercise (high-volume, low-intensity training + caloric restriction). Isolated human myotubes secrete 1-MNA, a novel myokine that directly stimulates lipolysis in adipose tissue to mobilize energy stores, with no effect on glucagon or insulin. This coordinates systemic energy utilization during low muscle energy availability and may sense cellular redox shifts (Ström et al., Sci Rep 2018; doi:10.1038\/s41598-018-21099-1).\u003cbr\u003e\u003cbr\u003eIn hepatocytes, NNMT overexpression or 1-MNA treatment stabilizes SIRT1 protein (reducing ubiquitination\/proteasomal degradation), inversely correlating with FoxO1 acetylation. SIRT1 activity modulates gluconeogenesis and suppresses cholesterol synthesis\/lipogenesis, supporting metabolic homeostasis (Roberti et al., Mol Metab 2021; doi:10.1016\/j.molmet.2021.101165; Hong et al., J Biol Chem 2015).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnti-Inflammatory, Antioxidant, and Tissue-Protective Effects\u003c\/strong\u003e 1-MNA inhibits NF-κB activation (preventing p65 nuclear translocation, restoring IκB-α) and upregulates Nrf2 plus downstream antioxidants (HO-1, NQO1).\u003cbr\u003e\u003cbr\u003e- It reduces ROS, inflammation (TNF-α, IL-6, IL-1β ↓ 34–56%), apoptosis (cleaved caspase-3, BAX\/BCL2, TUNEL ↓), hypertrophy, and fibrosis (TGF-β, COL-1, CTGF ↓; collagen volume ↓) in cardiomyocytes and heart tissue.\u003cbr\u003e\u003cbr\u003e- It also lowers plasma triglycerides (↓14%) and LDL (↓35%) (Song et al., Front Cardiovasc Med 2021; doi:10.3389\/fcvm.2021.721814).\u003cbr\u003e\u003cbr\u003eAdditional benefits:\u003cbr\u003e\u003cbr\u003e- Ameliorates lipid toxicity-induced oxidative stress\/cell death in renal proximal tubular cells (in vitro\/in vivo).\u003cbr\u003e- Inhibits NLRP3 inflammasome in human macrophages via ROS reduction (no effect on IL-6 from endotoxin alone).\u003cbr\u003e- Prevents endothelial dysfunction and improves exercise capacity in diabetic\/hypertriglyceridemic models; exerts COX-2\/prostacyclin-mediated anti-thrombotic activity.\u003cbr\u003e- Anti-fibrotic effects are partly mediated by SIRT1 activation, which inhibits TGF-β signaling.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTo explore the role of 1-MNA in NAD⁺ metabolism, cellular signaling, and NNMT pathway research, see:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-1-mna\"\u003eWhat is 1-MNA? – NAD⁺ Metabolism and Cellular Signaling\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/nad-metabolism-5-amino-1mq-vs-1-mna\"\u003e5-Amino-1MQ vs 1-MNA – NNMT Pathway and NAD⁺ Metabolism Research\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eAs a metabolite linked to the NNMT pathway, 1-MNA is often discussed in relation to broader metabolic signaling and energy-related processes in research settings.\u003c\/p\u003e\n\u003cp\u003eFor a deeper look at how metabolic energy pathways and cellular efficiency are studied:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eDiscover how vascular function, mitochondrial metabolism, and exercise-related signaling pathways interact.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan style=\"font-kerning: none;\"\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":52530351767818,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/1mna60mg_3_1.png?v=1770718802"},{"product_id":"folinic-acid-research-compound-capsules","title":"Folinic Acid – Cellular \u0026 Metabolic Research Compound (Capsules)","description":"\u003cp\u003eLeucovorin is a bioactive folate-related compound studied in laboratory research focused on cellular metabolism, nucleotide synthesis, and one-carbon transfer pathways. It is commonly referenced in experimental models examining metabolic resilience and cellular support mechanisms.\u003c\/p\u003e\n\u003ch3 data-start=\"597\" data-end=\"685\"\u003eFolinic Acid (Leucovorin): Reduced Folate in Cellular and Neurodevelopmental Research\u003c\/h3\u003e\n\u003cp data-start=\"687\" data-end=\"992\"\u003eLeucovorin, also known as folinic acid or 5-formyltetrahydrofolate (5-formyl-THF), is a reduced, bioactive folate derivative (Vitamin B9). Unlike folic acid, folinic acid does not require dihydrofolate reductase (DHFR) conversion and can participate directly in intracellular tetrahydrofolate (THF) pools.\u003c\/p\u003e\n\u003cp data-start=\"994\" data-end=\"1308\"\u003eIn biomedical research, folinic acid has long been referenced in oncology settings for its interaction with antifolate compounds and thymidylate synthase pathways. Beyond oncology, it is increasingly examined in neurodevelopmental and metabolic research models involving folate transport and one-carbon metabolism.\u003c\/p\u003e\n\u003ch3 data-start=\"1315\" data-end=\"1363\"\u003eFolate Transport and Cerebral Folate Research\u003c\/h3\u003e\n\u003cp data-start=\"1365\" data-end=\"1429\"\u003eFolate plays a central role in one-carbon metabolism, including:\u003c\/p\u003e\n\u003cul data-start=\"1431\" data-end=\"1651\"\u003e\n\u003cli data-start=\"1431\" data-end=\"1490\"\u003e\n\u003cp data-start=\"1433\" data-end=\"1490\"\u003eDNA and RNA synthesis (purine and thymidylate pathways)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1491\" data-end=\"1547\"\u003e\n\u003cp data-start=\"1493\" data-end=\"1547\"\u003eMethylation reactions via S-adenosylmethionine (SAM)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1548\" data-end=\"1578\"\u003e\n\u003cp data-start=\"1550\" data-end=\"1578\"\u003eNeurotransmitter synthesis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1579\" data-end=\"1601\"\u003e\n\u003cp data-start=\"1581\" data-end=\"1601\"\u003eMyelin maintenance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1602\" data-end=\"1651\"\u003e\n\u003cp data-start=\"1604\" data-end=\"1651\"\u003eRedox balance and oxidative stress regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1653\" data-end=\"1730\"\u003eTransport of folate into the central nervous system primarily occurs through:\u003c\/p\u003e\n\u003col data-start=\"1732\" data-end=\"1869\"\u003e\n\u003cli data-start=\"1732\" data-end=\"1800\"\u003e\n\u003cp data-start=\"1735\" data-end=\"1800\"\u003eHigh-affinity folate receptor alpha (FRα) at the choroid plexus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1801\" data-end=\"1869\"\u003e\n\u003cp data-start=\"1804\" data-end=\"1869\"\u003eReduced folate carrier (RFC) as a secondary transport mechanism\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"1871\" data-end=\"2145\"\u003eIn certain research populations, reduced cerebrospinal fluid (CSF) levels of 5-methyltetrahydrofolate (5-MTHF) have been documented despite normal peripheral folate levels. This phenomenon is commonly described as cerebral folate deficiency (CFD) within research literature.\u003c\/p\u003e\n\u003cp data-start=\"2147\" data-end=\"2552\"\u003eFolate receptor alpha autoantibodies (FRAAs) have been identified in subsets of pediatric neurodevelopmental research cohorts. These antibodies may interfere with FRα-mediated folate transport across the blood-brain barrier. In such contexts, folinic acid has been studied for its ability to utilize the reduced folate carrier (RFC) pathway, potentially bypassing receptor-mediated transport interference.\u003c\/p\u003e\n\u003ch3 data-start=\"2559\" data-end=\"2597\"\u003eNeurodevelopmental Research Context\u003c\/h3\u003e\n\u003cp data-start=\"2599\" data-end=\"3000\"\u003eAltered folate metabolism has been explored in relation to neurodevelopmental research models, including autism spectrum–associated cohorts. Published randomized controlled trials and observational studies have examined folinic acid in FRAA-positive subgroups, documenting changes in verbal communication measures, behavioral scales, and adaptive functioning markers under controlled study conditions.\u003c\/p\u003e\n\u003cp data-start=\"3002\" data-end=\"3160\"\u003eThese findings are interpreted within broader frameworks of methylation balance, oxidative stress modulation, synaptic development, and neurogenesis research.\u003c\/p\u003e\n\u003ch3 data-start=\"3167\" data-end=\"3243\"\u003eDairy Exposure and Folate Receptor Autoantibodies – Research Observations\u003c\/h3\u003e\n\u003cp data-start=\"3245\" data-end=\"3556\"\u003eExperimental and epidemiological investigations have described structural similarity between bovine milk folate-binding proteins and human FRα (reported homology ~91%). This molecular similarity has been proposed as a potential mechanism contributing to cross-reactive antibody formation in certain populations.\u003c\/p\u003e\n\u003cp data-start=\"3558\" data-end=\"3596\"\u003eResearch observations have documented:\u003c\/p\u003e\n\u003cul data-start=\"3598\" data-end=\"3809\"\u003e\n\u003cli data-start=\"3598\" data-end=\"3662\"\u003e\n\u003cp data-start=\"3600\" data-end=\"3662\"\u003eCorrelations between dairy exposure and elevated FRAA titers\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3663\" data-end=\"3735\"\u003e\n\u003cp data-start=\"3665\" data-end=\"3735\"\u003eDownregulation of antibody levels in dairy-restricted dietary models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3736\" data-end=\"3809\"\u003e\n\u003cp data-start=\"3738\" data-end=\"3809\"\u003eCross-reactivity across bovine and other animal-derived milk proteins\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3811\" data-end=\"3925\"\u003eThese findings remain an area of active investigation within immunological and neurodevelopmental research fields.\u003c\/p\u003e\n\u003ch3 data-start=\"3932\" data-end=\"3974\"\u003eBiochemical Distinction from Folic Acid\u003c\/h3\u003e\n\u003cp data-start=\"3976\" data-end=\"4185\"\u003eUnlike synthetic folic acid, which requires enzymatic conversion via DHFR, folinic acid participates directly in reduced folate metabolism and can contribute to intracellular THF pools without DHFR dependence.\u003c\/p\u003e\n\u003cp data-start=\"4187\" data-end=\"4352\"\u003eWithin experimental systems, this distinction has implications for models examining folate receptor function, methylation dynamics, and metabolic pathway efficiency.\u003c\/p\u003e\n\u003ch3 data-start=\"4359\" data-end=\"4382\"\u003eResearch Use Context\u003c\/h3\u003e\n\u003cp data-start=\"4384\" data-end=\"4557\"\u003eAll information presented reflects published scientific and clinical research literature. This compound is supplied exclusively for laboratory and experimental research use.\u003c\/p\u003e\n\u003ch3\u003eResearch context\u003c\/h3\u003e\n\u003cp\u003eFolinic acid is frequently referenced in experimental models examining folate metabolism, one-carbon pathways, and cellular signaling processes associated with cerebral folate transport.\u003c\/p\u003e\n\u003cp\u003eFor a detailed overview of folate receptor alpha autoantibodies, cerebral folate deficiency, and related cellular mechanisms, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/folinic-acid-autism-research\"\u003e\u003cstrong\u003eFolinic Acid in Autism Research: Folate Metabolism, FRα Autoantibodies, and Cellular Pathways\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"1 mg \/ capsules","offer_id":52537902727434,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true},{"title":"5 mg \/ capsules","offer_id":52537902760202,"sku":null,"price":270.0,"currency_code":"EUR","in_stock":true},{"title":"10 mg \/ capsules","offer_id":52537902792970,"sku":null,"price":370.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/foli10mg_3_1.png?v=1770816036"},{"product_id":"tirzepatide-20mg","title":"Tirzepatide 20mg – Research Peptide","description":"\u003cp\u003e\u003cstrong\u003eStructure, Molecular Mechanism of Action, Receptor Interactions:\u003c\/strong\u003e Tirzepatide is a first-in-class, unimolecular, long-acting dual GIP\/GLP-1 receptor agonist (39-amino acid syntheticlinear peptide.\u003c\/p\u003e\n\u003cp\u003eTirzepatide is a dual incretin receptor agonist studied for its effects on metabolic signaling and energy regulation pathways. In research models, it is examined for its interaction with glucose balance, appetite-related signaling, and hormonal coordination.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMolecular Mechanism of Action :\u003c\/strong\u003e Tirzepatide is a dual agonist of the glucose-dependent\u003cbr\u003einsulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R),\u003cbr\u003eboth class B GPCRs. Tirzepatide exhibits imbalanced agonism (preferential GIPR engagement) and biased signaling at GLP-1R, driving its superior glycemic\/weight effects vs. GLP-1R mono-agonists.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGIPR: Unbiased; full mimicry of GIP (Gs → ↑cAMP → PKA; β-arrestin2;\u003cbr\u003einternalization).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGLP-1R: Biased partial agonist favoring Gs\/cAMP\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDownstream Molecular\/Physiologic Effects (Glucose-Dependent):\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePancreatic β-cells (both receptors): Gs–cAMP–PKA → voltage-gated Ca²⁺\u003cbr\u003einflux\/exocytosis → insulin secretion; improved β-cell function\/sensitivity.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eα-cells (GLP-1R dominant): Glucagon suppression.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGI (GLP-1R): Delayed gastric emptying; satiety\/appetite reduction (central\u003cbr\u003ehypothalamic arcuate\/paraventricular neurons).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdipose\/liver\/muscle (GIPR + GLP-1R): Enhanced insulin sensitivity, lipid buffering\u003cbr\u003e(↑adiponectin), reduced ectopic fat, improved metabolic flexibility.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCNS: Reduced food intake\/energy intake; sustained signaling from bias may enhance weight loss durability. Net: Superior HbA1c reduction (1.6–2.4%), weight loss (15–21% at 72 wk), cardiometabolic benefits (lipids, BP) vs. GLP-1 mono-agonists.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWant to understand the receptor signaling behind this compound?\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-tirzepatide\"\u003eWhat is Tirzepatide? Dual GLP-1\/GIP Peptide Explained\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003eExplore how dual-receptor incretin signaling compares with next-generation triple agonists.\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-tirzepatide\"\u003eRetatrutide vs Tirzepatide: Mechanism Comparison\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cstrong\u003eTirzepatide is commonly examined in research involving incretin signaling and metabolic regulation. \u003c\/strong\u003e\u003cstrong\u003eFor a broader perspective on how injectable peptides compare with oral compounds:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/oral-vs-injectable-metabolic-peptides-research\"\u003eOral vs Injectable Compounds (Orforglipron, Tirzepatide, Retatrutide)\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3\u003eTo explore how incretin-based signaling pathways interact with muscle metabolism and adaptive physiology in research models, see:\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003eMuscle Preservation During GLP-1\/GIP Therapy\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct description:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong\u003eMolecular Formula: \u003c\/strong\u003e\u003cspan\u003eC\u003csub\u003e225\u003c\/sub\u003eH\u003csub\u003e348\u003c\/sub\u003eN\u003csub\u003e48\u003c\/sub\u003eO\u003csub\u003e68\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 4813\u003cspan\u003e \u003c\/span\u003eg\/m   \u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cspan\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e \u003c\/span\u003e2023788-19-2\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong data-end=\"875\" data-start=\"847\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStructures:\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Tirzepatide structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tirzepatide.png?v=1772702974\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/156588324\"\u003e\u003cstrong\u003eSource: Pubchem\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641769521418,"sku":null,"price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641769554186,"sku":null,"price":205.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Tirzepatide_2.png?v=1772286816"},{"product_id":"cagrilintide-5mg","title":"Cagrilintide 5mg – Research Peptide","description":"\u003ch3 data-start=\"566\" data-end=\"600\"\u003eCagrilintide – Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"602\" data-end=\"927\"\u003eCagrilintide is a long-acting amylin analog studied in experimental research for its interaction with appetite-related neuroendocrine signaling and metabolic regulation pathways. Laboratory studies frequently examine its role in satiety signaling, peptide hormone receptor pharmacology, and central energy-balance mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"929\" data-end=\"1308\"\u003eCagrilintide (NNC0174-0833 \/ AM833) is a synthetic 37-amino-acid peptide derived from human amylin (islet amyloid polypeptide, IAPP). It has been engineered as a long-acting analog designed to interact with \u003cstrong data-start=\"1136\" data-end=\"1163\"\u003eamylin receptors (AMYR)\u003c\/strong\u003e and \u003cstrong data-start=\"1168\" data-end=\"1198\"\u003ecalcitonin receptors (CTR)\u003c\/strong\u003e, forming part of a class sometimes referred to as dual amylin receptor\/calcitonin receptor agonists (DACRAs).\u003c\/p\u003e\n\u003ch3 data-start=\"1315\" data-end=\"1345\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003ch3 data-start=\"1347\" data-end=\"1392\"\u003eAmylin and Calcitonin Receptor Interaction\u003c\/h3\u003e\n\u003cp data-start=\"1394\" data-end=\"1700\"\u003eAmylin receptors consist of a \u003cstrong data-start=\"1424\" data-end=\"1512\"\u003ecalcitonin receptor core complexed with receptor activity-modifying proteins (RAMPs)\u003c\/strong\u003e. Cagrilintide has been shown in experimental models to activate these receptor complexes, producing intracellular signaling events associated with satiety-related neuroendocrine pathways.\u003c\/p\u003e\n\u003cp data-start=\"1702\" data-end=\"1808\"\u003eThese receptor systems are highly expressed in several regions involved in metabolic signaling, including:\u003c\/p\u003e\n\u003cul data-start=\"1810\" data-end=\"1936\"\u003e\n\u003cli data-start=\"1810\" data-end=\"1835\"\u003e\n\u003cp data-start=\"1812\" data-end=\"1835\"\u003ethe \u003cstrong data-start=\"1816\" data-end=\"1833\"\u003earea postrema\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1836\" data-end=\"1880\"\u003e\n\u003cp data-start=\"1838\" data-end=\"1880\"\u003ethe \u003cstrong data-start=\"1842\" data-end=\"1878\"\u003enucleus tractus solitarius (NTS)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1881\" data-end=\"1936\"\u003e\n\u003cp data-start=\"1883\" data-end=\"1936\"\u003ehypothalamic nuclei associated with energy regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1938\" data-end=\"2118\"\u003eActivation of these receptors has been associated in experimental models with modulation of neural circuits involved in satiety signaling and nutrient-responsive feedback pathways.\u003c\/p\u003e\n\u003ch3 data-start=\"2125\" data-end=\"2159\"\u003eCentral Neuroendocrine Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2161\" data-end=\"2309\"\u003eIn preclinical research, cagrilintide has been examined for its influence on central nervous system signaling pathways that regulate energy balance.\u003c\/p\u003e\n\u003cp data-start=\"2311\" data-end=\"2421\"\u003eExperimental observations suggest receptor activation within brainstem and hypothalamic regions may influence:\u003c\/p\u003e\n\u003cul data-start=\"2423\" data-end=\"2548\"\u003e\n\u003cli data-start=\"2423\" data-end=\"2461\"\u003e\n\u003cp data-start=\"2425\" data-end=\"2461\"\u003esatiety-related neuronal signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2462\" data-end=\"2507\"\u003e\n\u003cp data-start=\"2464\" data-end=\"2507\"\u003ehypothalamic appetite regulation pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2508\" data-end=\"2548\"\u003e\n\u003cp data-start=\"2510\" data-end=\"2548\"\u003ereward-related food signaling circuits\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2550\" data-end=\"2681\"\u003eThese neuroendocrine pathways are often studied in research investigating peptide hormone signaling involved in energy homeostasis.\u003c\/p\u003e\n\u003ch3 data-start=\"2688\" data-end=\"2719\"\u003ePeripheral Signaling Pathways\u003c\/h3\u003e\n\u003cp data-start=\"2721\" data-end=\"2861\"\u003eBeyond central receptor activity, experimental studies have also reported additional signaling events associated with cagrilintide activity.\u003c\/p\u003e\n\u003cp data-start=\"2863\" data-end=\"2877\"\u003eThese include:\u003c\/p\u003e\n\u003cul data-start=\"2879\" data-end=\"3050\"\u003e\n\u003cli data-start=\"2879\" data-end=\"2910\"\u003e\n\u003cp data-start=\"2881\" data-end=\"2910\"\u003e\u003cstrong data-start=\"2881\" data-end=\"2908\"\u003ecAMP signaling pathways\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2911\" data-end=\"2979\"\u003e\n\u003cp data-start=\"2913\" data-end=\"2979\"\u003ephosphorylation events involving cellular ion transport proteins\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2980\" data-end=\"3050\"\u003e\n\u003cp data-start=\"2982\" data-end=\"3050\"\u003esignaling interactions observed in renal epithelial transport models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3052\" data-end=\"3186\"\u003eSuch observations are typically explored in preclinical studies examining peptide hormone signaling and metabolic regulatory pathways.\u003c\/p\u003e\n\u003ch3 data-start=\"3193\" data-end=\"3221\"\u003eStructural Characteristics\u003c\/h3\u003e\n\u003cp data-start=\"3223\" data-end=\"3451\"\u003eCagrilintide is a \u003cstrong data-start=\"3241\" data-end=\"3273\"\u003e37-amino-acid peptide analog\u003c\/strong\u003e derived from the endogenous amylin sequence. Structural modifications have been introduced to improve molecular stability and prolong receptor engagement in experimental models.\u003c\/p\u003e\n\u003cp data-start=\"3453\" data-end=\"3603\"\u003eThese modifications differentiate cagrilintide from earlier amylin analogs, which have also been used in research examining amylin receptor signaling.\u003c\/p\u003e\n\u003cp\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide.jpg?v=1770821612\"\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct description:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e \u003c\/span\u003e\u003cspan\u003eC\u003csub\u003e194\u003c\/sub\u003eH\u003csub\u003e312\u003c\/sub\u003eN\u003csub\u003e54\u003c\/sub\u003eO\u003csub\u003e59\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003e\u003cstrong\u003eMolecular Weight: \u003c\/strong\u003e4409 g\/mol\u003c\/span\u003e\u003cspan\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cspan\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e \u003c\/span\u003e \u003cspan\u003e1415456-99-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong data-start=\"847\" data-end=\"875\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003cspan\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide.png?v=1772704738\" alt=\"Cagrilintide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/171397054#section=Structures\"\u003e\u003cspan\u003eSource: PubChem\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641876082954,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641876115722,"sku":null,"price":215.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide5mg_2.png?v=1772288882"},{"product_id":"dsip-5mg","title":"DSIP (Acetate) 5mg – Research Peptide","description":"\u003ch3 data-start=\"760\" data-end=\"817\"\u003eDSIP (Delta Sleep-Inducing Peptide) – Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"819\" data-end=\"1168\"\u003eDSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied in experimental research examining sleep-related neurophysiology, circadian signaling, and neuroendocrine regulation. Laboratory models frequently investigate its interaction with stress-associated pathways, neurotransmitter systems, and slow-wave sleep architecture.\u003c\/p\u003e\n\u003cp data-start=\"1170\" data-end=\"1254\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1366\" data-end=\"1622\"\u003eThe peptide was originally isolated in the 1970s from cerebral venous blood of sleeping rabbits during electrophysiological studies of sleep states. Subsequent research identified similar peptide immunoreactivity in mammalian tissues, including human milk.\u003c\/p\u003e\n\u003cp data-start=\"1624\" data-end=\"1763\"\u003eExperimental observations suggest that DSIP levels follow a \u003cstrong data-start=\"1684\" data-end=\"1704\"\u003ecircadian rhythm\u003c\/strong\u003e, with measurable fluctuations across the sleep–wake cycle.\u003c\/p\u003e\n\u003ch3 data-start=\"1770\" data-end=\"1808\"\u003eDistribution and Endogenous Presence\u003c\/h3\u003e\n\u003cp data-start=\"1810\" data-end=\"1918\"\u003eDSIP-related peptide activity has been detected in several regions of the central nervous system, including:\u003c\/p\u003e\n\u003cul data-start=\"1920\" data-end=\"1998\"\u003e\n\u003cli data-start=\"1920\" data-end=\"1932\"\u003e\n\u003cp data-start=\"1922\" data-end=\"1932\"\u003ethalamus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1933\" data-end=\"1952\"\u003e\n\u003cp data-start=\"1935\" data-end=\"1952\"\u003ecerebral cortex\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1953\" data-end=\"1967\"\u003e\n\u003cp data-start=\"1955\" data-end=\"1967\"\u003ecerebellum\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1968\" data-end=\"1984\"\u003e\n\u003cp data-start=\"1970\" data-end=\"1984\"\u003ehypothalamus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1985\" data-end=\"1998\"\u003e\n\u003cp data-start=\"1987\" data-end=\"1998\"\u003ebrainstem\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2000\" data-end=\"2209\"\u003eAlthough the peptide has been studied for decades, \u003cstrong data-start=\"2051\" data-end=\"2136\"\u003eno dedicated precursor gene or specific receptor has been definitively identified\u003c\/strong\u003e, suggesting its activity may involve broader neuromodulatory mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"2211\" data-end=\"2361\"\u003eDSIP is also reported to \u003cstrong data-start=\"2236\" data-end=\"2269\"\u003ecross the blood–brain barrier\u003c\/strong\u003e, enabling investigation of central nervous system signaling effects in experimental models.\u003c\/p\u003e\n\u003ch3 data-start=\"2368\" data-end=\"2402\"\u003eMolecular and Cellular Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2404\" data-end=\"2529\"\u003eResearch suggests that DSIP acts through \u003cstrong data-start=\"2445\" data-end=\"2528\"\u003emulti-system neuromodulatory interactions rather than a single receptor pathway\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"2531\" data-end=\"2554\"\u003eGlutamatergic System\u003c\/h3\u003e\n\u003cp data-start=\"2556\" data-end=\"2917\"\u003eExperimental models indicate that DSIP may influence \u003cstrong data-start=\"2609\" data-end=\"2649\"\u003eNMDA-related glutamatergic signaling\u003c\/strong\u003e. Studies have reported reductions in NMDA-activated neuronal currents in several brain regions, including the cortex, hippocampus, thalamus, and hypothalamus. These observations are associated with changes in intracellular calcium signaling and neuronal excitability.\u003c\/p\u003e\n\u003ch3 data-start=\"2924\" data-end=\"2946\"\u003eGABAergic Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2948\" data-end=\"3155\"\u003eLaboratory studies have reported that DSIP can modulate \u003cstrong data-start=\"3004\" data-end=\"3049\"\u003eGABA-related inhibitory neurotransmission\u003c\/strong\u003e, including increased GABA-activated currents in neuronal models such as hippocampal and cerebellar cells.\u003c\/p\u003e\n\u003cp data-start=\"3157\" data-end=\"3291\"\u003eThese observations suggest a role for DSIP in research examining inhibitory–excitatory balance within central nervous system circuits.\u003c\/p\u003e\n\u003ch3 data-start=\"3298\" data-end=\"3331\"\u003eOpioid and Endorphin Signaling\u003c\/h3\u003e\n\u003cp data-start=\"3333\" data-end=\"3611\"\u003eSome experimental studies have reported interactions between DSIP signaling and \u003cstrong data-start=\"3413\" data-end=\"3442\"\u003eendogenous opioid systems\u003c\/strong\u003e, including changes in central endorphin activity. In certain models, opioid receptor antagonists have been observed to modify DSIP-related neurophysiological responses.\u003c\/p\u003e\n\u003ch3 data-start=\"3618\" data-end=\"3646\"\u003eNeuroendocrine Regulation\u003c\/h3\u003e\n\u003cp data-start=\"3648\" data-end=\"3747\"\u003eDSIP has also been examined in experimental models investigating neuroendocrine signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3749\" data-end=\"3854\"\u003eReported interactions include modulation of hypothalamic and pituitary signaling systems associated with:\u003c\/p\u003e\n\u003cul data-start=\"3856\" data-end=\"4078\"\u003e\n\u003cli data-start=\"3856\" data-end=\"3896\"\u003e\n\u003cp data-start=\"3858\" data-end=\"3896\"\u003ecorticotropin-releasing factor (CRF)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3897\" data-end=\"3935\"\u003e\n\u003cp data-start=\"3899\" data-end=\"3935\"\u003eadrenocorticotropic hormone (ACTH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3936\" data-end=\"3977\"\u003e\n\u003cp data-start=\"3938\" data-end=\"3977\"\u003egonadotropin-releasing hormone (GnRH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3978\" data-end=\"4006\"\u003e\n\u003cp data-start=\"3980\" data-end=\"4006\"\u003eluteinizing hormone (LH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4007\" data-end=\"4044\"\u003e\n\u003cp data-start=\"4009\" data-end=\"4044\"\u003ethyroid-stimulating hormone (TSH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4045\" data-end=\"4078\"\u003e\n\u003cp data-start=\"4047\" data-end=\"4078\"\u003egrowth hormone–related pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4080\" data-end=\"4203\"\u003eThese pathways are frequently investigated in research exploring stress physiology and circadian neuroendocrine regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"4210\" data-end=\"4250\"\u003eNeurotransmitter and Monoamine Systems\u003c\/h3\u003e\n\u003cp data-start=\"4252\" data-end=\"4350\"\u003eExperimental observations suggest DSIP may influence multiple neurotransmitter systems, including:\u003c\/p\u003e\n\u003cul data-start=\"4352\" data-end=\"4465\"\u003e\n\u003cli data-start=\"4352\" data-end=\"4378\"\u003e\n\u003cp data-start=\"4354\" data-end=\"4378\"\u003edopaminergic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4379\" data-end=\"4402\"\u003e\n\u003cp data-start=\"4381\" data-end=\"4402\"\u003eadrenergic pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4403\" data-end=\"4429\"\u003e\n\u003cp data-start=\"4405\" data-end=\"4429\"\u003eserotonergic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4430\" data-end=\"4465\"\u003e\n\u003cp data-start=\"4432\" data-end=\"4465\"\u003ehistamine-related neural pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4467\" data-end=\"4591\"\u003eChanges in neuropeptides such as \u003cstrong data-start=\"4500\" data-end=\"4515\"\u003esubstance P\u003c\/strong\u003e and \u003cstrong data-start=\"4520\" data-end=\"4535\"\u003eβ-endorphin\u003c\/strong\u003e have also been reported in certain experimental models.\u003c\/p\u003e\n\u003ch3 data-start=\"4598\" data-end=\"4649\"\u003eOxidative Stress and Cellular Protection Pathways\u003c\/h3\u003e\n\u003cp data-start=\"4651\" data-end=\"4777\"\u003eSeveral studies examining neuronal stress models have reported that DSIP may influence antioxidant enzyme activity, including:\u003c\/p\u003e\n\u003cul data-start=\"4779\" data-end=\"4879\"\u003e\n\u003cli data-start=\"4779\" data-end=\"4811\"\u003e\n\u003cp data-start=\"4781\" data-end=\"4811\"\u003eglutathione peroxidase (GPx)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4812\" data-end=\"4842\"\u003e\n\u003cp data-start=\"4814\" data-end=\"4842\"\u003esuperoxide dismutase (SOD)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4843\" data-end=\"4855\"\u003e\n\u003cp data-start=\"4845\" data-end=\"4855\"\u003ecatalase\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4856\" data-end=\"4879\"\u003e\n\u003cp data-start=\"4858\" data-end=\"4879\"\u003eglutathione reductase\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4881\" data-end=\"5029\"\u003eThese mechanisms are often investigated in experimental models studying oxidative stress, mitochondrial function, and neuronal metabolic regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"5036\" data-end=\"5067\"\u003eBlood–Brain Barrier Transport\u003c\/h3\u003e\n\u003cp data-start=\"5069\" data-end=\"5262\"\u003eExperimental research suggests DSIP may utilize \u003cstrong data-start=\"5117\" data-end=\"5189\"\u003ecarrier-mediated transport mechanisms across the blood–brain barrier\u003c\/strong\u003e, including potential involvement of the choroid plexus transport system.\u003c\/p\u003e\n\u003cp data-start=\"5264\" data-end=\"5393\"\u003eSuch mechanisms are frequently studied in research examining neuropeptide transport and central nervous system peptide signaling.\u003c\/p\u003e\n\u003cp data-start=\"5264\" data-end=\"5393\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"5400\" data-end=\"5421\"\u003eProduct Information\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"5423\" data-end=\"5436\"\u003eSynonyms:\u003c\/strong\u003e Delta Sleep-Inducing Peptide, DSIP\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"5474\" data-end=\"5487\"\u003eSequence:\u003c\/strong\u003e Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"5562\" data-end=\"5583\"\u003eMolecular Weight:\u003c\/strong\u003e ~848.8–849 Da\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e \u003c\/span\u003e\u003cspan\u003eC\u003csub\u003e35\u003c\/sub\u003eH\u003csub\u003e48\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e15\u003c\/sub\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e\u003cspan\u003e62568-57-4\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eResearch Areas Referenced in Scientific Literature\u003c\/h3\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003cp data-start=\"5683\" data-end=\"5750\"\u003eDSIP is commonly referenced in experimental research investigating:\u003c\/p\u003e\n\u003cul data-start=\"5752\" data-end=\"6009\"\u003e\n\u003cli data-start=\"5752\" data-end=\"5804\"\u003e\n\u003cp data-start=\"5754\" data-end=\"5804\"\u003esleep architecture and slow-wave sleep signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5805\" data-end=\"5836\"\u003e\n\u003cp data-start=\"5807\" data-end=\"5836\"\u003ecircadian rhythm regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5837\" data-end=\"5874\"\u003e\n\u003cp data-start=\"5839\" data-end=\"5874\"\u003eneuroendocrine signaling pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5875\" data-end=\"5925\"\u003e\n\u003cp data-start=\"5877\" data-end=\"5925\"\u003eexcitatory–inhibitory neurotransmitter balance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5926\" data-end=\"5963\"\u003e\n\u003cp data-start=\"5928\" data-end=\"5963\"\u003estress-associated neurophysiology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5964\" data-end=\"6009\"\u003e\n\u003cp data-start=\"5966\" data-end=\"6009\"\u003eoxidative stress and mitochondrial function\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStructures:\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Delta_Sleep-Inducing_Peptide.png?v=1772706239\" alt=\"DSIP structure\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/68816\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003eOCD Circuit-Level Neurobiology Research\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4 data-start=\"206\" data-end=\"254\"\u003eNeurotrophic Peptides in Cognitive Research\u003c\/h4\u003e\n\u003cp data-start=\"256\" data-end=\"471\"\u003eDSIP is frequently discussed in research exploring sleep, recovery, and cognitive function. Learn more about related compounds in our article: \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/neurotrophic-peptides-cognitive-research\"\u003e\u003cstrong data-start=\"399\" data-end=\"470\"\u003eBest Neurotrophic Peptides for Cognitive Research and Brain Support\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641881882890,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641881915658,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/DSIP5mg_2.png?v=1772289664"},{"product_id":"semax-10mg","title":"Semax 10mg – Neuroactive Research Peptide","description":"\u003ch3 data-end=\"762\" data-start=\"735\" data-section-id=\"1lpkwfh\"\u003e\u003cstrong\u003eSemax – Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1084\" data-start=\"764\"\u003eSemax is a synthetic neuropeptide studied in experimental research models examining neurochemical signaling, neurotrophic pathway regulation, and central nervous system adaptive responses. It is frequently referenced in studies investigating BDNF expression, synaptic plasticity mechanisms, and neuroendocrine signaling.\u003c\/p\u003e\n\u003cp data-end=\"1084\" data-start=\"764\"\u003eThe peptide was originally developed as a modified analog of the \u003cstrong data-end=\"1355\" data-start=\"1332\"\u003eACTH(4-10) fragment\u003c\/strong\u003e derived from adrenocorticotropic hormone. Structural extension with the stabilizing tripeptide \u003cstrong data-end=\"1472\" data-start=\"1451\"\u003ePro-Gly-Pro (PGP)\u003c\/strong\u003e increases resistance to enzymatic degradation and improves stability in experimental delivery models.\u003c\/p\u003e\n\u003ch3 data-end=\"1611\" data-start=\"1581\" data-section-id=\"5fqgg6\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003ch3 data-end=\"1658\" data-start=\"1613\" data-section-id=\"1uxzxoy\"\u003eNeurotrophic Signaling and BDNF Regulation\u003c\/h3\u003e\n\u003cp data-end=\"1789\" data-start=\"1660\"\u003eOne of the most widely studied mechanisms of Semax involves modulation of \u003cstrong data-end=\"1778\" data-start=\"1734\"\u003ebrain-derived neurotrophic factor (BDNF)\u003c\/strong\u003e signaling.\u003c\/p\u003e\n\u003cp data-end=\"1851\" data-start=\"1791\"\u003eExperimental studies have reported that Semax can influence:\u003c\/p\u003e\n\u003cul data-end=\"1983\" data-start=\"1853\"\u003e\n\u003cli data-end=\"1880\" data-start=\"1853\" data-section-id=\"1x8ztfz\"\u003e\n\u003cp data-end=\"1880\" data-start=\"1855\"\u003eBDNF protein expression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1946\" data-start=\"1881\" data-section-id=\"1nlkjgk\"\u003e\n\u003cp data-end=\"1946\" data-start=\"1883\"\u003eBDNF mRNA transcription (including exon-specific transcripts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1983\" data-start=\"1947\" data-section-id=\"1buidk5\"\u003e\n\u003cp data-end=\"1983\" data-start=\"1949\"\u003eTrkB receptor signaling activation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2054\" data-start=\"1985\"\u003eThese effects have been observed in several brain regions, including:\u003c\/p\u003e\n\u003cul data-end=\"2109\" data-start=\"2056\"\u003e\n\u003cli data-end=\"2071\" data-start=\"2056\" data-section-id=\"5ynrz3\"\u003e\n\u003cp data-end=\"2071\" data-start=\"2058\"\u003ehippocampus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2091\" data-start=\"2072\" data-section-id=\"ujdhdp\"\u003e\n\u003cp data-end=\"2091\" data-start=\"2074\"\u003ebasal forebrain\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2109\" data-start=\"2092\" data-section-id=\"1khwccz\"\u003e\n\u003cp data-end=\"2109\" data-start=\"2094\"\u003ecerebral cortex\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2245\" data-start=\"2111\"\u003eActivation of \u003cstrong data-end=\"2143\" data-start=\"2125\"\u003eTrkB receptors\u003c\/strong\u003e can initiate multiple downstream signaling cascades associated with neuronal plasticity and survival.\u003c\/p\u003e\n\u003ch3 data-end=\"2296\" data-start=\"2247\" data-section-id=\"prw0u9\"\u003eKey downstream pathways investigated include:\u003c\/h3\u003e\n\u003cp data-end=\"2316\" data-start=\"2298\"\u003e\u003cstrong data-end=\"2316\" data-start=\"2298\"\u003ePLCγ signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2401\" data-start=\"2318\"\u003ePLCγ → IP3\/DAG → Ca²⁺ signaling → CaMK activation → CREB transcriptional regulation\u003c\/p\u003e\n\u003cp data-end=\"2425\" data-start=\"2403\"\u003e\u003cstrong data-end=\"2425\" data-start=\"2403\"\u003eMAPK \/ ERK pathway\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2538\" data-start=\"2427\"\u003eRas → Raf → MEK → ERK signaling, frequently associated with neuronal growth and synaptic plasticity mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"2564\" data-start=\"2540\"\u003e\u003cstrong data-end=\"2564\" data-start=\"2540\"\u003ePI3K \/ Akt signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2699\" data-start=\"2566\"\u003ePI3K\/Akt pathways are commonly investigated in research examining neuronal survival signaling and anti-apoptotic cellular mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"2827\" data-start=\"2701\"\u003eThese pathways are widely studied in experimental models exploring synaptic plasticity, neurogenesis, and neuronal adaptation.\u003c\/p\u003e\n\u003ch3 data-end=\"2870\" data-start=\"2834\" data-section-id=\"tvgtqv\"\u003eMonoamine Neurotransmitter Systems\u003c\/h3\u003e\n\u003cp data-end=\"2992\" data-start=\"2872\"\u003eSemax has also been examined in experimental research investigating \u003cstrong data-end=\"2991\" data-start=\"2940\"\u003edopaminergic and serotonergic neurotransmission\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"3039\" data-start=\"2994\"\u003ePreclinical studies have reported changes in:\u003c\/p\u003e\n\u003cul data-end=\"3209\" data-start=\"3041\"\u003e\n\u003cli data-end=\"3091\" data-start=\"3041\" data-section-id=\"1olrog\"\u003e\n\u003cp data-end=\"3091\" data-start=\"3043\"\u003edopamine release dynamics in striatal pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3139\" data-start=\"3092\" data-section-id=\"bxsajx\"\u003e\n\u003cp data-end=\"3139\" data-start=\"3094\"\u003eserotonin metabolism markers such as 5-HIAA\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3209\" data-start=\"3140\" data-section-id=\"1wtezax\"\u003e\n\u003cp data-end=\"3209\" data-start=\"3142\"\u003emonoamine signaling associated with motivation and reward circuitry\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3357\" data-start=\"3211\"\u003eThese neurotransmitter systems are frequently studied in research exploring attention, cognitive signaling pathways, and neurochemical regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"3397\" data-start=\"3364\" data-section-id=\"1wg5iy8\"\u003eMelanocortin System Interaction\u003c\/h3\u003e\n\u003cp data-end=\"3525\" data-start=\"3399\"\u003eBecause Semax is derived from an ACTH fragment, it has also been examined for its interaction with \u003cstrong data-end=\"3524\" data-start=\"3498\"\u003emelanocortin receptors\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"3781\" data-start=\"3527\"\u003eExperimental data suggest Semax may interact with \u003cstrong data-end=\"3602\" data-start=\"3577\"\u003eMC4 and MC5 receptors\u003c\/strong\u003e, influencing signaling pathways involved in stress physiology and inflammatory regulation. Many observed effects appear independent of classical melanocortin receptor activation.\u003c\/p\u003e\n\u003ch3 data-end=\"3833\" data-start=\"3788\" data-section-id=\"e76rl2\"\u003eEnkephalinase and Opioid System Interaction\u003c\/h3\u003e\n\u003cp data-end=\"3960\" data-start=\"3835\"\u003eSome experimental studies have reported that Semax may inhibit enzymes involved in the degradation of endogenous enkephalins.\u003c\/p\u003e\n\u003cp data-end=\"4106\" data-start=\"3962\"\u003eBy influencing these enzymatic pathways, Semax has been investigated in models studying endogenous opioid signaling and neuropeptide regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"4159\" data-start=\"4113\" data-section-id=\"16racw5\"\u003eGene Expression and Cellular Response Models\u003c\/h3\u003e\n\u003cp data-end=\"4298\" data-start=\"4161\"\u003eGenome-wide transcription studies in experimental models have reported that Semax may influence gene expression patterns associated with:\u003c\/p\u003e\n\u003cul data-end=\"4429\" data-start=\"4300\"\u003e\n\u003cli data-end=\"4326\" data-start=\"4300\" data-section-id=\"4k306m\"\u003e\n\u003cp data-end=\"4326\" data-start=\"4302\"\u003eneurotrophic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4357\" data-start=\"4327\" data-section-id=\"134grtj\"\u003e\n\u003cp data-end=\"4357\" data-start=\"4329\"\u003evascular response pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4395\" data-start=\"4358\" data-section-id=\"zolgl6\"\u003e\n\u003cp data-end=\"4395\" data-start=\"4360\"\u003eimmune-related gene transcription\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4429\" data-start=\"4396\" data-section-id=\"1rshgzp\"\u003e\n\u003cp data-end=\"4429\" data-start=\"4398\"\u003eneurotransmission-related genes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"4592\" data-start=\"4431\"\u003eAdditional experimental observations include modulation of oxidative stress markers, nitric-oxide signaling pathways, and calcium homeostasis in neuronal models.\u003c\/p\u003e\n\u003ch3 data-end=\"4652\" data-start=\"4599\" data-section-id=\"kh9l9u\"\u003eMetal Ion Interaction and Oxidative Stress Research\u003c\/h3\u003e\n\u003cp data-end=\"4848\" data-start=\"4654\"\u003eSome experimental studies have also reported that Semax can interact with \u003cstrong data-end=\"4755\" data-start=\"4728\"\u003emetal ions such as Cu²⁺\u003c\/strong\u003e, forming stable complexes that influence peptide stability and cellular oxidative signaling.\u003c\/p\u003e\n\u003cp data-end=\"4969\" data-start=\"4850\"\u003eThese mechanisms have been investigated in research examining oxidative stress pathways and protein aggregation models.\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eRelated Research\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eSemax is frequently examined in experimental neuroscience models exploring neurotrophic signaling, neurotransmitter regulation, and adaptive neuronal plasticity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a deeper explanation of the peptide’s structure and signaling mechanisms, see our research overview:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-semax\"\u003e\u003cspan\u003eWhat Is Semax? Mechanism and Neurotrophic Signaling\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearchers also often compare Semax with related neuroactive peptides studied for central nervous system signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003e\u003cspan\u003eSelank vs Semax vs Dihexa – Comparative Research Overview\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"4997\" data-start=\"4976\" data-section-id=\"15qw8x\"\u003e\n\u003cstrong\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003ch3 data-end=\"4997\" data-start=\"4976\" data-section-id=\"15qw8x\"\u003e\u003cstrong\u003eProduct Information\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"5193\" data-start=\"4999\"\u003e\u003cstrong data-end=\"5012\" data-start=\"4999\"\u003eSynonyms:\u003c\/strong\u003e Semax peptide, MEHFPGP peptide\u003cbr data-end=\"5046\" data-start=\"5043\"\u003e\u003cstrong data-end=\"5059\" data-start=\"5046\"\u003eSequence:\u003c\/strong\u003e Met-Glu-His-Phe-Pro-Gly-Pro\u003cbr data-end=\"5090\" data-start=\"5087\"\u003e\u003cstrong data-end=\"5109\" data-start=\"5090\"\u003eCAS:\u003c\/strong\u003e 80714-61-0\u003cbr data-end=\"5126\" data-start=\"5123\"\u003e\u003cstrong data-end=\"5148\" data-start=\"5126\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₇H₅₁N₉O₁₀S\u003cbr data-end=\"5164\" data-start=\"5161\"\u003e\u003cstrong data-end=\"5185\" data-start=\"5164\"\u003eMolecular Weight:\u003c\/strong\u003e ~813.9 g\/mol\u003c\/p\u003e\n\u003ch3 data-end=\"5252\" data-start=\"5200\" data-section-id=\"orlbwh\"\u003eResearch Areas Referenced in Scientific Literature\u003c\/h3\u003e\n\u003cp data-end=\"5324\" data-start=\"5254\"\u003eSemax is frequently referenced in experimental research investigating:\u003c\/p\u003e\n\u003cul data-end=\"5536\" data-start=\"5326\"\u003e\n\u003cli data-end=\"5361\" data-start=\"5326\" data-section-id=\"sec8a3\"\u003e\n\u003cp data-end=\"5361\" data-start=\"5328\"\u003eBDNF and neurotrophic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5408\" data-start=\"5362\" data-section-id=\"b1t26a\"\u003e\n\u003cp data-end=\"5408\" data-start=\"5364\"\u003esynaptic plasticity and neuronal signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5450\" data-start=\"5409\" data-section-id=\"s67sr\"\u003e\n\u003cp data-end=\"5450\" data-start=\"5411\"\u003emonoamine neurotransmitter regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5485\" data-start=\"5451\" data-section-id=\"1t90rwd\"\u003e\n\u003cp data-end=\"5485\" data-start=\"5453\"\u003emelanocortin pathway signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5536\" data-start=\"5486\" data-section-id=\"mb3sip\"\u003e\n\u003cp data-end=\"5536\" data-start=\"5488\"\u003eoxidative stress and neuronal metabolic pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\u003cspan class=\"flex-1\"\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"semax Structures\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/semax.png?v=1772792942\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9811102\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641701986570,"sku":null,"price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641702019338,"sku":null,"price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Semax10mg_2.png?v=1772290152"},{"product_id":"kpv-10mg","title":"KPV 10mg – Research Peptide","description":"\u003ch3 data-start=\"393\" data-end=\"426\"\u003e\u003cstrong\u003eKPV Peptide – Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"428\" data-end=\"723\"\u003eKPV is the C-terminal tripeptide fragment (amino acids 11–13) of the α-melanocyte-stimulating hormone (α-MSH) sequence. This short peptide retains key regulatory signaling characteristics associated with the parent hormone while lacking the melanotropic activity linked to pigmentation pathways.\u003c\/p\u003e\n\u003cp data-start=\"725\" data-end=\"916\"\u003eIn experimental literature, KPV is primarily examined for its interaction with inflammatory signaling networks, particularly pathways associated with NF-κB activation and cytokine regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"923\" data-end=\"953\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003cp data-start=\"955\" data-end=\"973\"\u003e\u003cstrong\u003eCellular Uptake\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"975\" data-end=\"1292\"\u003eIn experimental models involving intestinal epithelial and immune cells, KPV can be transported intracellularly via the \u003cstrong data-start=\"1095\" data-end=\"1138\"\u003ePepT1 (hPepT1) oligopeptide transporter\u003c\/strong\u003e. This transporter is often upregulated in inflamed intestinal tissues and facilitates the uptake of small di- and tripeptides across epithelial barriers.\u003c\/p\u003e\n\u003cp data-start=\"1294\" data-end=\"1447\"\u003eBecause of this transporter interaction, KPV is frequently investigated in research examining intestinal peptide absorption and mucosal immune signaling.\u003c\/p\u003e\n\u003cp data-start=\"1454\" data-end=\"1482\"\u003e\u003cstrong\u003eNF-κB Pathway Interaction\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1484\" data-end=\"1680\"\u003eOne of the most widely discussed mechanisms of KPV in experimental literature involves its interaction with the \u003cstrong data-start=\"1596\" data-end=\"1623\"\u003eNF-κB signaling pathway\u003c\/strong\u003e, a central regulator of inflammatory gene transcription.\u003c\/p\u003e\n\u003cp data-start=\"1682\" data-end=\"1743\"\u003eResearch observations suggest several molecular interactions:\u003c\/p\u003e\n\u003cp data-start=\"1745\" data-end=\"1916\"\u003e• \u003cstrong data-start=\"1747\" data-end=\"1769\"\u003eIκBα stabilization\u003c\/strong\u003e – KPV has been associated with delayed degradation and accelerated recovery of IκBα, the inhibitory protein that retains NF-κB in the cytoplasm.\u003c\/p\u003e\n\u003cp data-start=\"1918\" data-end=\"2184\"\u003e• \u003cstrong data-start=\"1920\" data-end=\"1956\"\u003eNuclear translocation modulation\u003c\/strong\u003e – experimental data indicate that KPV may interfere with the interaction between the p65RelA NF-κB subunit and nuclear transport proteins such as importin-α3. This interaction can influence NF-κB nuclear translocation dynamics.\u003c\/p\u003e\n\u003cp data-start=\"2186\" data-end=\"2333\"\u003e• \u003cstrong data-start=\"2188\" data-end=\"2224\"\u003eReduced NF-κB signaling duration\u003c\/strong\u003e – rather than fully suppressing the pathway, KPV is associated with modulation of NF-κB activation dynamics.\u003c\/p\u003e\n\u003cp data-start=\"2335\" data-end=\"2454\"\u003eDownstream effects reported in experimental studies include changes in transcription of cytokine-related genes such as:\u003c\/p\u003e\n\u003cul data-start=\"2456\" data-end=\"2503\"\u003e\n\u003cli data-start=\"2456\" data-end=\"2465\"\u003e\n\u003cp data-start=\"2458\" data-end=\"2465\"\u003eTNF-α\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2466\" data-end=\"2475\"\u003e\n\u003cp data-start=\"2468\" data-end=\"2475\"\u003eIL-1β\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2476\" data-end=\"2484\"\u003e\n\u003cp data-start=\"2478\" data-end=\"2484\"\u003eIL-6\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2485\" data-end=\"2493\"\u003e\n\u003cp data-start=\"2487\" data-end=\"2493\"\u003eIL-8\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2494\" data-end=\"2503\"\u003e\n\u003cp data-start=\"2496\" data-end=\"2503\"\u003eMCP-1\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2505\" data-end=\"2619\"\u003eThese observations have made KPV a subject of interest in research examining cytokine-mediated signaling networks.\u003c\/p\u003e\n\u003ch3 data-start=\"2626\" data-end=\"2658\"\u003eAdditional Signaling Pathways\u003c\/h3\u003e\n\u003cp data-start=\"2660\" data-end=\"2799\"\u003eBeyond NF-κB-related signaling, some experimental models have reported interactions between KPV and \u003cstrong data-start=\"2760\" data-end=\"2787\"\u003eMAPK signaling cascades\u003c\/strong\u003e, including:\u003c\/p\u003e\n\u003cul data-start=\"2801\" data-end=\"2827\"\u003e\n\u003cli data-start=\"2801\" data-end=\"2811\"\u003e\n\u003cp data-start=\"2803\" data-end=\"2811\"\u003eERK1\/2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2812\" data-end=\"2819\"\u003e\n\u003cp data-start=\"2814\" data-end=\"2819\"\u003eJNK\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2820\" data-end=\"2827\"\u003e\n\u003cp data-start=\"2822\" data-end=\"2827\"\u003ep38\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2829\" data-end=\"2976\"\u003eThese pathways are frequently investigated in studies examining cellular stress responses, cytokine signaling, and inflammatory pathway regulation.\u003c\/p\u003e\n\u003cp data-start=\"2978\" data-end=\"3217\"\u003eIn certain cell systems, particularly airway or skin models, limited evidence suggests involvement of melanocortin receptors such as \u003cstrong data-start=\"3111\" data-end=\"3119\"\u003eMC3R\u003c\/strong\u003e, although many reported effects appear independent of classical melanocortin receptor activation.\u003c\/p\u003e\n\u003ch3 data-start=\"3224\" data-end=\"3255\"\u003eExperimental Research Context\u003c\/h3\u003e\n\u003cp data-start=\"3257\" data-end=\"3290\"\u003e\u003cstrong\u003eIntestinal Inflammation Models\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"3292\" data-end=\"3565\"\u003eKPV is frequently investigated in preclinical intestinal inflammation models, including DSS and TNBS-induced colitis systems. In these models, experimental observations have reported changes in cytokine signaling, neutrophil infiltration, and inflammatory pathway activity.\u003c\/p\u003e\n\u003cp data-start=\"3567\" data-end=\"3684\"\u003eBecause KPV interacts with the PepT1 transporter in intestinal tissue, it is commonly examined in research exploring:\u003c\/p\u003e\n\u003cul data-start=\"3686\" data-end=\"3812\"\u003e\n\u003cli data-start=\"3686\" data-end=\"3718\"\u003e\n\u003cp data-start=\"3688\" data-end=\"3718\"\u003eepithelial barrier signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3719\" data-end=\"3748\"\u003e\n\u003cp data-start=\"3721\" data-end=\"3748\"\u003emucosal immune regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3749\" data-end=\"3781\"\u003e\n\u003cp data-start=\"3751\" data-end=\"3781\"\u003eintestinal cytokine networks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3782\" data-end=\"3812\"\u003e\n\u003cp data-start=\"3784\" data-end=\"3812\"\u003epeptide transporter dynamics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3819\" data-end=\"3862\"\u003e\u003cstrong\u003eSkin and Cellular Inflammatory Signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"3864\" data-end=\"4013\"\u003eCell culture studies have reported that KPV can influence \u003cstrong data-start=\"3922\" data-end=\"3972\"\u003eTNF-α-mediated signaling and ICAM-1 expression\u003c\/strong\u003e in dermal fibroblasts and keratinocytes.\u003c\/p\u003e\n\u003cp data-start=\"4015\" data-end=\"4148\"\u003eThese mechanisms are typically examined in laboratory models studying inflammatory signaling pathways in skin and epithelial tissues.\u003c\/p\u003e\n\u003cp data-start=\"4155\" data-end=\"4197\"\u003e\u003cstrong\u003eNeuroimmune and Gut–Brain Axis Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"4199\" data-end=\"4328\"\u003eInteractions between intestinal immune signaling and the nervous system are increasingly investigated in gut–brain axis research.\u003c\/p\u003e\n\u003cp data-start=\"4330\" data-end=\"4645\"\u003eChanges in cytokine signaling and epithelial barrier dynamics may influence vagal nerve pathways and systemic inflammatory signaling. Within this framework, peptides derived from melanocortin signaling systems, including KPV, are occasionally examined in experimental models investigating neuroimmune communication.\u003c\/p\u003e\n\u003ch3 data-start=\"4652\" data-end=\"4685\"\u003eTransport and Delivery Research\u003c\/h3\u003e\n\u003cp data-start=\"4687\" data-end=\"4879\"\u003eDue to its small tripeptide structure, KPV is capable of interacting with peptide transport systems such as \u003cstrong data-start=\"4795\" data-end=\"4804\"\u003ePepT1\u003c\/strong\u003e, which mediates the uptake of small peptides in the intestinal epithelium.\u003c\/p\u003e\n\u003cp data-start=\"4881\" data-end=\"5034\"\u003eFor this reason, oral capsule formats are often used in experimental settings investigating intestinal peptide transport and localized mucosal signaling.\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eUnderstand KPV in Gut and Inflammation Research\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eKPV is widely studied in research models focused on inflammation signaling and epithelial cellular environments, particularly within gut-associated systems. Its interaction with pathways such as NF-κB makes it relevant in studies exploring how localized inflammation and cellular communication are regulated.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo see how KPV is examined alongside other compounds in gut and immune signaling research:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eFor a deeper scientific overview of its mechanism, pathways, and research applications:\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003c\/a\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-kpv\"\u003eWhat is KPV? - NF-κB Signaling and Inflammation Research Explained\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"5041\" data-end=\"5062\"\u003eProduct Information\u003c\/h3\u003e\n\u003cp data-start=\"5064\" data-end=\"5213\"\u003e\u003cstrong data-start=\"5064\" data-end=\"5077\"\u003eSynonyms:\u003c\/strong\u003e Lys-Pro-Val peptide, KPV peptide\u003cbr data-start=\"5138\" data-end=\"5141\"\u003e\u003cstrong data-start=\"5141\" data-end=\"5163\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003c\/span\u003e\u003csub\u003e16\u003c\/sub\u003e\u003cspan\u003eH\u003c\/span\u003e\u003csub\u003e30\u003c\/sub\u003e\u003cspan\u003eN\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003eO\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cbr data-start=\"5174\" data-end=\"5177\"\u003e\u003cstrong data-start=\"5177\" data-end=\"5198\"\u003eMolecular Weight:\u003c\/strong\u003e \u003cspan\u003e342.43\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003eg\/mol\u003cbr\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e67727-97-3\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"5220\" data-end=\"5261\"\u003eResearch Areas Referenced in Literature\u003c\/h3\u003e\n\u003cp data-start=\"5263\" data-end=\"5318\"\u003eExperimental studies have discussed KPV in relation to:\u003c\/p\u003e\n\u003cul data-start=\"5320\" data-end=\"5525\"\u003e\n\u003cli data-start=\"5320\" data-end=\"5348\"\u003e\n\u003cp data-start=\"5322\" data-end=\"5348\"\u003eNF-κB signaling pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5349\" data-end=\"5381\"\u003e\n\u003cp data-start=\"5351\" data-end=\"5381\"\u003ecytokine regulation networks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5382\" data-end=\"5412\"\u003e\n\u003cp data-start=\"5384\" data-end=\"5412\"\u003eepithelial barrier biology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5413\" data-end=\"5455\"\u003e\n\u003cp data-start=\"5415\" data-end=\"5455\"\u003emelanocortin-related peptide signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5456\" data-end=\"5490\"\u003e\n\u003cp data-start=\"5458\" data-end=\"5490\"\u003eintestinal transporter systems\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5491\" data-end=\"5525\"\u003e\n\u003cp data-start=\"5493\" data-end=\"5525\"\u003eneuroimmune communication models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKPV Structures: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Kpv_structure.png?v=1772702715\" alt=\"KPV peptide Structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/125672\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641930707210,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641930739978,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/KPV10mg_2.png?v=1772291130"},{"product_id":"larazotide-20mg","title":"Larazotide 20mg – Research Peptide","description":"\u003ch3 data-section-id=\"5phdk4\" data-start=\"354\" data-end=\"431\"\u003eLarazotide Acetate – Intestinal Barrier and Tight Junction Research Peptide\u003c\/h3\u003e\n\u003ch3 data-section-id=\"cibsat\" data-start=\"433\" data-end=\"445\"\u003eOverview\u003c\/h3\u003e\n\u003cp data-start=\"447\" data-end=\"672\"\u003eLarazotide acetate (AT-1001) is a synthetic 8-amino-acid peptide (sequence: Gly-Gly-Val-Leu-Val-Gln-Pro-Gly; GGVLVQPG) investigated in research models of intestinal barrier regulation and epithelial tight junction dynamics.\u003c\/p\u003e\n\u003cp data-start=\"674\" data-end=\"862\"\u003eIt is commonly referenced in studies examining zonulin-associated signaling pathways and the molecular mechanisms that influence paracellular permeability within the intestinal epithelium.\u003c\/p\u003e\n\u003cp data-start=\"864\" data-end=\"1046\"\u003eUnlike many systemically active peptides, larazotide is designed to act primarily within the intestinal lumen, where it interacts locally with epithelial barrier signaling processes.\u003c\/p\u003e\n\u003ch3 data-section-id=\"o4rtew\" data-start=\"1053\" data-end=\"1084\"\u003eMolecular Mechanism of Action\u003c\/h3\u003e\n\u003cp data-start=\"1086\" data-end=\"1263\"\u003eLarazotide is studied as a \u003cstrong data-start=\"1113\" data-end=\"1172\"\u003ecompetitive antagonist of the zonulin signaling pathway\u003c\/strong\u003e, a regulatory system involved in the modulation of epithelial tight junction permeability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"vmv2z6\" data-start=\"1265\" data-end=\"1305\"\u003eZonulin-Associated Signaling Cascade\u003c\/h3\u003e\n\u003cp data-start=\"1307\" data-end=\"1526\"\u003eIn experimental models, intestinal permeability can increase when zonulin is released by enterocytes in response to environmental triggers such as microbial products, inflammatory cytokines, or certain dietary peptides.\u003c\/p\u003e\n\u003cp data-start=\"1528\" data-end=\"1571\"\u003eThe pathway proceeds through several steps:\u003c\/p\u003e\n\u003col data-start=\"1573\" data-end=\"1595\"\u003e\n\u003cli data-section-id=\"qd2dee\" data-start=\"1573\" data-end=\"1595\"\u003e\n\u003cp data-start=\"1576\" data-end=\"1595\"\u003e\u003cstrong data-start=\"1576\" data-end=\"1595\"\u003eZonulin release\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"1597\" data-end=\"1745\"\u003eCertain luminal stimuli activate CXCR3-MyD88 signaling in enterocytes, leading to secretion of zonulin (prehaptoglobin-2) into the intestinal lumen.\u003c\/p\u003e\n\u003col start=\"2\" data-start=\"1747\" data-end=\"1774\"\u003e\n\u003cli data-section-id=\"1lol22z\" data-start=\"1747\" data-end=\"1774\"\u003e\n\u003cp data-start=\"1750\" data-end=\"1774\"\u003e\u003cstrong data-start=\"1750\" data-end=\"1774\"\u003eReceptor interaction\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"1776\" data-end=\"1986\"\u003eZonulin binds to receptors on the \u003cstrong data-start=\"1810\" data-end=\"1844\"\u003eapical membrane of enterocytes\u003c\/strong\u003e, particularly \u003cstrong data-start=\"1859\" data-end=\"1899\"\u003eprotease-activated receptor-2 (PAR2)\u003c\/strong\u003e, which can subsequently transactivate the \u003cstrong data-start=\"1942\" data-end=\"1985\"\u003eepidermal growth factor receptor (EGFR)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003col start=\"3\" data-start=\"1988\" data-end=\"2029\"\u003e\n\u003cli data-section-id=\"19celmm\" data-start=\"1988\" data-end=\"2029\"\u003e\n\u003cp data-start=\"1991\" data-end=\"2029\"\u003e\u003cstrong data-start=\"1991\" data-end=\"2029\"\u003eIntracellular signaling activation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2031\" data-end=\"2092\"\u003eThis interaction activates phospholipase C (PLC), leading to:\u003c\/p\u003e\n\u003cul data-start=\"2094\" data-end=\"2196\"\u003e\n\u003cli data-section-id=\"47notx\" data-start=\"2094\" data-end=\"2119\"\u003e\n\u003cp data-start=\"2096\" data-end=\"2119\"\u003eIP3 and DAG signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"awcxnp\" data-start=\"2120\" data-end=\"2155\"\u003e\n\u003cp data-start=\"2122\" data-end=\"2155\"\u003eintracellular Ca²⁺ mobilization\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"16y0kun\" data-start=\"2156\" data-end=\"2196\"\u003e\n\u003cp data-start=\"2158\" data-end=\"2196\"\u003eactivation of protein kinase Cα (PKCα)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col start=\"4\" data-start=\"2198\" data-end=\"2228\"\u003e\n\u003cli data-section-id=\"1025c4r\" data-start=\"2198\" data-end=\"2228\"\u003e\n\u003cp data-start=\"2201\" data-end=\"2228\"\u003e\u003cstrong data-start=\"2201\" data-end=\"2228\"\u003eCytoskeletal remodeling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2230\" data-end=\"2260\"\u003eDownstream signaling promotes:\u003c\/p\u003e\n\u003cul data-start=\"2262\" data-end=\"2392\"\u003e\n\u003cli data-section-id=\"16ahnd7\" data-start=\"2262\" data-end=\"2336\"\u003e\n\u003cp data-start=\"2264\" data-end=\"2336\"\u003ephosphorylation of \u003cstrong data-start=\"2283\" data-end=\"2311\"\u003emyosin light chain (MLC)\u003c\/strong\u003e via MLCK\/ROCK pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1qsdsjv\" data-start=\"2337\" data-end=\"2392\"\u003e\n\u003cp data-start=\"2339\" data-end=\"2392\"\u003econtraction of the \u003cstrong data-start=\"2358\" data-end=\"2392\"\u003eperijunctional actomyosin ring\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col start=\"5\" data-start=\"2394\" data-end=\"2429\"\u003e\n\u003cli data-section-id=\"v9ze9r\" data-start=\"2394\" data-end=\"2429\"\u003e\n\u003cp data-start=\"2397\" data-end=\"2429\"\u003e\u003cstrong data-start=\"2397\" data-end=\"2429\"\u003eTight junction rearrangement\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2431\" data-end=\"2514\"\u003eThis process can result in redistribution of key tight junction proteins including:\u003c\/p\u003e\n\u003cul data-start=\"2516\" data-end=\"2579\"\u003e\n\u003cli data-section-id=\"132jsld\" data-start=\"2516\" data-end=\"2528\"\u003e\n\u003cp data-start=\"2518\" data-end=\"2528\"\u003e\u003cstrong data-start=\"2518\" data-end=\"2526\"\u003eZO-1\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1ln1t31\" data-start=\"2529\" data-end=\"2545\"\u003e\n\u003cp data-start=\"2531\" data-end=\"2545\"\u003e\u003cstrong data-start=\"2531\" data-end=\"2543\"\u003eoccludin\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"yz2n4z\" data-start=\"2546\" data-end=\"2562\"\u003e\n\u003cp data-start=\"2548\" data-end=\"2562\"\u003e\u003cstrong data-start=\"2548\" data-end=\"2560\"\u003eclaudins\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"cj802m\" data-start=\"2563\" data-end=\"2579\"\u003e\n\u003cp data-start=\"2565\" data-end=\"2579\"\u003e\u003cstrong data-start=\"2565\" data-end=\"2579\"\u003eE-cadherin\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2581\" data-end=\"2740\"\u003eThe resulting structural changes may increase \u003cstrong data-start=\"2627\" data-end=\"2656\"\u003eparacellular permeability\u003c\/strong\u003e, allowing macromolecules or luminal antigens to pass across the epithelial barrier.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1m23dbz\" data-start=\"2747\" data-end=\"2801\"\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2928\" data-end=\"2977\"\u003e \u003c\/p\u003e\n\u003ch3 data-section-id=\"x0xfe9\" data-start=\"3706\" data-end=\"3754\"\u003eFindings from Cellular and Experimental Models\u003c\/h3\u003e\n\u003cp data-start=\"3756\" data-end=\"3954\"\u003eIn commonly used epithelial cell models (including \u003cstrong data-start=\"3807\" data-end=\"3856\"\u003eCaco-2, MDCK, IEC-6, and intestinal organoids\u003c\/strong\u003e), larazotide exposure has been associated with measurable changes in barrier function indicators:\u003c\/p\u003e\n\u003cp data-start=\"3956\" data-end=\"4186\"\u003e• Increased \u003cstrong data-start=\"3968\" data-end=\"4016\"\u003etransepithelial electrical resistance (TEER)\u003c\/strong\u003e\u003cbr data-start=\"4016\" data-end=\"4019\"\u003e• Reduced \u003cstrong data-start=\"4029\" data-end=\"4068\"\u003eparacellular flux of macromolecules\u003c\/strong\u003e (e.g., FITC-dextran)\u003cbr data-start=\"4089\" data-end=\"4092\"\u003e• Preservation of tight junction protein localization during inflammatory or stress conditions\u003c\/p\u003e\n\u003cp data-start=\"4188\" data-end=\"4292\"\u003eThese findings have positioned larazotide as a compound frequently used in laboratory studies exploring:\u003c\/p\u003e\n\u003cul data-start=\"4294\" data-end=\"4416\"\u003e\n\u003cli data-section-id=\"wf19nu\" data-start=\"4294\" data-end=\"4332\"\u003e\n\u003cp data-start=\"4296\" data-end=\"4332\"\u003eintestinal permeability regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"q1q9q\" data-start=\"4333\" data-end=\"4364\"\u003e\n\u003cp data-start=\"4335\" data-end=\"4364\"\u003eepithelial barrier dynamics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1a2efgc\" data-start=\"4365\" data-end=\"4416\"\u003e\n\u003cp data-start=\"4367\" data-end=\"4416\"\u003eimmune-epithelial interaction at mucosal surfaces\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-section-id=\"zlqbtv\" data-start=\"4423\" data-end=\"4475\"\u003eResearch Context: Gut Barrier and Immune Signaling\u003c\/h3\u003e\n\u003cp data-start=\"4477\" data-end=\"4655\"\u003eBarrier integrity of the intestinal epithelium is increasingly studied as an important interface between microbial exposure, immune signaling, and systemic inflammatory pathways.\u003c\/p\u003e\n\u003cp data-start=\"4657\" data-end=\"4754\"\u003eExperimental literature has explored whether modulation of epithelial permeability may influence:\u003c\/p\u003e\n\u003cul data-start=\"4756\" data-end=\"4872\"\u003e\n\u003cli data-section-id=\"16pt98t\" data-start=\"4756\" data-end=\"4791\"\u003e\n\u003cp data-start=\"4758\" data-end=\"4791\"\u003emicrobial antigen translocation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"u2819a\" data-start=\"4792\" data-end=\"4814\"\u003e\n\u003cp data-start=\"4794\" data-end=\"4814\"\u003ecytokine signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1ainr7i\" data-start=\"4815\" data-end=\"4872\"\u003e\n\u003cp data-start=\"4817\" data-end=\"4872\"\u003eimmune cell trafficking from the intestinal environment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4874\" data-end=\"5121\"\u003eAnimal studies investigating autoimmune and inflammatory models have reported that restoration of epithelial barrier integrity can influence systemic immune responses, including modulation of T-cell populations and inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"5123\" data-end=\"5261\"\u003eLarazotide has therefore been examined in research settings focused on \u003cstrong data-start=\"5194\" data-end=\"5226\"\u003egut-immune axis interactions\u003c\/strong\u003e and epithelial barrier regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6tnc4l\" data-start=\"5268\" data-end=\"5298\"\u003eClinical Development Context\u003c\/h3\u003e\n\u003cp data-start=\"5300\" data-end=\"5425\"\u003eLarazotide acetate has been investigated in multiple clinical research programs examining intestinal permeability modulation.\u003c\/p\u003e\n\u003cp data-start=\"5427\" data-end=\"5500\"\u003eClinical trials have primarily explored larazotide in contexts involving:\u003c\/p\u003e\n\u003cul data-start=\"5502\" data-end=\"5619\"\u003e\n\u003cli data-section-id=\"1fbr3ro\" data-start=\"5502\" data-end=\"5536\"\u003e\n\u003cp data-start=\"5504\" data-end=\"5536\"\u003eepithelial barrier dysfunction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"b67wo0\" data-start=\"5537\" data-end=\"5580\"\u003e\n\u003cp data-start=\"5539\" data-end=\"5580\"\u003egluten-triggered permeability responses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"15p3k4o\" data-start=\"5581\" data-end=\"5619\"\u003e\n\u003cp data-start=\"5583\" data-end=\"5619\"\u003einflammatory intestinal environments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"5621\" data-end=\"5796\"\u003eAcross published studies, larazotide has demonstrated a \u003cstrong data-start=\"5677\" data-end=\"5739\"\u003efavorable safety profile and localized mechanism of action\u003c\/strong\u003e, consistent with its design as a gut-restricted peptide.\u003c\/p\u003e\n\u003cp data-start=\"5798\" data-end=\"5929\"\u003eThe compound remains \u003cstrong data-start=\"5819\" data-end=\"5862\"\u003einvestigational and under ongoing study\u003c\/strong\u003e in several research programs examining epithelial barrier biology.\u003c\/p\u003e\n\u003ch3 data-section-id=\"15vs70q\" data-start=\"5936\" data-end=\"5963\"\u003eMolecular Characteristics\u003c\/h3\u003e\n\u003cp data-start=\"5965\" data-end=\"6234\"\u003e\u003cstrong data-start=\"5965\" data-end=\"5978\"\u003eSynonyms:\u003c\/strong\u003e Larazotide acetate, AT-1001\u003cbr data-start=\"6006\" data-end=\"6009\"\u003e\u003cstrong data-start=\"6009\" data-end=\"6030\"\u003ePeptide Sequence:\u003c\/strong\u003e Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (GGVLVQPG)\u003cbr data-start=\"6073\" data-end=\"6076\"\u003e\u003cstrong data-start=\"6076\" data-end=\"6098\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₅₅N₉O₁₀\u003cbr data-start=\"6110\" data-end=\"6113\"\u003e\u003cstrong data-start=\"6113\" data-end=\"6146\"\u003eMolecular Weight:\u003c\/strong\u003e ~725.8 g\/mol\u003cbr\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e258818-34-7\u003c\/p\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\u003cspan class=\"flex-1\"\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Larazotide.png?v=1772793744\" alt=\"Larazotide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9810532\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641934672138,"sku":null,"price":240.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641934704906,"sku":null,"price":265.0,"currency_code":"EUR","in_stock":true},{"title":"Capsules","offer_id":53149016391946,"sku":null,"price":290.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Larazotide20mg_4_1.png?v=1780478333"},{"product_id":"thymulin-20mg","title":"Thymulin 20mg – Research Peptide","description":"\u003cdiv style=\"text-align: start;\"\u003e\n\u003ch3 data-end=\"355\" data-start=\"283\" data-section-id=\"1xsa5r5\"\u003eThymulin – Zinc-Dependent Thymic Peptide for Immune Signaling Research\u003c\/h3\u003e\n\u003ch3 data-end=\"368\" data-start=\"357\" data-section-id=\"rzkdgm\"\u003eOverview\u003c\/h3\u003e\n\u003cp data-end=\"709\" data-start=\"370\"\u003eThymulin, also known as serum thymic factor (FTS), is a naturally occurring zinc-dependent nonapeptide hormone produced by thymic epithelial cells. In research settings, thymulin is frequently studied as a regulatory signal involved in T-cell differentiation, immune signaling coordination, and immune–neuroendocrine communication.\u003c\/p\u003e\n\u003cp data-end=\"1039\" data-start=\"711\"\u003eUnlike broader thymic peptide extracts such as thymalin, which contain multiple short peptides, thymulin represents a single, well-defined regulatory molecule. Its activity depends on complex formation with zinc ions (Zn²⁺), which induces a structural conformation required for receptor interaction and biological signaling.\u003c\/p\u003e\n\u003cp data-end=\"1233\" data-start=\"1041\"\u003eBecause of its highly specific signaling profile, thymulin is commonly examined in laboratory models investigating immune maturation, cytokine balance, and immune–brain axis communication.\u003c\/p\u003e\n\u003cp data-end=\"1586\" data-start=\"1373\"\u003eThe peptide alone exists in an apo-form that is biologically inactive. Binding to equimolar zinc ions produces the active metallopeptide complex capable of interacting with thymocyte and immune cell receptors.\u003c\/p\u003e\n\u003cp data-end=\"1782\" data-start=\"1588\"\u003eThis zinc-dependent structural activation distinguishes thymulin from many other thymic peptides and contributes to its role as a precise regulatory signal within immune maturation pathways.\u003c\/p\u003e\n\u003ch3 data-end=\"1869\" data-start=\"1823\" data-section-id=\"6bd1ur\"\u003eInteraction with T-Cell Development Pathways\u003c\/h3\u003e\n\u003cp data-end=\"1976\" data-start=\"1871\"\u003eThymulin has been extensively studied in models of T-lymphocyte differentiation and thymic signaling.\u003c\/p\u003e\n\u003cp data-end=\"2085\" data-start=\"1978\"\u003eExperimental findings suggest that thymulin participates in several processes related to T-cell maturation:\u003c\/p\u003e\n\u003cp data-end=\"2356\" data-start=\"2087\"\u003e• differentiation of bone-marrow-derived prothymocytes into mature T-lymphocytes\u003cbr data-end=\"2174\" data-start=\"2171\"\u003e• regulation of T-cell surface markers including CD3, CD4, CD8, and CD90 (Thy-1)\u003cbr data-end=\"2261\" data-start=\"2258\"\u003e• modulation of functional activity in helper, cytotoxic, and regulatory T-cell populations\u003c\/p\u003e\n\u003cp data-end=\"2539\" data-start=\"2358\"\u003eResearch models have also examined thymulin’s potential influence on Foxp3-positive regulatory T-cell development, which plays an important role in maintaining immune tolerance.\u003c\/p\u003e\n\u003cp data-end=\"2682\" data-start=\"2541\"\u003eIn addition, thymulin signaling has been associated with modulation of natural killer (NK) cell activity in certain experimental systems.\u003c\/p\u003e\n\u003ch3 data-end=\"2731\" data-start=\"2689\" data-section-id=\"7kso8o\"\u003eCytokine Signaling and Immune Regulation\u003c\/h3\u003e\n\u003cp data-end=\"2870\" data-start=\"2733\"\u003eThymulin has been studied for its role in coordinating pro- and anti-inflammatory cytokine networks within immune signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"3019\" data-start=\"2872\"\u003eIn laboratory models, thymulin exposure has been associated with balanced expression of cytokines involved in adaptive immune responses, including:\u003c\/p\u003e\n\u003cp data-end=\"3049\" data-start=\"3021\"\u003e• IL-2\u003cbr data-end=\"3030\" data-start=\"3027\"\u003e• IFN-γ\u003cbr data-end=\"3040\" data-start=\"3037\"\u003e• IL-10\u003c\/p\u003e\n\u003cp data-end=\"3122\" data-start=\"3051\"\u003ewhile modulating excessive signaling of inflammatory mediators such as:\u003c\/p\u003e\n\u003cp data-end=\"3149\" data-start=\"3124\"\u003e• IL-1\u003cbr data-end=\"3133\" data-start=\"3130\"\u003e• IL-6\u003cbr data-end=\"3142\" data-start=\"3139\"\u003e• TNF-α\u003c\/p\u003e\n\u003cp data-end=\"3300\" data-start=\"3151\"\u003eThese findings have positioned thymulin as a compound of interest in research exploring immune system regulation and cytokine signaling dynamics.\u003c\/p\u003e\n\u003ch3 data-end=\"3354\" data-start=\"3307\" data-section-id=\"efvsnp\"\u003eNeuroendocrine and Immune–Brain Axis Research\u003c\/h3\u003e\n\u003cp data-end=\"3460\" data-start=\"3356\"\u003eThymulin is notable among thymic peptides for its interaction with neuroendocrine signaling systems.\u003c\/p\u003e\n\u003cp data-end=\"3661\" data-start=\"3462\"\u003eExperimental literature has described bidirectional communication between the thymus and the hypothalamic–pituitary axis, with thymulin participating in signaling pathways involving hormones such as:\u003c\/p\u003e\n\u003cp data-end=\"3722\" data-start=\"3663\"\u003e• growth hormone (GH)\u003cbr data-end=\"3687\" data-start=\"3684\"\u003e• prolactin\u003cbr data-end=\"3701\" data-start=\"3698\"\u003e• ACTH\u003cbr data-end=\"3710\" data-start=\"3707\"\u003e• TSH\u003cbr data-end=\"3718\" data-start=\"3715\"\u003e• LH\u003c\/p\u003e\n\u003cp data-end=\"3894\" data-start=\"3724\"\u003eStudies have also explored thymulin’s presence in central nervous system environments, including its interaction with glial cells and inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"4117\" data-start=\"3896\"\u003eIn neuroinflammatory research models, thymulin has been observed to influence pathways associated with NF-κB signaling in neural tissues, suggesting potential relevance in investigations of immune–brain communication.\u003c\/p\u003e\n\u003ch3 data-end=\"4154\" data-start=\"4124\" data-section-id=\"1hfvtej\"\u003eAge-Related Thymic Signaling\u003c\/h3\u003e\n\u003cp data-end=\"4321\" data-start=\"4156\"\u003eCirculating thymulin levels decline with age in parallel with thymic involution, a well-described biological process involving reduced thymic activity over time.\u003c\/p\u003e\n\u003cp data-end=\"4395\" data-start=\"4323\"\u003eFor this reason, thymulin is frequently referenced in studies examining:\u003c\/p\u003e\n\u003cp data-end=\"4510\" data-start=\"4397\"\u003e• immune aging mechanisms\u003cbr data-end=\"4425\" data-start=\"4422\"\u003e• thymic signaling decline\u003cbr data-end=\"4454\" data-start=\"4451\"\u003e• adaptive immune system development across the lifespan\u003c\/p\u003e\n\u003cp data-end=\"4662\" data-start=\"4512\"\u003eThese research contexts have contributed to growing interest in thymulin as a model peptide for studying age-related changes in immune regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"4712\" data-start=\"4669\" data-section-id=\"s1sill\"\u003eZinc Dependence and Structural Activation\u003c\/h3\u003e\n\u003cp data-end=\"4779\" data-start=\"4714\"\u003eA defining feature of thymulin is its strict zinc dependence.\u003c\/p\u003e\n\u003cp data-end=\"5024\" data-start=\"4781\"\u003eWithout zinc binding, thymulin remains in an inactive conformation. When Zn²⁺ ions bind to the peptide, the resulting metallopeptide undergoes a structural transition that allows high-affinity receptor interaction and downstream signaling.\u003c\/p\u003e\n\u003cp data-end=\"5234\" data-start=\"5026\"\u003eBecause of this requirement, many experimental systems examining thymulin activity also investigate zinc availability and metallopeptide formation as critical factors influencing thymic hormone signaling.\u003c\/p\u003e\n\u003ch3 data-end=\"5268\" data-start=\"5241\" data-section-id=\"15vs70q\"\u003eMolecular Characteristics\u003c\/h3\u003e\n\u003cp data-end=\"5496\" data-start=\"5270\"\u003e\u003cstrong data-end=\"5283\" data-start=\"5270\"\u003eSynonyms:\u003c\/strong\u003e Thymulin, Serum Thymic Factor (FTS), Facteur Thymique Sérique\u003cbr data-end=\"5348\" data-start=\"5345\"\u003e\u003cstrong data-end=\"5369\" data-start=\"5348\"\u003ePeptide Sequence:\u003c\/strong\u003e pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH\u003cbr data-end=\"5412\" data-start=\"5409\"\u003e\u003cstrong data-end=\"5433\" data-start=\"5412\"\u003eMolecular Weight:\u003c\/strong\u003e ~858.86 Da\u003cbr data-end=\"5447\" data-start=\"5444\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSummary Table of Key MOA Layers\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable style=\"width: 88.75%; height: 108px;\" height=\"142\" width=\"262\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eLevel\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003eMechanism\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003e Main Outcomes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eMolecular\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003eZn²⁺ binding → active conformation \u0026amp; receptor signaling\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eProper receptor activation, marker induction, NF-κB modulation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eCellular\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003e\n\u003cp\u003eProthymocyte → mature T-cell differentiation\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eBalanced CD4\/CD8\/Treg populations,↑ NK activity, cytokine balance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eTissue\/Organ\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003e\n\u003cp\u003eThymic hormonal microenvironment signal\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eT-cell maturation, immune tolerance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.625px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.625px;\"\u003eSystemic\/Neuro\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.625px;\"\u003e\n\u003cp\u003eNeuroendocrine-immune axis integration\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.625px;\"\u003eAnti-inflammation, analgesia, circadian regulation, homeostasis \u0026amp; longevity\u003cbr\u003esupport\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641940504842,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641940537610,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Thymulin20mg_2.png?v=1772292079"},{"product_id":"slu-pp-332-10mg","title":"SLU-PP-332 10mg – Metabolic \u0026 Exercise Signaling Research Compound","description":"\u003ch2 data-end=\"604\" data-start=\"139\"\u003e\u003cstrong data-end=\"162\" data-start=\"139\"\u003eSLU-PP-332 sQ\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"421\" data-start=\"83\"\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. SLU-PP-332 is examined in experimental models focused on metabolic efficiency, mitochondrial activation, and exercise-mimetic signaling pathways. Research interest centers on how cells adapt to increased energy demand without physical stress.\u003c\/p\u003e\n\u003cp data-end=\"665\" data-start=\"423\"\u003eSLU-PP-332 is studied for its potential role in modulating metabolic processes and regulating cellular energy dynamics. This compound is used in research settings exploring metabolic signaling, mitochondrial function, and cellular adaptation.\u003c\/p\u003e\n\u003cp data-end=\"742\" data-start=\"667\"\u003eExperimental studies have indicated that SLU-PP-332 may be associated with:\u003c\/p\u003e\n\u003cul data-end=\"884\" data-start=\"744\"\u003e\n\u003cli data-end=\"781\" data-start=\"744\" data-section-id=\"1bjsqce\"\u003eregulation of metabolic processes\u003c\/li\u003e\n\u003cli data-end=\"832\" data-start=\"782\" data-section-id=\"km3mdj\"\u003ecellular adaptation to increased energy demand\u003c\/li\u003e\n\u003cli data-end=\"884\" data-start=\"833\" data-section-id=\"9oarl7\"\u003esignaling pathways related to physical activity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1201\" data-start=\"886\"\u003eTraditionally, the physiological benefits associated with physical exercise have been difficult to replicate in pharmacological models. With the introduction of SLU-PP-332, a new area of research has emerged focused on studying the mechanisms underlying exercise-related metabolic signaling and cellular adaptation.\u003c\/p\u003e\n\u003ch3 data-end=\"206\" data-start=\"168\"\u003ePrimary metabolic research pairing\u003c\/h3\u003e\n\u003cp data-end=\"424\" data-start=\"208\"\u003eIn experimental and laboratory research settings, SLU-PP-332 is commonly examined alongside compounds involved in mitochondrial energy signaling, metabolic efficiency, and systemic energy regulation pathways.\u003c\/p\u003e\n\u003cp data-end=\"624\" data-start=\"426\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-end=\"440\" data-start=\"428\"\u003eCJC-1295\u003c\/strong\u003e – growth hormone–related metabolic signaling research\u003c\/a\u003e\u003cbr data-end=\"497\" data-start=\"494\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-end=\"514\" data-start=\"499\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-end=\"561\" data-start=\"558\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-end=\"577\" data-start=\"563\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"685\" data-start=\"631\"\u003eMitochondrial and cellular energy research context\u003c\/h3\u003e\n\u003cp data-end=\"852\" data-start=\"687\"\u003eSome experimental frameworks explore SLU-PP-332 in parallel with compounds studied for mitochondrial function, bioenergetics, and cellular stress adaptation.\u003c\/p\u003e\n\u003cp data-end=\"1017\" data-start=\"854\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-50mg-per-vial\"\u003e\u003cstrong data-end=\"880\" data-start=\"856\"\u003eSS-31 (Elamipretide)\u003c\/strong\u003e – mitochondrial stabilization and respiration research\u003c\/a\u003e\u003cbr data-end=\"938\" data-start=\"935\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/mots-c-peptide-10-mg-research-grade\"\u003e\u003cstrong data-end=\"950\" data-start=\"940\"\u003eMOTS-c\u003c\/strong\u003e – mitochondrial-derived peptide and metabolic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1080\" data-start=\"1024\"\u003eRedox balance and metabolic support research context\u003c\/h3\u003e\n\u003cp data-end=\"1239\" data-start=\"1082\"\u003eAdditional research models reference SLU-PP-332 alongside compounds examined for redox balance, cellular resilience, and metabolic cofactor pathways.\u003c\/p\u003e\n\u003cp data-end=\"1384\" data-start=\"1241\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cstrong data-end=\"1251\" data-start=\"1243\"\u003eNAD+\u003c\/strong\u003e – cellular energy metabolism and redox signaling research\u003c\/a\u003e\u003cbr data-end=\"1312\" data-start=\"1309\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"1331\" data-start=\"1314\"\u003eL-Glutathione\u003c\/strong\u003e – oxidative stress and antioxidant system research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"376\" data-start=\"101\"\u003eSLU-PP-332 represents a notable advancement in this research category. It is an estrogen-related receptor (ERR) agonist designed to selectively target ERR alpha and gamma subtypes. In laboratory research, SLU-PP-332 has been examined in relation to several areas of interest:\u003c\/p\u003e\n\u003cul data-end=\"578\" data-start=\"378\"\u003e\n\u003cli data-end=\"432\" data-start=\"378\" data-section-id=\"1ia0ibu\"\u003emuscular endurance in experimental exercise models\u003c\/li\u003e\n\u003cli data-end=\"485\" data-start=\"433\" data-section-id=\"x5wjn6\"\u003emetabolic regulation and weight-related pathways\u003c\/li\u003e\n\u003cli data-end=\"525\" data-start=\"486\" data-section-id=\"1i8xedd\"\u003ecardiovascular signaling mechanisms\u003c\/li\u003e\n\u003cli data-end=\"578\" data-start=\"526\" data-section-id=\"1yqydh7\"\u003eneurobiological research models related to aging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"897\" data-start=\"580\"\u003eBy engaging metabolic pathways similar to those activated during physical exercise, SLU-PP-332 has generated significant interest within the scientific community. Researchers focusing on longevity, energy metabolism, and cellular adaptation continue to investigate its role in these interconnected biological systems.\u003c\/p\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1060\" data-start=\"899\"\u003eThese research directions contribute to a broader understanding of how metabolic signaling and cellular responses may influence long-term physiological function.\u003c\/p\u003e\n\u003cp data-end=\"107\" data-start=\"64\"\u003e\u003cstrong data-end=\"107\" data-start=\"64\"\u003eFurther Research \u0026amp; Scientific Resources\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"322\" data-start=\"109\"\u003eTo explore the scientific background, molecular mechanisms, and research applications of \u003cstrong data-end=\"212\" data-start=\"198\"\u003eSLU-PP-332\u003c\/strong\u003e, read our detailed overview:\u003cbr data-end=\"244\" data-start=\"241\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-slu-pp-332\"\u003eWhat is SLU-PP-332? – Mechanism, metabolic signaling, and research context\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"457\" data-start=\"324\"\u003eSLU-PP-332 is investigated in experimental models focused on \u003cstrong data-end=\"456\" data-start=\"385\"\u003emitochondrial function, energy metabolism, and metabolic efficiency\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"638\" data-start=\"459\"\u003eFor a broader understanding of \u003cstrong data-end=\"552\" data-start=\"490\"\u003emetabolic energy pathways and performance-related research\u003c\/strong\u003e:\u003cbr data-end=\"556\" data-start=\"553\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"638\" data-start=\"459\"\u003e\u003cspan style=\"font-kerning: none;\"\u003eLearn how exercise-mimetic signaling and mitochondrial biogenesis pathways are connected in our detailed article on exercise and mitochondrial health.\u003cbr\u003e\u003cspan\u003e → \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003e\u003c\/strong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"672\" data-start=\"645\"\u003e\u003cstrong data-end=\"672\" data-start=\"645\"\u003eRelated Research Topics\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"858\" data-start=\"674\"\u003eTo understand how \u003cstrong data-end=\"744\" data-start=\"692\"\u003emitochondrial efficiency and metabolic signaling\u003c\/strong\u003e relate to \u003cstrong data-end=\"790\" data-start=\"755\"\u003emuscle performance and recovery\u003c\/strong\u003e, explore:\u003cbr data-end=\"803\" data-start=\"800\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"168\" data-start=\"130\"\u003eProduct Description – SLU-PP-332\u003c\/h3\u003e\n\u003cp data-end=\"434\" data-start=\"170\"\u003e\u003cstrong data-end=\"183\" data-start=\"170\"\u003eSynonyms:\u003c\/strong\u003e 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide\u003cbr data-end=\"240\" data-start=\"237\"\u003e\u003cstrong data-end=\"255\" data-start=\"240\"\u003eMolar Mass:\u003c\/strong\u003e 290.32 g\/mol\u003cbr data-end=\"271\" data-start=\"268\"\u003e\u003cstrong data-end=\"286\" data-start=\"271\"\u003eCAS Number:\u003c\/strong\u003e 303760-60-3\u003cbr data-end=\"301\" data-start=\"298\"\u003e\u003cstrong data-end=\"316\" data-start=\"301\"\u003ePubChem ID:\u003c\/strong\u003e 5338394\u003cbr data-end=\"327\" data-start=\"324\"\u003e\u003cstrong data-end=\"355\" data-start=\"327\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-end=\"407\" data-start=\"404\"\u003e\u003cstrong data-end=\"422\" data-start=\"407\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-end=\"434\" data-start=\"170\"\u003e\u003cstrong\u003eSLU-PP-332 Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg alt=\"Chemical structure diagram of SLU-PP-332\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Slu-PP-332.png?v=1755158769\"\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52711336182026,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52711336214794,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/slupp332_10mg_2.png?v=1773991050"},{"product_id":"slu-pp-915-100-mg","title":"SLU-PP-915 100 mg – Experimental Metabolic Signaling Compound","description":"\u003ch3\u003eSLU-PP-915: Molecular Mechanism of Action and Preclinical Studies\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eSLU-PP-915 (chemical identifier: 2,5-disubstituted thiophene amide with boronic acid; CAS not specified in primary sources) is a synthetic, orally bioavailable pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ). It was developed through structure-based optimization of a new acyl hydrazide-derived chemical series at Saint Louis University, distinct from the earlier pan-ERR agonist SLU-PP-332. The key innovation is the incorporation of a boronic acid moiety, which replaces phenolic or aniline groups found in prior scaffolds. This modification enhances metabolic stability and maintains potent agonist activity across all three ERR isoforms (EC₅₀ values ≈ 414 nM for ERRα, 435 nM for ERRβ, and 378 nM for ERRγ).\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eNo human clinical trials have been conducted or reported as of April 2026. All available data are preclinical (in vitro cell assays, ex vivo tissues, and animal models). SLU-PP-915 remains an experimental research tool.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003eMolecular Mechanism of Action (MOA)\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the molecular level, SLU-PP-915 functions as a direct ligand that binds the ligand-binding domain (LBD) of ERRs. Binding was validated using biophysical methods, including ¹H NMR protein-ligand titration experiments with the ERRγ LBD. The boronic acid group acts as a hydrogen-bond donor, stabilizing the receptor-ligand complex in a manner that mimics natural phenolic interactions in earlier agonists.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eLigand binding induces a conformational shift in the ERR LBD, promoting recruitment of coactivators such as PGC-1α. This activates ERR-dependent transcription at ERR response elements (ERREs) in promoter regions of target genes.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003ePrimary upregulated pathways include:\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• Mitochondrial biogenesis and oxidative phosphorylation (OXPHOS): Induction of PPARGC1A (PGC-1α), electron transport chain components, and TCA cycle enzymes (e.g., Aco2, Sdhb).  \u003c\/div\u003e\n\u003cdiv\u003e• Fatty acid oxidation (FAO) and metabolic reprogramming: Upregulation of PDK4, ACSL1, CPT1B, and ACADM, shifting cellular energy utilization toward fatty acids and mitochondrial efficiency.  \u003c\/div\u003e\n\u003cdiv\u003e• Exercise-mimetic and stress-response genes: Induction of DDIT4 and LDHA.  \u003c\/div\u003e\n\u003cdiv\u003e• Autophagy and lysosomal biogenesis: Activation of TFEB, leading to increased expression of LAMP1, LAMP2, CTSD, MCOLN1, and p62\/SQSTM1, supporting autophagic flux and cellular maintenance.  \u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eERRγ appears to be a dominant mediator of these effects in cardiomyocytes and skeletal muscle, although the compound demonstrates balanced activity across all ERR isoforms. Genetic knockdown studies confirm that a large proportion of transcriptional changes induced by SLU-PP-915 are ERR-dependent, with ERRγ contributing significantly to metabolic pathway regulation.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThe overall effect observed in experimental systems is a shift toward enhanced mitochondrial function, fatty acid oxidation, and cellular energy efficiency.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003ePreclinical Studies and Observed Effects\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e1. Exercise Capacity and Skeletal Muscle\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn controlled experimental models, SLU-PP-915 administration (oral and parenteral routes) was associated with measurable increases in endurance-related parameters, including running distance and duration in treadmill-based assays.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eGene expression analysis demonstrated induction of metabolic and mitochondrial pathways consistent with endurance adaptation. Chronic exposure in combination with training protocols further amplified oxidative and mitochondrial gene programs.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePharmacokinetic evaluations indicate improved oral bioavailability compared to earlier compounds in this class, supporting its use in research models examining systemic metabolic regulation.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e2. Cardiovascular Research Models\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn pressure-overload experimental models, SLU-PP-915 administration was associated with improvements in cardiac functional parameters, including left ventricular performance and metabolic gene expression profiles.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eObserved effects included:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• modulation of cardiac energy metabolism  \u003c\/div\u003e\n\u003cdiv\u003e• improved mitochondrial structure and function  \u003c\/div\u003e\n\u003cdiv\u003e• reduced markers associated with fibrotic remodeling  \u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese outcomes were strongly linked to ERRγ-mediated signaling pathways in cardiac tissue.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e3. Autophagy and Cellular Maintenance\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn cellular models, SLU-PP-915 exposure was associated with increased TFEB expression and activation of lysosomal and autophagy-related gene networks.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis translated to:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• enhanced autophagic flux  \u003c\/div\u003e\n\u003cdiv\u003e• increased lysosomal activity  \u003c\/div\u003e\n\u003cdiv\u003e• improved clearance of damaged cellular components  \u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese findings support its relevance in studies examining cellular maintenance, stress response, and metabolic adaptation.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003eTranslational Research Context (Allometric Models)\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn preclinical research, exposure frameworks are sometimes evaluated using allometric scaling approaches to compare biological responses across species.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eFor SLU-PP-915, experimental exposure ranges have been explored in controlled animal models to investigate metabolic, mitochondrial, and cardiovascular outcomes. These values are used exclusively for comparative and mechanistic research purposes.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAll findings remain within preclinical contexts and are not intended to represent human application parameters.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003eComparative Research Context\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003ctable height=\"32\" style=\"width: 95.3405%;\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003e Parameter\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eSLU-PP-332\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eSLU-PP-915\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eChemical Scaffold\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eAcyl hydrazide-based\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003e2,5-disubstituted thiophene amide with boronic acid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eKey Structural Feature\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003ePhenolic\/aniline groups\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eBoronic acid moiety\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eOral Bioavailability\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eLimited\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eImproved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eMetabolic Stability\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eLower\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eHigher\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eERRα EC₅₀\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003e98 nM\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003e414 nM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eERRβ EC₅₀\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003e~230 nM\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003e435 nM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eERRγ EC₅₀\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003e~430 nM\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003e378 nM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003ePotency Profile\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eERRα-preferring\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eBalanced pan-ERR agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eExercise Model Effects\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eIncreased endurance parameters\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eComparable effects with improved exposure profile\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 41.2548%;\"\u003eCardiovascular Models\u003c\/td\u003e\n\u003ctd style=\"width: 31.4782%;\"\u003eImproved functional markers\u003c\/td\u003e\n\u003ctd style=\"width: 26.5066%;\"\u003eComparable metabolic and functional outcomes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eSummary\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eSLU-PP-915 is an orally active pan-ERR agonist studied in experimental models for its effects on metabolic regulation, mitochondrial function, fatty acid oxidation, and autophagy.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePreclinical studies demonstrate its role in modulating transcriptional programs associated with energy metabolism and cellular adaptation, with ERRγ playing a central role in mediating these effects.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAll available data remain within controlled laboratory and preclinical research contexts.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 data-end=\"400\" data-start=\"376\" data-section-id=\"10kdm3j\"\u003e\u003cspan role=\"text\"\u003eResearch Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp data-end=\"498\" data-start=\"402\"\u003eExplore the scientific context, signaling pathways, and experimental research behind SLU-PP-915:\u003c\/p\u003e\n\u003cp data-end=\"579\" data-start=\"500\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-slu-pp-915\"\u003eWhat is SLU-PP-915? – Molecular Mechanism and Metabolic Research Overview\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"579\" data-start=\"500\"\u003e\u003cspan style=\"font-kerning: none;\"\u003eExplore the molecular relationship between ERR activation, mitochondrial metabolism, and exercise-induced cellular adaptation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"579\" data-start=\"500\"\u003e\u003cspan style=\"font-kerning: none;\"\u003e\u003cspan\u003e → \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong data-start=\"645\" data-end=\"672\"\u003eRelated Research Topics\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp data-start=\"459\" data-end=\"638\"\u003eFor a broader understanding of \u003cstrong data-start=\"490\" data-end=\"552\"\u003emetabolic energy pathways and performance-related research\u003c\/strong\u003e:\u003cbr data-start=\"553\" data-end=\"556\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":52711337394442,"sku":null,"price":290.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/slu-pp915_100mg_2.png?v=1773990584"},{"product_id":"ara-290-10mg","title":"ARA-290 10mg - Peptide for Inflammation \u0026 Tissue Signaling Research","description":"\u003ch3\u003eARA-290 (Cibinetide, CAS 1208243-50-8) – Molecular Mechanism of Action and Research Overview\u003c\/h3\u003e\n\u003cp\u003eARA-290, also known as cibinetide (CAS 1208243-50-8), is a synthetic 11-amino-acid linear peptide (sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH; molecular formula C₅₁H₈₄N₁₆O₂₁; molecular weight 1,257.31 Da). It was engineered from the three-dimensional structure of helix B of erythropoietin (EPO). Unlike full-length recombinant human EPO, ARA-290 is non-erythropoietic and does not bind the classical EPOR homodimer associated with hematopoietic activity.\u003c\/p\u003e\n\u003cp\u003eInstead, ARA-290 selectively activates the innate repair receptor (IRR), a tissue-protective heteromeric complex composed of one EPOR subunit and the β-common receptor (βcR, CD131). The IRR is minimally expressed under baseline conditions but becomes upregulated in response to cellular stress, injury, or inflammation across multiple cell types, including neurons, endothelial cells, macrophages, and glial cells. This inducible expression profile localizes signaling activity to affected tissues.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eMolecular Mechanism of Action (MOA)\u003c\/h3\u003e\n\u003cp\u003eLigand interaction with the IRR initiates several intracellular signaling cascades:\u003c\/p\u003e\n\u003cp\u003e• JAK2\/STAT3 and PI3K\/Akt pathways:\u003cbr\u003eAssociated with cellular survival signaling, anti-apoptotic regulation (e.g., Bcl-2\/Bax balance), and tissue-repair–related processes.\u003c\/p\u003e\n\u003cp\u003e• Anti-inflammatory signaling:\u003cbr\u003eARA-290 modulates NF-κB pathway activity, leading to reduced transcription of pro-inflammatory mediators such as TNF-α and IL-6. It also influences oxidative stress pathways by reducing reactive oxygen species (ROS), which contributes to suppression of inflammasome activation (e.g., NLRP3).\u003c\/p\u003e\n\u003cp\u003e• Immune modulation:\u003cbr\u003eResearch models indicate a shift in macrophage and microglial signaling profiles toward regulatory (M2-like) states.\u003c\/p\u003e\n\u003cp\u003e• Neurosensory signaling pathways:\u003cbr\u003ePreclinical data suggest modulation of TRPV1-related pathways and chemokine signaling (e.g., CCL2), which are associated with nociceptive and neuroimmune interactions.\u003c\/p\u003e\n\u003cp\u003eAlthough the peptide exhibits a short plasma half-life, downstream signaling effects may persist due to activation of intracellular regulatory pathways.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003ePreclinical and Clinical Research Context\u003c\/h3\u003e\n\u003cp\u003eARA-290 has been investigated primarily in experimental and early-phase clinical research models related to small-fiber neuropathy (SFN), metabolic signaling, and inflammatory conditions.\u003c\/p\u003e\n\u003cp\u003eAcross these research settings, observations include:\u003c\/p\u003e\n\u003cp\u003e• Modulation of neuropathic symptom-related endpoints\u003cbr\u003e• Changes in markers associated with nerve fiber structure and regeneration\u003cbr\u003e• Alterations in inflammatory and metabolic signaling parameters\u003cbr\u003e• Improvements in functional and quality-of-life–associated measurements in controlled study environments\u003c\/p\u003e\n\u003cp\u003eImportantly, available data originate from controlled research settings, including in vitro systems, animal models, and early-phase human studies. No completed Phase 3 trials have been reported as of 2026.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eMetabolic and Inflammatory Research Observations\u003c\/h3\u003e\n\u003cp\u003eIn experimental models examining metabolic signaling:\u003c\/p\u003e\n\u003cp\u003e• Changes in glucose-related biomarkers have been reported\u003cbr\u003e• Modulation of inflammatory cytokine profiles has been observed\u003cbr\u003e• Endothelial and microvascular signaling pathways have been explored\u003c\/p\u003e\n\u003cp\u003eThese findings are generally interpreted within the broader context of inflammation-linked metabolic regulation rather than as direct therapeutic outcomes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eNeuroprotective and Cognitive Research Context\u003c\/h3\u003e\n\u003cp\u003eBeyond peripheral systems, ARA-290 has been studied in central nervous system (CNS) models due to its interaction with the innate repair receptor.\u003c\/p\u003e\n\u003cp\u003ePreclinical research includes:\u003c\/p\u003e\n\u003cp\u003e• Neuroinflammation modulation in neurodegenerative models\u003cbr\u003e• Effects on amyloid-related pathways in transgenic systems\u003cbr\u003e• Regulation of tau-associated signaling in experimental models\u003cbr\u003e• Reduced markers of neuronal stress and apoptosis in ischemic and injury models\u003c\/p\u003e\n\u003cp\u003eAdditional experimental observations:\u003c\/p\u003e\n\u003cp\u003e• Modulation of monocyte and microglial signaling\u003cbr\u003e• Changes in neuroimmune communication pathways\u003cbr\u003e• Effects on behavioral and cognitive test outcomes in controlled models\u003c\/p\u003e\n\u003cp\u003eLimited exploratory human research has examined cognitive and emotional processing, indicating subtle modulation of affective processing pathways without broad systemic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eSafety and Research Status\u003c\/h3\u003e\n\u003cp\u003eARA-290 is currently classified as an experimental research peptide.\u003c\/p\u003e\n\u003cp\u003eAvailable data from early-phase investigations suggest:\u003c\/p\u003e\n\u003cp\u003e• No activation of erythropoietic pathways\u003cbr\u003e• No consistent signals related to hematologic or cardiovascular parameters\u003cbr\u003e• Generally favorable tolerability profiles in controlled research settings\u003c\/p\u003e\n\u003cp\u003eHowever, comprehensive evaluation of long-term safety, pharmacokinetics, and broader applications requires further investigation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eResearch Use Context\u003c\/h3\u003e\n\u003cp\u003eAll information presented reflects published scientific literature and experimental findings.\u003c\/p\u003e\n\u003cp\u003eThis material is intended exclusively for laboratory research and scientific investigation.\u003cbr\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52895609913610,"sku":null,"price":215.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52895609946378,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ara290_10mg.png?v=1776848054"},{"product_id":"cortagen-peptide","title":"Cortagen Peptide - Brain Longevity Bioregulator Research","description":"\u003ch3\u003e\u003cstrong\u003eCortagen Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCortagen is a lab-made chain of four amino acids that targets the brain and nerves. It helps the cells in the nervous system activate specific genes that support repair and healthy function. By working inside the cell nucleus, it influences how proteins are made to protect neurons from damage. This action can reduce harmful effects from oxidative stress and inflammation in the brain. In research with animals, Cortagen has helped damaged peripheral nerves regenerate faster and function better after injury. It has also supported recovery in models of reduced blood flow to the brain, improving behavior and protecting brain tissue. Older animals treated with it showed better performance in memory and learning tasks. Cortagen promotes the growth of connections between brain cells and strengthens communication signals. While most evidence comes from laboratory and animal research, there are observations of benefits for nerve recovery in some human cases. It offers a promising way to support nervous system health at a fundamental cellular level.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eMolecular Mechanisms of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCortagen, chemically defined as the tetrapeptide Ala-Glu-Asp-Pro (AEDP), represents a member of the short-chain bioregulatory peptide class pioneered through analysis of tissue-derived polypeptide extracts from cerebral cortex. As a synthetic analog of an active fraction isolated from such natural cortical peptide complexes, its compact structure confers high membrane permeability, enabling direct intracellular and intranuclear access without reliance on surface receptor-mediated signaling pathways typical of larger neurotrophic proteins or classical neurotransmitter modulators.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the biochemical level, this tetrapeptide interacts with chromatin architecture in a sequence-preferential manner, favoring motifs that facilitate targeted transcriptional modulation within neuronal and glial populations, particularly those of cortical origin.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe core molecular mechanism hinges on epigenetic reprogramming via chromatin remodeling. In differentiated post-mitotic neurons, progressive heterochromatin condensation accumulates with age or stress, silencing clusters of genes essential for maintenance functions such as ribosomal biogenesis, cytoskeletal dynamics, and stress-response cascades. Cortagen induces deheterochromatinization, loosening compact chromatin domains and increasing accessibility of promoter regions to the transcriptional machinery.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis process reactivates ribosomal RNA gene clusters (evidenced by enhanced nucleolar organizer region activity and silver-staining patterns in cytogenetic assays), thereby elevating overall protein synthetic capacity within neurons—a critical bottleneck in regenerative states where high metabolic demand for axon extension, synaptic vesicle recycling, and membrane expansion occurs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMicroarray profiling across tissue models reveals modulation of over one hundred genes, encompassing categories of signal transduction, oxidative defense, differentiation programs, and synaptic architecture components. Specific upregulation includes transcripts for brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), which in turn activate TrkB and TrkA receptor tyrosine kinase cascades, promoting downstream MAPK\/ERK and PI3K\/Akt pathways that converge on anti-apoptotic Bcl-2 family members and inhibition of caspase executioners.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSynaptic Plasticity and Neuroprotection\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eSynaptic plasticity represents another layer of molecular action. Cortagen elevates expression of key postsynaptic density proteins such as PSD-95, Arc, and Homer1, which scaffold glutamate receptor complexes (particularly NMDA and AMPA subtypes) and stabilize dendritic spine morphology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis enhances long-term potentiation (LTP) efficacy by optimizing receptor clustering, calcium influx regulation, and actin cytoskeleton remodeling via Rho GTPases and cofilin phosphorylation. Glutamatergic transmission gains balance through subtle shifts in excitatory-inhibitory tone, mitigating excitotoxic calcium overload while preserving NMDA-dependent signaling required for plasticity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn parallel, antioxidant enzyme gene sets (superoxide dismutase isoforms, catalase, glutathione peroxidase) undergo transcriptional activation, directly countering reactive oxygen species (ROS) accumulation that otherwise drives lipid peroxidation of polyunsaturated fatty acids in neuronal membranes, protein carbonylation of enzymes like creatine kinase or mitochondrial complexes, and DNA base oxidation leading to strand breaks.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe net outcome is a reduction in mitochondrial permeability transition pore opening, preservation of ATP synthesis, and attenuation of cytochrome c release—biochemical hallmarks that collectively block intrinsic apoptotic pathways under ischemic, traumatic, or age-associated oxidative burden.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese molecular events translate to cellular phenotypes observable in explant and primary culture systems: accelerated neurite outgrowth, increased dendritic arborization complexity (measured by Sholl analysis parameters), and elevated spine density, all driven by the interplay of neurotrophin autocrine loops and cytoskeletal gene activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnlike bulk neurotrophic factors that require extracellular binding and endosomal trafficking, Cortagen’s nuclear entry bypasses receptor desensitization and provides sustained, tissue-autonomous regulation, rendering it particularly suited for chronic degenerative or regenerative contexts where sustained low-level gene tuning outperforms acute pharmacological spikes.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003ePotential research applications stem directly from this mechanistic profile and center on conditions characterized by neuronal loss, synaptic failure, oxidative imbalance, or impaired regenerative capacity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn experimental cerebrovascular ischemia or stroke-related models, where hypoxia-reperfusion triggers massive ROS generation, mitochondrial failure, and penumbral neuronal apoptosis, Cortagen’s ability to counter lipid peroxidation while restoring antioxidant reserves and synaptic gene programs positions it as a promising neuro-supportive research peptide capable of supporting peri-lesional plasticity and cellular resilience.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePost-traumatic brain injury research settings may similarly benefit from enhanced BDNF-driven neurogenesis in the subventricular zone and hippocampal dentate gyrus, combined with PSD-95-mediated stabilization of newly formed circuits associated with cognitive and motor recovery pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePeripheral nerve injury models, including crush or transection paradigms commonly explored in orthopedic or neurosurgical research, may leverage the peptide’s promotion of axonal sprouting, Schwann cell support via paracrine neurotrophin signaling, and myelin sheath maturation reflected in conduction velocity improvements—offering a molecular bridge during the natural regeneration window limited by Wallerian degeneration kinetics.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAge-related cognitive decline and mild cognitive impairment research represent another domain, where progressive heterochromatinization and declining neurotrophin levels erode hippocampal and prefrontal synaptic density. By reactivating silenced repair genes and boosting dendritic spine turnover, Cortagen may support pathways associated with executive function, episodic memory consolidation, and attentional network maintenance without broadly altering neurotransmitter signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn neurodegenerative research areas such as Alzheimer’s disease (amyloid-driven oxidative stress and synaptic pruning) or Parkinson’s disease (dopaminergic terminal loss with mitochondrial complex I deficits), the peptide’s multifaceted antioxidant and anti-apoptotic actions, coupled to NGF\/BDNF support of dopaminergic and cholinergic populations, suggest potential relevance for studies focused on neuronal resilience and progression-associated cellular stress.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSecondary applications emerge in immune-neural crosstalk, given observed modulation of cytokine-responsive genes and IL-2 pathways, potentially relevant in neuroinflammatory states or post-viral encephalopathy research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEven cardiovascular-neural overlap appears plausible based on cross-tissue gene expression data showing stress-response reprogramming in myocardial models, hinting at broader cytoprotective utility in comorbid cerebrovascular-cardiac research contexts.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAnimal Research and Experimental Findings\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAnimal trial summaries consistently demonstrate these mechanisms in functional readouts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn rodent models of sciatic nerve transection followed by microsurgical repair, Cortagen administration accelerated axonal regrowth across the suture site, yielding approximately twenty-seven percent faster fiber elongation rates and forty percent higher compound muscle action potential conduction velocities—particularly evident in large-diameter myelinated A-fibers—accompanied by histologically reduced neuroma formation and improved end-organ reinnervation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eElectron microscopy confirmed enhanced myelin thickness and nodal architecture, aligning with upregulated myelin basic protein transcripts and cytoskeletal genes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn chronic cerebral ischemia paradigms induced by bilateral carotid occlusion or similar hypoperfusion protocols, animals exhibited accelerated restoration of exploratory behavior, spatial navigation, and avoidance learning across high- and low-hypoxia-resistant subgroups.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBiochemical assays revealed prevention of ischemia-induced spikes in thiobarbituric acid-reactive substances (markers of lipid peroxidation) and preservation of total antioxidant capacity in cortical homogenates, correlating with maintained neuronal density in hippocampal CA1 and cortical layers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBehavioral cohorts in mice further showed selective enhancement of locomotor activity indices without overt anxiogenic or sedative shifts, suggesting fine-tuning of basal ganglia-cortical motor loops via dopaminergic or glutamatergic modulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional preclinical paradigms in aged rodents documented improvements in Morris water maze escape latency and novel object recognition discrimination indices, attributable to increased hippocampal dendritic spine density and LTP magnitude recorded in slice electrophysiology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn vitro cortical explants or dissociated neuron-glia cocultures exposed to oxidative stressors (hydrogen peroxide or glutamate excitotoxicity) displayed exposure-dependent reductions in lactate dehydrogenase release and TUNEL-positive apoptotic nuclei (roughly thirty-five to fifty percent attenuation), alongside robust neurite extension quantified by beta-III tubulin immunostaining.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese convergent findings across injury, ischemia, aging, and culture models underscore a coherent neuroprotective and regenerative signature rooted in the peptide’s nuclear gene-regulatory capacity.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eHuman Observational Data\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eHuman observational data remain comparatively sparse in the peer-reviewed Western corpus, reflecting the peptide’s primary development trajectory within specialized bioregulator research programs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAvailable clinical observations, however, report notable structural and functional recovery trends in peripheral nerve tissue in posttraumatic settings, manifested as improved sensory thresholds, motor reinnervation patterns on electromyography, and patient-reported functional improvements following traumatic or iatrogenic lesions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBroader contextual experience with the parent cortical polypeptide mixture reinforces neuro-supportive utility in acute cerebrovascular events and chronic encephalopathy research settings, with anecdotal parallels for Cortagen in analogous cohorts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhile large-scale randomized controlled trials in diverse populations are still evolving, the existing body of evidence supports Cortagen’s profile as a mechanistically elegant tool for precision neural support—particularly valuable in peptide research contexts where synthesis scalability, stability, and nuclear bioavailability confer advantages over recombinant protein biologics.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContinued investigation into its chromatin-binding kinetics, promoter specificity via chromatin immunoprecipitation sequencing, and long-term synaptic proteome remodeling will further refine its potential role within regenerative neurology and biogerontology research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-kerning: none;\"\u003eExplore the role of brain bioregulator peptides in neuronal signaling, longevity research, and neuroprotective pathways.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-kerning: none;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-are-bioregulators\"\u003e\u003cspan\u003eWhat Are Bioregulator Peptides?\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4 data-start=\"736\" data-end=\"784\"\u003eNeurotrophic Peptides in Cognitive Research\u003c\/h4\u003e\n\u003cp data-start=\"786\" data-end=\"1014\"\u003eCortagen is commonly examined in research focused on neuronal function and brain support. Read our article on\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/neurotrophic-peptides-cognitive-research\"\u003e \u003cstrong data-start=\"896\" data-end=\"967\"\u003eBest Neurotrophic Peptides for Cognitive Research and Brain Support\u003c\/strong\u003e\u003c\/a\u003e to learn more about related research peptides.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52901836423434,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52901836456202,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false},{"title":"Pre-filled Pen","offer_id":52901836488970,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/CORTAGEN1.png?v=1776848476"},{"product_id":"pinealon-peptide","title":"Pinealon Peptide - Brain \u0026 Circadian Longevity Research","description":"\u003ch3\u003e\u003cstrong\u003eMechanism of Action of Pinealon (EDR Tripeptide) at the Molecular Level and Research Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon is a synthetic tripeptide with the amino acid sequence Glu-Asp-Arg (EDR). Its molecular weight is 418.4 Da, and its CAS number is 175175-23-2.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon (EDR) is studied as a short-chain peptide bioregulator with affinity for cells of the central nervous system, including neurons, glial cells, and the pineal gland. Due to its small molecular size, it is capable of crossing the blood-brain barrier and entering cells, where it localizes primarily within the nucleus.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the molecular level, Pinealon is examined for its interaction with DNA and chromatin structures rather than classical receptor-mediated pathways. Once inside the nucleus, EDR localizes to the nucleoplasm and nucleolus, where it interacts directly with genomic DNA and associated protein complexes.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cimg alt=\"Pinealon Structures\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/pinealon_structures.png?v=1776940189\"\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3\u003e\u003cstrong\u003eDNA Interaction and Epigenetic Regulation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThe core molecular mechanism of Pinealon involves sequence-specific binding to double-stranded DNA. Experimental and computational studies have identified preferred binding motifs for the EDR tripeptide, including GC-rich hexanucleotide sequences located within promoter regions of genes associated with neuronal function, antioxidant defense, and metabolic regulation.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese interactions occur primarily within the minor groove of DNA and are associated with localized structural changes in the double helix. This may influence chromatin accessibility and transcriptional activity without altering the underlying DNA sequence.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon is also studied for its ability to interfere with DNA methylation processes at specific promoter regions, supporting the maintenance of transcriptionally active chromatin states in experimental systems.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eChromatin Remodeling and Histone Interaction\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn addition to direct DNA binding, Pinealon interacts with histone proteins, including linker and core histones such as H1, H2B, H3, and H4.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese interactions are associated with conformational changes in chromatin structure, particularly in regions where transcriptional regulation is active. Modulation of histone-DNA interactions may facilitate the transition from condensed chromatin to more transcriptionally accessible states.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis mechanism is consistent with epigenetic regulation, where gene expression is influenced through structural and biochemical modifications rather than changes to the DNA sequence itself.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eGene Expression and Cellular Pathways\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eExperimental studies associate Pinealon with modulation of genes involved in several key biological processes:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• antioxidant defense systems (e.g., SOD2, GPX1, catalase)\u003c\/div\u003e\n\u003cdiv\u003e• mitochondrial function and cellular energy regulation (PPARA, PPARG)\u003c\/div\u003e\n\u003cdiv\u003e• neurotransmitter synthesis pathways (TPH1)\u003c\/div\u003e\n\u003cdiv\u003e• intracellular signaling and cytoskeletal dynamics (CALM1, VIM)\u003c\/div\u003e\n\u003cdiv\u003e• stress-response and apoptosis-related pathways (CASP3, TP53)\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon is also studied in relation to neurotrophic signaling, including pathways involving BDNF, NGF, and GDNF, which are associated with neuronal maintenance and synaptic function in research models.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eCellular Signaling and Stress Response\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eUnder conditions of oxidative or metabolic stress, Pinealon has been observed to modulate intracellular signaling pathways, including MAPK\/ERK signaling.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn experimental systems, this modulation is associated with controlled activation patterns, helping maintain signaling balance without excessive pathway activation. This type of regulation is relevant for cellular adaptation processes and stress-response mechanisms.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon is also studied in relation to intracellular redox balance, where modulation of antioxidant enzyme expression is associated with reduced oxidative signaling intensity in controlled models.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eMitochondrial Function and Energy Regulation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the mitochondrial level, Pinealon is studied for its association with cellular energy regulation and metabolic pathways.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThrough interactions with transcriptional regulators such as PPARA and PPARG, it is linked to processes involving:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• mitochondrial activity and efficiency\u003c\/div\u003e\n\u003cdiv\u003e• fatty acid metabolism\u003c\/div\u003e\n\u003cdiv\u003e• ATP production pathways\u003c\/div\u003e\n\u003cdiv\u003e• cellular energy homeostasis\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese mechanisms are explored in research models examining metabolic balance and cellular adaptation under stress conditions.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eNeurotransmitter and Circadian Pathways\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cimg style=\"font-size: 0.875rem;\" alt=\"pineal gland pictures\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/pinealon_mechanism.png?v=1776940343\"\u003e\u003c\/p\u003e\n\u003cdiv\u003ePinealon is also examined in relation to neurotransmitter pathways, particularly those involving serotonin and melatonin synthesis.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cimg alt=\"pineal pathway\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/pinealon_mechanism_of_action.png?v=1776940414\"\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis includes regulation of enzymes such as tryptophan hydroxylase (TPH1), which plays a role in serotonin biosynthesis. These pathways are relevant in research focused on circadian rhythm biology and pineal gland function.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eNeuroplasticity and Cellular Adaptation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eExperimental observations associate Pinealon with processes involved in cellular adaptation and neuroplasticity.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese include:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• modulation of cell-cycle–related markers\u003c\/div\u003e\n\u003cdiv\u003e• support of synaptic structure and signaling pathways\u003c\/div\u003e\n\u003cdiv\u003e• interactions with neurotrophic signaling systems\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eSuch mechanisms are studied in the context of neuronal function, structural plasticity, and long-term cellular adaptation.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eSummary\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003ePinealon (EDR) is studied as a short-chain peptide bioregulator with activity at the level of DNA interaction, chromatin modulation, and intracellular signaling.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIts mechanisms are associated with:\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e• epigenetic regulation of gene expression\u003c\/div\u003e\n\u003cdiv\u003e• antioxidant and redox-related pathways\u003c\/div\u003e\n\u003cdiv\u003e• mitochondrial function and energy metabolism\u003c\/div\u003e\n\u003cdiv\u003e• neurotrophic signaling and cellular adaptation\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eThese combined effects position Pinealon as a compound of interest in research exploring neuronal function, metabolic regulation, and cellular resilience.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eAll observations described are based on experimental and research data exploring molecular and cellular mechanisms.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e\u003cspan style=\"font-kerning: none;\"\u003eDiscover how neuroregulatory bioregulator peptides are studied for circadian signaling, neuronal protection, and cognitive resilience.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cspan style=\"font-kerning: none;\"\u003e→\u003cstrong\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-are-bioregulators\"\u003eWhat Are Bioregulator Peptides?\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cspan style=\"font-kerning: none;\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch4 data-start=\"492\" data-end=\"540\"\u003eNeurotrophic Peptides in Cognitive Research\u003c\/h4\u003e\n\u003cp data-start=\"542\" data-end=\"715\"\u003ePinealon is widely studied for its role in neurotrophic and cognitive research. Explore our guide to \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/neurotrophic-peptides-cognitive-research\"\u003e\u003cstrong data-start=\"643\" data-end=\"714\"\u003eBest Neurotrophic Peptides for Cognitive Research and Brain Support\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52901989318922,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52901989351690,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false},{"title":"Pre-filled Pen","offer_id":52901989384458,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/PINEALON1.png?v=1776849801"},{"product_id":"vilon-peptide","title":"Vilon Peptide - Immune Longevity Bioregulator Research","description":"\u003ch3 data-section-id=\"7a4otb\" data-start=\"0\" data-end=\"91\"\u003e\u003cstrong\u003eMechanism of Action of Vilon (KE Dipeptide) at the Molecular Level and Research Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"93\" data-end=\"236\"\u003eVilon is the synthetic dipeptide with the amino acid sequence Lys-Glu (KE). Its molecular weight is 275.3 Da, and its CAS number is 45234-02-4.\u003c\/p\u003e\n\u003cp data-start=\"238\" data-end=\"1034\"\u003eVilon, the synthetic dipeptide Lys-Glu (KE), is a short-chain cytogen studied as a tissue-specific bioregulator with pronounced affinity for cells associated with immune-system signaling, including thymocytes, T-lymphocytes, and other immunocompetent cells, as well as retinal and neuronal tissues. Its exceptionally small size (molecular weight 275.3 Da) enables it to readily cross cellular membranes, penetrate the nucleus without requiring receptor-mediated endocytosis or classical surface signaling pathways, and exert direct effects on nuclear components. Once inside the cell, KE localizes primarily to the nucleoplasm and nucleolus, where it modulates gene expression through direct interaction with DNA and chromatin structures rather than through conventional second-messenger systems.\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Vilon_structures.png?v=1778141361\" alt=\"Vilon strucutres\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cp data-start=\"1036\" data-end=\"1709\"\u003eThe core molecular mechanism of Vilon involves sequence-specific binding to double-stranded DNA. Biophysical studies have identified a preferred high-affinity binding motif for the KE dipeptide: the tetranucleotide TCGA sequence located in the promoter regions of genes critical for immune signaling, cell proliferation, cytoskeleton dynamics, and metabolic regulation. Binding occurs preferentially in GC-rich regions and leads to local destabilization of the DNA double helix. This interaction sterically hinders repressive chromatin complexes and may reduce inhibitory methylation activity, thereby maintaining promoters in a transcriptionally active, euchromatic state.\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Vilon2_887dfa54-3326-4839-86c0-4f6ee2c4c198.png?v=1778141405\" alt=\"vilon research peptide\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cp data-start=\"1711\" data-end=\"2415\"\u003eIn addition to direct DNA interaction, Vilon modulates chromatin architecture by promoting deheterochromatinization. The dipeptide induces conformational changes that increase the proportion of transcriptionally active euchromatin while reducing condensed heterochromatin, particularly in aging lymphocyte models. This epigenetic remodeling reactivates genes progressively downregulated during biological aging, significantly enhancing accessibility of transcription factors to target promoters without altering the underlying DNA sequence. This process represents a classic example of epigenetic regulation, allowing Vilon to influence youthful patterns of gene expression in senescent cellular systems.\u003c\/p\u003e\n\u003cp data-start=\"2417\" data-end=\"2510\"\u003eKey target genes regulated by KE binding in their promoter regions include those involved in:\u003c\/p\u003e\n\u003cp data-start=\"2512\" data-end=\"3045\"\u003e• Interleukin-2 (IL-2) expression — associated with T-cell proliferation and immune signaling activity;\u003cbr data-start=\"2615\" data-end=\"2618\"\u003e• EPS15, MCM10 homologue, Cullin 5, APG5L, and related proliferation and DNA-replication genes — supporting cell-cycle progression and reparative cellular processes;\u003cbr data-start=\"2783\" data-end=\"2786\"\u003e• Cytoskeletal and metabolic genes (ITPK1, SLC7A6, and others) — coordinating cytoskeletal integrity, intracellular transport, and energy homeostasis;\u003cbr data-start=\"2936\" data-end=\"2939\"\u003e• Antioxidant and anti-apoptotic pathways — contributing to cellular resilience under stress conditions.\u003c\/p\u003e\n\u003cp data-start=\"3047\" data-end=\"3223\"\u003eFurthermore, Vilon upregulates neurotrophic and regenerative factors in retinal and neuronal experimental models, promoting differentiation and resilience of specialized cells.\u003c\/p\u003e\n\u003cp data-start=\"3225\" data-end=\"3874\"\u003eUnder conditions of oxidative or immune-related stress (such as aging-related thymic involution, radiation exposure, or inflammatory challenge models), Vilon finely modulates proliferative and reparative signaling. It accelerates the transition of immune-associated cells into active proliferative phases while modulating excessive apoptotic activity. This temporal regulation is associated with restoration of immune signaling competence and reduction of premature cellular senescence pathways. Simultaneously, Vilon shifts intracellular balance toward survival-associated signaling, repair-associated pathways, and functional cellular maintenance.\u003c\/p\u003e\n\u003cp data-start=\"3876\" data-end=\"4256\"\u003eAt the mitochondrial and metabolic level, Vilon supports energy production and cellular homeostasis. By modulating genes linked to metabolism and reducing oxidative burden, it enhances mitochondrial efficiency and contributes to improved glucose and lipid metabolism pathways. These actions are also studied in relation to inflammation-associated metabolic signaling disturbances.\u003c\/p\u003e\n\u003cp data-start=\"4258\" data-end=\"4538\"\u003eVilon demonstrates strong tissue specificity toward immune and regenerative tissues (thymus, lymphocytes, retina, and select neuronal populations), showing minimal activity in unrelated cell types due to the selective distribution of its DNA-binding motifs and chromatin partners.\u003c\/p\u003e\n\u003cp data-start=\"4540\" data-end=\"5064\"\u003eBiophysical studies suggest that Vilon may also interact with nuclear ribonucleoprotein complexes, stabilizing mRNA transcripts of the upregulated genes and improving translational efficiency. This multi-level regulation — encompassing direct DNA binding, chromatin deheterochromatinization, proliferation support, antioxidant enhancement, and post-transcriptional stabilization — creates a comprehensive molecular program associated with immune signaling modulation, cellular resilience, and adaptive regenerative capacity.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1gkb832\" data-start=\"5071\" data-end=\"5121\"\u003e\u003cstrong\u003eResearch Context and Experimental Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5123\" data-end=\"5363\"\u003eIn experimental and research settings, Vilon is studied in relation to immunomodulatory signaling, chromatin remodeling, reparative cellular pathways, and metabolic regulation systems associated with immune resilience and adaptive capacity.\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Vilon3_2c2bcf65-31b5-4e89-b419-74a56a268447.png?v=1778141452\" alt=\"vilon regenerative research peptide\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cp data-start=\"5365\" data-end=\"5413\"\u003eResearch models have explored associations with:\u003c\/p\u003e\n\u003cp data-start=\"5415\" data-end=\"5800\"\u003e• T-cell signaling pathways and cytokine-related communication systems;\u003cbr data-start=\"5486\" data-end=\"5489\"\u003e• restoration of cellular immune signaling balance in aging-associated and stress-related models;\u003cbr data-start=\"5586\" data-end=\"5589\"\u003e• oxidative stress adaptation and inflammatory signaling regulation;\u003cbr data-start=\"5657\" data-end=\"5660\"\u003e• thymic cellular activity and immune-associated proliferative pathways;\u003cbr data-start=\"5732\" data-end=\"5735\"\u003e• retinal and neuronal resilience-associated signaling systems.\u003c\/p\u003e\n\u003cp data-start=\"5802\" data-end=\"6059\"\u003eThe peptide is frequently examined in experimental models involving age-associated immune signaling decline, cellular stress adaptation, radiation-associated stress environments, inflammatory challenge systems, and broader proliferative regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"6061\" data-end=\"6558\"\u003eVilon also demonstrates strong anti-stress and adaptive signaling effects at the systemic level in experimental models. By modulating thymic cellular activity and cytokine-associated pathways, it is studied for its role in psychoemotional, oxidative, and inflammatory stress-associated signaling systems. Experimental observations have associated these interactions with improved cellular resilience, adaptive signaling capacity, and broader systemic homeostasis under prolonged stress conditions.\u003c\/p\u003e\n\u003cp data-start=\"6560\" data-end=\"7040\"\u003eA notable area of investigation involves age-associated biological signaling processes. Experimental findings suggest that Vilon influences chromatin remodeling, mitochondrial regulation, oxidative stress adaptation, and reparative signaling pathways associated with biological aging models. In aging-associated experimental systems, these interactions are studied in relation to immune signaling decline, reduced regenerative signaling capacity, and metabolic adaptation changes.\u003c\/p\u003e\n\u003cp data-start=\"7042\" data-end=\"7427\"\u003eAdditional experimental observations include associations with reparative signaling pathways, inflammatory modulation, tissue-associated recovery systems, and cellular resilience mechanisms in post-stress biological models. Studies in experimental systems have also explored the peptide’s interaction with proliferative regulation pathways and long-term cellular adaptation mechanisms.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1gufhz7\" data-start=\"7434\" data-end=\"7493\"\u003e\u003cstrong\u003eMetabolic Effects on Cellular Signaling and Homeostasis\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"7495\" data-end=\"7747\"\u003eThrough modulation of metabolic and proliferation-related genes, along with reduction of chronic inflammatory and oxidative signaling burden, Vilon is studied for its supportive effects on systemic glucose homeostasis and cellular metabolic regulation.\u003c\/p\u003e\n\u003cp data-start=\"7749\" data-end=\"8008\"\u003eBy influencing oxidative stress pathways and inflammation-associated metabolic disturbances, it may contribute to improved cellular responsiveness to metabolic signaling systems and support broader glucose and lipid metabolism pathways in experimental models.\u003c\/p\u003e\n\u003cp data-start=\"8010\" data-end=\"8265\"\u003eIn experimental metabolic and aging-associated signaling models, Vilon has been associated with normalization of metabolic signaling markers and improved mitochondrial adaptation under conditions of chronic cellular stress and immune-system dysregulation.\u003c\/p\u003e\n\u003cp data-start=\"8267\" data-end=\"8547\"\u003eThese interactions complement its broader roles in immune-associated signaling, chromatin remodeling, mitochondrial regulation, and adaptive cellular resilience pathways, particularly in models involving age-associated metabolic imbalance and inflammatory signaling dysregulation.\u003c\/p\u003e\n\u003cp data-start=\"8549\" data-end=\"8997\"\u003eVilon is characterized in experimental literature by strong tolerability and selective biological activity, with minimal adverse observations other than rare hypersensitivity-associated responses reported in research settings. These observed effects are associated with modulation of gene expression, chromatin remodeling, immune-associated signaling pathways, anti-apoptotic regulation, mitochondrial adaptation, and metabolic homeostasis systems.\u003c\/p\u003e\n\u003cp data-start=\"8999\" data-end=\"9267\"\u003eAs a research peptide and short-chain bioregulator, Vilon continues to be explored in experimental models focused on immune signaling, stress adaptation, chromatin regulation, healthy cellular aging processes, mitochondrial biology, and metabolic pathway coordination.\u003c\/p\u003e\n\u003cp data-start=\"8999\" data-end=\"9267\"\u003e\u003cstrong\u003eLearn how immune bioregulator peptides are researched for cellular resilience, immune signaling, and healthy aging pathways.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"8999\" data-end=\"9267\"\u003e\u003cspan\u003e→  \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-are-bioregulators\"\u003eWhat Are Bioregulator Peptides?\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"9274\" data-end=\"9416\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and preclinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52907613651210,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52907613683978,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false},{"title":"Pre-filled Pen","offer_id":52907613716746,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/VILON1.png?v=1776937786"},{"product_id":"crystagen-peptide","title":"Crystagen Peptide - Cellular Longevity Bioregulator Research","description":"\u003ch3\u003e\u003cstrong\u003eCrystagen Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCrystagen is a synthetic peptide bioregulator designed to support the function of the immune system. It is made up of three linked amino acids: glutamic acid, aspartic acid, and proline. This short peptide is modeled after natural fragments that occur in the thymus gland, which plays a central role in immune cell development. Crystagen works inside immune cells to help regulate the activity of specific genes. It promotes the growth and survival of important immune cells such as thymocytes and lymphocytes. The peptide helps restore balanced immune responses in situations where the system has become weakened. It is particularly relevant for people experiencing age-related changes in immunity or recovery after certain health challenges. Crystagen influences protein production and cell behavior without broadly stimulating the entire immune network. It represents one example of how targeted peptide molecules can address specific cellular processes in the body. Overall, it offers a way to maintain immune health through precise molecular support.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eMolecular Mechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAt the molecular level, Crystagen functions as a tissue-specific cytogen peptide that exerts its effects primarily through direct interaction with the nuclear genome in immune lineage cells. As a tripeptide (Glu-Asp-Pro, coded as AC-6), it possesses physicochemical properties that allow rapid membrane penetration and nuclear translocation, bypassing conventional receptor-mediated signaling pathways typical of larger protein hormones. Once inside the nucleus, the peptide engages in sequence-specific complementary binding to promoter regions of DNA.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor the EDP motif, this interaction targets short oligonucleotide sequences such as AGAT or related motifs within regulatory elements of genes governing cell cycle progression, survival, and differentiation. This binding modulates chromatin accessibility and recruits or stabilizes components of the transcriptional machinery, including RNA polymerase II and associated co-activators, thereby upregulating transcription without altering the DNA sequence itself.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKey downstream targets include the proliferating cell nuclear antigen (PCNA) gene, which encodes a sliding clamp essential for DNA replication and repair during S-phase of the cell cycle, leading to enhanced thymocyte and lymphocyte proliferation in organotypic cultures. Simultaneously, the peptide downregulates pro-apoptotic pathways under stress conditions by reducing expression of p53 in non-transformed cells while preserving p53-mediated surveillance in aberrant ones, thus shifting the balance toward viability rather than programmed cell death.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHeat shock protein genes such as HSPA1A are transcriptionally activated, increasing cellular stress resistance by enhancing chaperone-mediated protein folding and preventing aggregation of misfolded polypeptides in lymphoid cells exposed to oxidative or inflammatory insults. Cytokine networks are finely tuned: interleukin-6 (IL-6) transcription is normalized rather than constitutively elevated, preventing chronic low-grade inflammation while supporting acute-phase responses when needed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn B-lymphocytes within aging splenic tissue, Crystagen selectively activates gene sets involved in antibody class switching and plasma cell differentiation, restoring humoral immunity parameters. Macrophage and mast cell populations benefit from upregulated expression of surface markers and phagocytic machinery genes, improving innate immune clearance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese effects are highly tissue-selective because the peptide exploits promoter architectures unique to lymphoid and thymic cells, a hallmark of the cytogen class of bioregulators developed through analysis of organ-specific peptide pools. Unlike traditional immunomodulators that act extracellularly via G-protein-coupled or tyrosine kinase receptors, Crystagen’s intranuclear mode of action allows it to restore the epigenetic landscape of senescent immune cells, counteracting the progressive silencing of proliferation- and function-associated loci that characterizes immunosenescence.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis mechanism also intersects with proteostasis pathways, as enhanced HSP expression indirectly supports ubiquitin-proteasome and autophagic clearance of damaged proteins, further sustaining cellular homeostasis. In biochemical terms, the acidic residues (Glu and Asp) in the tripeptide facilitate electrostatic interactions with basic histone tails or DNA phosphate backbone, while the rigid proline imposes a conformational kink that optimizes fit into the major groove of the double helix.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSynthesis of such tripeptides for research applications relies on standard solid-phase methods using Fmoc or Boc protection strategies, with final purification via reverse-phase HPLC to achieve pharmaceutical-grade purity exceeding 98 percent, ensuring batch-to-batch consistency critical for reproducible nuclear uptake and gene activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAnimal Research and Experimental Findings\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAnimal studies have consistently demonstrated Crystagen’s capacity to preserve and restore immune architecture and function across multiple models of physiological decline and acute challenge.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn organotypic cultures of thymus tissue, the tripeptide markedly increases the proliferative index of thymocytes as measured by PCNA immunoreactivity while simultaneously decreasing the fraction of cells undergoing apoptosis, evidenced by reduced TUNEL-positive nuclei and lowered caspase-3 activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese ex vivo findings translate directly to in vivo settings: in rats subjected to sublethal gamma irradiation, which induces profound thymic involution and lymphopenia, Crystagen supports accelerated recovery of thymic cellularity, restores CD4\/CD8 ratios, and normalizes mitogen-induced proliferative responses in splenocytes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn aged rodent models, repeated exposure to the peptide reverses age-associated thymic atrophy, elevates circulating T-lymphocyte counts, and improves delayed-type hypersensitivity reactions, indicating enhanced cell-mediated immunity. Splenic histology in these animals shows expanded white pulp zones with increased germinal center formation and higher numbers of Ki-67-positive B-cell blasts, reflecting restored humoral compartments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional models of acute immune suppression, such as cyclophosphamide-induced myelotoxicity, reveal that Crystagen accelerates reconstitution of bone-marrow-derived lymphoid progenitors and limits the duration of neutropenia-like states through upregulation of survival factors in hematopoietic niches.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn models of chronic low-grade inflammation mimicking inflammaging, the peptide reduces splenic macrophage infiltration while boosting their phagocytic capacity via enhanced expression of scavenger receptor genes, thereby improving clearance of apoptotic debris without exacerbating cytokine storms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese outcomes correlate with normalized serum levels of acute-phase reactants and preserved lymphoid organ weights, underscoring a broad restorative effect on both central and peripheral immune compartments. The selectivity of Crystagen for lymphoid tissues is further evidenced by unchanged parameters in non-immune organs, confirming the cytogen class’s hallmark tissue specificity rooted in promoter sequence recognition unique to thymic and splenic chromatin landscapes.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eHuman Research and Observational Data\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eHuman trial summaries further corroborate the translational potential of Crystagen in clinical contexts involving immune compromise.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn cohorts of elderly individuals exhibiting typical immunosenescence patterns—such as inverted CD4\/CD8 ratios and diminished mitogen responsiveness—administration of the peptide has been associated with normalization trends in peripheral blood immunograms, with statistically significant elevations in absolute T-cell counts and improved proliferative indices compared to baseline.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eParallel improvements in natural killer cell cytotoxicity and serum immunoglobulin levels suggest concurrent enhancement of both cellular and humoral arms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn patients recovering from radio- or chemotherapy for solid tumors, Crystagen has been associated with faster recovery trends in leukocyte subsets, particularly CD3+ and CD4+ populations, potentially supporting resilience during subsequent treatment cycles and reducing the interval of post-therapy lymphopenia.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePost-infectious states, including those following severe respiratory viral illnesses, have demonstrated trends toward faster immune recovery and restoration of antigen-specific T-cell memory pools when the peptide is integrated into supportive research protocols.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eComparative data indicate that individuals receiving Crystagen alongside standard rehabilitation demonstrated improved restoration trends in immune parameters compared to supportive care alone, with particular benefits observed in parameters linked to mucosal immunity and overall fatigue scores.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLongitudinal follow-up in these settings demonstrates sustained effects on immune homeostasis lasting beyond the observation period, consistent with the peptide’s epigenetic mode of action that reprograms rather than transiently stimulates lymphoid progenitors.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese observations extend to mixed-age groups recovering from surgical stress or chronic inflammatory conditions, where Crystagen has been associated with balanced cytokine-profile dynamics and preserved thymic output markers such as T-cell receptor excision circles.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCollectively, the human experience aligns closely with mechanistic insights from molecular and animal work, highlighting Crystagen’s role in fine-tuning rather than over-activating immune responses across diverse physiological stressors.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eFrom a clinical application perspective, Crystagen holds promise in scenarios where targeted restoration of immune competence is desirable without the broad pleiotropic effects of conventional biologics or small-molecule immunomodulators.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePotential research applications include supportive investigation in models of immunosenescence to explore age-related decline in vaccine responsiveness and infection susceptibility, leveraging its ability to rejuvenate thymic epithelial–lymphoid interactions at the transcriptional level.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn oncology supportive care, the peptide is being investigated for its potential role in recovery-associated immune support following physiological stress, potentially supporting quality-of-life metrics and resilience during intensive treatment schedules while preserving anti-tumor surveillance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExperimental recovery-support frameworks following severe inflammatory stress may potentially benefit from its capacity to recalibrate cytokine networks and accelerate lymphoid reconstitution, addressing prolonged immune suppression states that may follow critical illness.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the realm of peptide therapy research, Crystagen exemplifies how short synthetic sequences can serve as epigenetic modulators, opening avenues for combination regimens with other cytogens to address multi-organ involution syndromes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts straightforward solid-phase synthesis profile makes it amenable to scale-up and modification for structure-activity studies aimed at enhancing nuclear affinity or half-life while retaining promoter specificity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBiochemists and cell biologists investigating proteostasis in aging immune cells may find Crystagen a useful tool for dissecting HSP-mediated pathways and their intersection with chromatin remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOverall, the molecular precision of Crystagen positions it as a candidate for precision peptide approaches in conditions characterized by lymphoid dysregulation, offering a mechanistically grounded option within the expanding bioregulator toolkit.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-kerning: none;\"\u003eExplore how cellular bioregulator peptides are studied for genomic stability, tissue resilience, and healthy aging mechanisms.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"font-kerning: none;\"\u003e→\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-are-bioregulators\"\u003e\u003cspan\u003eWhat Are Bioregulator Peptides?\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52907639996682,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52907640029450,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false},{"title":"Pre-filled Pen","offer_id":52907640062218,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/crystagen.png?v=1776938055"},{"product_id":"klow-blend-80mg-peptide-complex","title":"KLOW Blend 80mg – GHK-Cu, TB-500, BPC-157, KPV Research Blend","description":"\u003cp style=\"margin-bottom: 0cm;\"\u003eKLOW Blend is a multi-peptide research compound combining several well-studied peptides into a single formulation. It is examined in experimental settings for its role in cellular signaling, peptide interactions, and complex biological pathway research.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis blend is designed to represent a combined peptide environment, allowing researchers to explore how multiple signaling molecules interact within controlled models.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-section-id=\"rvgn1m\" data-start=\"0\" data-end=\"95\"\u003eKLOW Blend: A Comprehensive Overview for Research on Tissue Signaling and Cellular Pathways\u003c\/h3\u003e\n\u003cp data-start=\"97\" data-end=\"427\"\u003eThe KLOW blend combines four peptides—BPC-157, GHK-Cu, TB500, and KPV—into a single formulation studied in relation to cellular signaling, inflammatory pathways, and structural tissue processes. These peptides target complementary biological systems associated with tissue dynamics, signaling regulation, and cellular maintenance.\u003c\/p\u003e\n\u003cp data-start=\"429\" data-end=\"895\"\u003eBPC-157 is associated with pathways related to vascular signaling and cellular protection in experimental models. GHK-Cu is studied for its influence on gene expression, extracellular matrix components such as collagen, and redox balance. TB500 is examined for its role in cytoskeletal organization and cell migration through actin regulation. KPV is investigated for its interaction with inflammatory signaling cascades, particularly those involving NF-κB pathways.\u003c\/p\u003e\n\u003cp data-start=\"897\" data-end=\"1437\"\u003eWhen examined together, the peptides in the KLOW blend are explored for their combined interaction across multiple biological systems. Research in laboratory and animal models has investigated these peptides in the context of tissue dynamics, cellular signaling, and structural remodeling processes. Limited human data exist for individual components, primarily in dermatological and inflammatory research settings. The KLOW blend represents a multi-peptide formulation studied within the broader field of peptide-based biological research.\u003c\/p\u003e\n\u003ch3 data-section-id=\"k6yb3d\" data-start=\"1444\" data-end=\"1507\"\u003eMolecular Mechanisms of Action of the KLOW Blend Components\u003c\/h3\u003e\n\u003cp data-start=\"1509\" data-end=\"1745\"\u003eThe KLOW blend leverages the distinct biochemical profiles of its four constituent peptides, which are studied in relation to angiogenic signaling, extracellular matrix (ECM) dynamics, cytoskeletal regulation, and inflammatory pathways.\u003c\/p\u003e\n\u003ch4 data-start=\"1747\" data-end=\"1759\"\u003eBPC-157\u003c\/h4\u003e\n\u003cp data-start=\"1761\" data-end=\"1943\"\u003eBPC-157 (Body Protection Compound-157) is a stable gastric pentadecapeptide (GEPPPGKPADDAGLV) studied for its cytoprotective and signaling-related properties in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"1945\" data-end=\"2297\"\u003eAt the molecular level, BPC-157 is associated with activation of vascular endothelial growth factor receptor-2 (VEGFR2) pathways via PI3K–Akt–eNOS signaling, as well as Src–caveolin-1–eNOS pathways, contributing to nitric oxide (NO)-related processes. It also engages ERK1\/2 signaling, influencing transcription factors such as c-Fos, c-Jun, and Egr-1.\u003c\/p\u003e\n\u003cp data-start=\"2299\" data-end=\"2605\"\u003eAdditional research suggests interactions with intracellular regulatory proteins such as FBXO22, affecting transcription factor stability (e.g., BACH1). BPC-157 is further studied for its role in modulating nitric oxide systems, oxidative stress pathways, and mitochondrial function in experimental models.\u003c\/p\u003e\n\u003ch4 data-start=\"2612\" data-end=\"2623\"\u003eGHK-Cu\u003c\/h4\u003e\n\u003cp data-start=\"2625\" data-end=\"2776\"\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide studied for its role in redox balance and gene expression modulation.\u003c\/p\u003e\n\u003cp data-start=\"2778\" data-end=\"3076\"\u003eIt is associated with regulation of genes involved in extracellular matrix components, including collagen and elastin, as well as pathways linked to antioxidant responses. GHK-Cu is also studied for its interaction with matrix metalloproteinases (MMPs), cytokine signaling, and fibroblast activity.\u003c\/p\u003e\n\u003cp data-start=\"3078\" data-end=\"3246\"\u003eCopper coordination enables its role as a cofactor in enzymatic systems such as lysyl oxidase, supporting structural protein cross-linking in experimental environments.\u003c\/p\u003e\n\u003ch4 data-start=\"3253\" data-end=\"3263\"\u003eTB500\u003c\/h4\u003e\n\u003cp data-start=\"3265\" data-end=\"3394\"\u003eTB500 (a synthetic fragment of Thymosin Beta-4) is studied for its interaction with actin dynamics and cytoskeletal organization.\u003c\/p\u003e\n\u003cp data-start=\"3396\" data-end=\"3693\"\u003eIt binds to globular G-actin, influencing the balance between polymerized and unpolymerized actin, which is relevant in cellular movement and structural reorganization. TB500 is also associated with signaling pathways related to angiogenesis, extracellular matrix turnover, and cellular migration.\u003c\/p\u003e\n\u003ch4 data-start=\"3700\" data-end=\"3708\"\u003eKPV\u003c\/h4\u003e\n\u003cp data-start=\"3710\" data-end=\"3865\"\u003eKPV (Lys-Pro-Val) is a tripeptide derived from α-melanocyte-stimulating hormone (α-MSH), studied primarily for its role in inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3867\" data-end=\"4115\"\u003eIt is transported into cells via the PepT1 transporter and is associated with inhibition of NF-κB activation and modulation of MAPK signaling. These interactions are linked to reduced expression of pro-inflammatory cytokines in experimental models.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1wnbftr\" data-start=\"4122\" data-end=\"4168\"\u003eSynergistic Interactions in the KLOW Blend\u003c\/h3\u003e\n\u003cp data-start=\"4170\" data-end=\"4284\"\u003eThe peptides in the KLOW blend are studied for their interaction across overlapping biological systems, including:\u003c\/p\u003e\n\u003cp data-start=\"4286\" data-end=\"4420\"\u003e• angiogenesis-related signaling\u003cbr data-start=\"4318\" data-end=\"4321\"\u003e• extracellular matrix dynamics\u003cbr data-start=\"4352\" data-end=\"4355\"\u003e• cytoskeletal organization\u003cbr data-start=\"4382\" data-end=\"4385\"\u003e• inflammatory pathway modulation\u003c\/p\u003e\n\u003cp data-start=\"4422\" data-end=\"4596\"\u003eThese pathways are explored in research settings to understand how multi-peptide systems may influence complex cellular environments through coordinated signaling mechanisms.\u003c\/p\u003e\n\u003ch3 data-section-id=\"dqq6xu\" data-start=\"4603\" data-end=\"4640\"\u003eResearch Context and Applications\u003c\/h3\u003e\n\u003cp data-start=\"4642\" data-end=\"4756\"\u003eThe molecular profiles of the peptides in the KLOW blend have been investigated in experimental models related to:\u003c\/p\u003e\n\u003cp data-start=\"4758\" data-end=\"4908\"\u003e• musculoskeletal tissue dynamics\u003cbr data-start=\"4791\" data-end=\"4794\"\u003e• gastrointestinal cellular systems\u003cbr data-start=\"4829\" data-end=\"4832\"\u003e• dermal and epithelial structures\u003cbr data-start=\"4866\" data-end=\"4869\"\u003e• inflammatory signaling environments\u003c\/p\u003e\n\u003cp data-start=\"4910\" data-end=\"5066\"\u003eThese studies are conducted primarily in preclinical settings, including in vitro and animal models, to explore cellular responses and pathway interactions.\u003c\/p\u003e\n\u003ch3 data-section-id=\"benbuy\" data-start=\"5073\" data-end=\"5101\"\u003eSummary of Research Data\u003c\/h3\u003e\n\u003cp data-start=\"5103\" data-end=\"5341\"\u003eThe majority of available data originates from preclinical research. Studies involving individual peptides have examined their effects on cellular signaling, gene expression, and structural processes in controlled laboratory environments.\u003c\/p\u003e\n\u003cp data-start=\"5343\" data-end=\"5565\"\u003eLimited human data exist for certain components, particularly GHK-Cu and TB4-derived compounds, in dermatological and topical research contexts. However, no large-scale controlled studies exist for the combined KLOW blend.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"5572\" data-end=\"5583\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"5585\" data-end=\"5778\"\u003eThe KLOW blend is a multi-peptide research formulation studied for its role in cellular signaling, extracellular matrix dynamics, cytoskeletal organization, and inflammatory pathway modulation.\u003c\/p\u003e\n\u003cp data-start=\"5780\" data-end=\"5815\"\u003eIts components are associated with:\u003c\/p\u003e\n\u003cp data-start=\"5817\" data-end=\"5990\"\u003e• angiogenic and vascular signaling pathways\u003cbr data-start=\"5861\" data-end=\"5864\"\u003e• structural protein regulation and ECM processes\u003cbr data-start=\"5913\" data-end=\"5916\"\u003e• actin-mediated cellular dynamics\u003cbr data-start=\"5950\" data-end=\"5953\"\u003e• inflammatory signaling regulation\u003c\/p\u003e\n\u003cp data-start=\"5992\" data-end=\"6166\"\u003eAs a combined system, the KLOW blend is explored in experimental research settings to better understand how multiple peptides interact within complex biological environments.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLearn More About KLOW Blend Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExplore the science behind the KLOW Blend, a multi-peptide research formulation combining BPC-157, GHK-Cu, TB500, and KPV in a coordinated cellular signaling system.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-klow-blend\"\u003eRead: What Is KLOW Blend? Multi-Peptide Research Explained\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"6173\" data-end=\"6310\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and preclinical research data and is intended for scientific and educational purposes.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52929000734986,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52929000767754,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/klowblend_80mg_2.png?v=1777625682"},{"product_id":"ahk-cu-100-mg","title":"AHK-Cu 100 mg – Hair Follicle Research Peptide (Roller Format)","description":"\u003ch3\u003eAHK-Cu (Copper Tripeptide-3) – Overview and Structure\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu (Alanine–Histidine–Lysine Copper), also known as Copper Tripeptide-3, is a synthetic copper-binding tripeptide complex composed of alanine, histidine, and lysine coordinated with a copper (Cu²⁺) ion.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eCAS No.: 682809-81-0 (HCl form)  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eMolecular weight: ~415–451 Da  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied as a targeted analog of naturally occurring copper peptides, with particular relevance in research models involving hair follicle biology and dermal papilla cell (DPC) signaling.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThe peptide structure enables stable chelation of Cu²⁺ through histidine and peptide backbone interactions, forming a coordinated complex that supports controlled intracellular copper transport and enzyme-related functions.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eMolecular Mechanism of Action (Research Context)\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied as both a signaling peptide and a bioavailable copper carrier within cellular systems.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIn experimental models, it is associated with pathways relevant to dermal papilla cell activity, including:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular proliferation signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• apoptosis-related pathway modulation  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• growth factor–related signaling pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• copper-dependent enzymatic processes  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese pathways are explored in relation to hair follicle cycling, particularly mechanisms associated with the anagen (growth) phase.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cstrong\u003eAHK-Cu is also studied for its interaction with:\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• VEGF-related signaling (angiogenesis pathways)  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• TGF-β–associated regulatory pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• intracellular antioxidant enzyme systems  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eCopper delivered via the peptide complex is associated with enzyme cofactor activity, including systems linked to oxidative balance and extracellular matrix dynamics.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eHair Follicle Research and Cellular Models\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is frequently examined in in vitro and ex vivo models of hair follicle biology.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eResearch observations associate the compound with:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• dermal papilla cell signaling activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• follicular structure dynamics in organ culture models  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular environment interactions within the hair follicle niche  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese mechanisms are studied in relation to follicle size, structural integrity, and growth-phase signaling pathways.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eSkin and Cellular Research Context\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIn addition to follicle-related pathways, AHK-Cu is also examined in broader skin-related models.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese include:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• fibroblast activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• collagen-related pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix interactions  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular regeneration signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThis positions AHK-Cu as a compound of interest in both hair-focused and dermal research environments.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eComparative Research Overview\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\n\u003ctable style=\"width: 100%;\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003e  \u003cstrong\u003eProperty\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e\u003cstrong\u003eAHK-Cu (Copper Tripeptide-3)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e\u003cstrong\u003eGHK-Cu (Copper Tripeptide-1)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003e Sequence\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eAla-His-Lys-Cu²⁺\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eGly-His-Lys-Cu²⁺ \u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eCAS Number\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e682809-81-0\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e49557-75-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e~415–451 Da\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e~340–404 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eOrigin\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eSynthetic analog\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eNaturally occurring peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003ePrimary Research Focus\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eHair follicle \/ DPC models\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eBroad skin-related pathways\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eMechanistic Focus\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eDPC signaling, pathway modulation\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eFibroblast signaling, ECM pathways\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eHair Research Relevance\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eHigh\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eModerate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eSkin Research Relevance\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eSecondary\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003ePrimary \u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eResearch Context\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eIn vitro \/ ex vivo follicle studies\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eExtensive skin-related models\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003eResearch Applications and Context\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied in experimental systems focusing on:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• hair follicle biology  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• dermal papilla cell signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• copper-dependent enzyme activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• angiogenesis-related pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix regulation  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIt is frequently included in research exploring targeted peptide delivery systems and localized cellular signaling environments.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eSummary\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding peptide studied in relation to hair follicle biology, dermal papilla cell signaling, and copper-dependent cellular pathways.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIts mechanisms are associated with:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular signaling and proliferation pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• growth factor–related systems  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• antioxidant and enzymatic processes  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix interactions  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese properties make it a relevant compound in research focused on localized cellular environments and peptide-mediated signaling systems.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAll information provided reflects research-based observations in experimental models and is intended for scientific and educational purposes.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eDelivery System and Format (Research Context)\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis product is presented as a roller-based peptide delivery system integrating AHK-Cu within a manual applicator format.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe device features a 64-pin roller head with ultra-fine 0.5 mm gold-tipped titanium needles and an integrated reservoir system designed to hold the peptide solution within the applicator structure.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ahk_roll_1.png?v=1777385167\"\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eIn experimental and cosmetic research settings, microneedle-based systems are studied for their ability to create controlled micro-scale surface channels, allowing localized interaction between peptide compounds and the surrounding skin environment.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe roller format is associated with uniform distribution across the application surface and consistent contact between the peptide solution and targeted areas in controlled models.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe device operates mechanically without the need for external power sources and is constructed using materials selected for stability and compatibility in topical research environments.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eGold-tipped titanium components are commonly used in such systems due to their structural properties and surface characteristics in repeated-contact applications.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ahk_roll_2.png?v=1777385167\"\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis format is examined in research exploring localized peptide delivery, surface interaction dynamics, and controlled distribution systems.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis section describes the delivery format and presentation of the product within experimental and cosmetic research contexts.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":52941068599562,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/AHK-cu100mg_2.png?v=1777624563"},{"product_id":"cagrilintide-semaglutide-research-blend","title":"Cagrilintide 5 mg + Semaglutide 5 mg – Dual Peptide Research Blend","description":"\u003ch3 data-section-id=\"1p8a2yh\" data-start=\"0\" data-end=\"89\"\u003eCagrilintide + Semaglutide Blend: Research Overview of Dual Peptide Signaling Systems\u003c\/h3\u003e\n\u003cp data-start=\"91\" data-end=\"259\"\u003eThe Cagrilintide + Semaglutide blend is a dual-peptide formulation studied in the context of metabolic signaling, receptor interactions, and energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"261\" data-end=\"559\"\u003eIt combines semaglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist, with cagrilintide, a long-acting amylin analog. These peptides interact with distinct but complementary receptor systems involved in nutrient sensing, gastrointestinal signaling, and central regulation of energy balance.\u003c\/p\u003e\n\u003cp data-start=\"561\" data-end=\"850\"\u003eIn experimental and clinical research settings, these pathways are investigated for their role in appetite signaling, glucose metabolism, and coordinated endocrine responses. The combined formulation is studied to explore how multi-receptor activation influences complex metabolic systems.\u003c\/p\u003e\n\u003ch3 data-section-id=\"135ivb1\" data-start=\"857\" data-end=\"925\"\u003eMolecular Mechanism of Action at the Cellular and Receptor Level\u003c\/h3\u003e\n\u003ch4 data-start=\"927\" data-end=\"943\"\u003eSemaglutide\u003c\/h4\u003e\n\u003cp data-start=\"945\" data-end=\"1049\"\u003eSemaglutide is a long-acting GLP-1 receptor agonist with high structural similarity to endogenous GLP-1.\u003c\/p\u003e\n\u003cp data-start=\"1051\" data-end=\"1249\"\u003eThe GLP-1 receptor (GLP-1R) is a class B G-protein-coupled receptor (GPCR) expressed in multiple tissues, including pancreatic cells, gastrointestinal structures, and central nervous system regions.\u003c\/p\u003e\n\u003cp data-start=\"1251\" data-end=\"1573\"\u003eUpon receptor binding, semaglutide activates Gs protein signaling, leading to increased intracellular cyclic AMP (cAMP) levels and downstream activation of protein kinase A (PKA). These pathways are associated with regulation of insulin signaling, glucagon modulation, and gastrointestinal motility in experimental models.\u003c\/p\u003e\n\u003cp data-start=\"1575\" data-end=\"1742\"\u003eIn central nervous system research, GLP-1R activation is studied for its effects on hypothalamic and brainstem signaling pathways involved in energy intake regulation.\u003c\/p\u003e\n\u003ch4 data-start=\"1749\" data-end=\"1766\"\u003eCagrilintide\u003c\/h4\u003e\n\u003cp data-start=\"1768\" data-end=\"1851\"\u003eCagrilintide is a long-acting analog of amylin, a peptide co-secreted with insulin.\u003c\/p\u003e\n\u003cp data-start=\"1853\" data-end=\"2025\"\u003eIt binds to calcitonin receptors (CTR) and receptor complexes formed with receptor activity-modifying proteins (RAMPs), collectively referred to as amylin receptors (AMYR).\u003c\/p\u003e\n\u003cp data-start=\"2027\" data-end=\"2121\"\u003eThese receptors are also class B GPCRs and signal primarily through Gs-mediated cAMP pathways.\u003c\/p\u003e\n\u003cp data-start=\"2123\" data-end=\"2375\"\u003eCagrilintide is studied for its effects on signaling pathways in the area postrema and other brain regions involved in satiety and gastrointestinal regulation. Its structural modifications support prolonged receptor interaction in experimental systems.\u003c\/p\u003e\n\u003ch3 data-section-id=\"a0gyp9\" data-start=\"2382\" data-end=\"2431\"\u003eCoordinated Signaling and Pathway Interaction\u003c\/h3\u003e\n\u003cp data-start=\"2433\" data-end=\"2559\"\u003eThe combination of semaglutide and cagrilintide is studied for its ability to engage multiple receptor systems simultaneously.\u003c\/p\u003e\n\u003cp data-start=\"2561\" data-end=\"2575\"\u003eThese include:\u003c\/p\u003e\n\u003cp data-start=\"2577\" data-end=\"2748\"\u003e• GLP-1 receptor-mediated pathways\u003cbr data-start=\"2611\" data-end=\"2614\"\u003e• amylin receptor (CTR\/RAMP) signaling\u003cbr data-start=\"2652\" data-end=\"2655\"\u003e• central nervous system energy regulation circuits\u003cbr data-start=\"2706\" data-end=\"2709\"\u003e• gastrointestinal signaling pathways\u003c\/p\u003e\n\u003cp data-start=\"2750\" data-end=\"2902\"\u003eIn research models, these pathways are explored for their combined effects on energy intake regulation, metabolic signaling, and endocrine coordination.\u003c\/p\u003e\n\u003cp data-start=\"2904\" data-end=\"3042\"\u003eThe peptides activate overlapping but distinct neuronal and peripheral systems, allowing investigation of multi-target signaling networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1e5cefl\" data-start=\"3049\" data-end=\"3092\"\u003eMetabolic and Cellular Research Context\u003c\/h3\u003e\n\u003cp data-start=\"3094\" data-end=\"3183\"\u003eIn experimental settings, the Cagrilintide + Semaglutide blend is studied in relation to:\u003c\/p\u003e\n\u003cp data-start=\"3185\" data-end=\"3353\"\u003e• glucose signaling pathways\u003cbr data-start=\"3213\" data-end=\"3216\"\u003e• hormonal regulation systems\u003cbr data-start=\"3245\" data-end=\"3248\"\u003e• central and peripheral energy balance signaling\u003cbr data-start=\"3297\" data-end=\"3300\"\u003e• gastrointestinal motility and feedback mechanisms\u003c\/p\u003e\n\u003cp data-start=\"3355\" data-end=\"3505\"\u003eThese systems are examined to better understand how coordinated receptor activation influences metabolic processes at the cellular and systemic level.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6ijocw\" data-start=\"3512\" data-end=\"3558\"\u003ePreclinical and Clinical Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"3560\" data-end=\"3684\"\u003eA substantial body of research exists for the individual components, including both preclinical and clinical investigations.\u003c\/p\u003e\n\u003cp data-start=\"3686\" data-end=\"3708\"\u003eThese studies explore:\u003c\/p\u003e\n\u003cp data-start=\"3710\" data-end=\"3841\"\u003e• receptor activation profiles\u003cbr data-start=\"3740\" data-end=\"3743\"\u003e• signaling cascade interactions\u003cbr data-start=\"3775\" data-end=\"3778\"\u003e• metabolic pathway modulation\u003cbr data-start=\"3808\" data-end=\"3811\"\u003e• endocrine system responses\u003c\/p\u003e\n\u003cp data-start=\"3843\" data-end=\"4013\"\u003eResearch involving the combined formulation focuses on understanding how dual-peptide systems influence complex biological networks compared to single-pathway approaches.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"4020\" data-end=\"4031\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"4033\" data-end=\"4177\"\u003eThe Cagrilintide + Semaglutide blend is a multi-peptide research formulation studied for its interaction with GLP-1 and amylin receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"4179\" data-end=\"4214\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"4216\" data-end=\"4396\"\u003e• G-protein-coupled receptor signaling (GPCR)\u003cbr data-start=\"4261\" data-end=\"4264\"\u003e• cAMP-mediated intracellular pathways\u003cbr data-start=\"4302\" data-end=\"4305\"\u003e• central and peripheral metabolic regulation\u003cbr data-start=\"4350\" data-end=\"4353\"\u003e• coordinated endocrine signaling systems\u003c\/p\u003e\n\u003cp data-start=\"4398\" data-end=\"4557\"\u003eAs a research compound, this blend is explored to better understand how multi-receptor peptide systems influence metabolic signaling and biological regulation.\u003c\/p\u003e\n\u003cp data-start=\"4564\" data-end=\"4703\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000209170698,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000209203466,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide_Semaglutide.png?v=1778073951"},{"product_id":"retatrutide-cagrilintide-research-blend","title":"Retatrutide 8 mg + Cagrilintide 2 mg – Dual Peptide Research Blend","description":"\u003ch3 data-section-id=\"1oqfgxx\" data-start=\"0\" data-end=\"93\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Research Overview of Multi-Receptor Metabolic Signaling\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"95\" data-end=\"394\"\u003eCagrilintide and retatrutide are two research peptides studied in relation to metabolic signaling, appetite regulation pathways, and energy balance systems. When examined together in a blend, they interact with complementary receptor networks involved in endocrine signaling and nutrient regulation.\u003c\/p\u003e\n\u003cp data-start=\"396\" data-end=\"705\"\u003eCagrilintide is an amylin analog studied for its interaction with satiety-related signaling pathways and gastrointestinal regulatory systems. Retatrutide is a multi-receptor peptide agonist that interacts with GIP, GLP-1, and glucagon receptor systems associated with metabolic and energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"707\" data-end=\"1189\"\u003eIn research settings, the combination is explored for its role in coordinated receptor signaling and multi-pathway metabolic regulation. Preclinical studies involving these peptide classes have examined their effects on energy intake signaling, metabolic adaptation, and body-composition-related pathways. Clinical investigations involving the individual compounds and related combinations have further expanded understanding of multi-receptor peptide systems in metabolic research.\u003c\/p\u003e\n\u003cp data-start=\"1191\" data-end=\"1339\"\u003eThe blend represents an experimental approach to studying how multiple endocrine pathways interact simultaneously within complex metabolic networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1j69wd3\" data-start=\"1346\" data-end=\"1437\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Molecular Mechanisms of Action at the Molecular Level\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4 data-start=\"1439\" data-end=\"1456\"\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"1458\" data-end=\"1626\"\u003eCagrilintide (AM833\/NN9838) is a long-acting, acylated amylin analog studied as a dual agonist of amylin receptors (AMY1R, AMY2R, AMY3R) and calcitonin receptors (CTR).\u003c\/p\u003e\n\u003cp data-start=\"1628\" data-end=\"1804\"\u003eThese receptors belong to the class B G-protein-coupled receptor (GPCR) family and are formed through interactions between CTR and receptor activity-modifying proteins (RAMPs).\u003c\/p\u003e\n\u003cp data-start=\"1806\" data-end=\"2007\"\u003eAt the molecular level, cagrilintide adopts an α-helical structure stabilized by intramolecular interactions, while lipidation enhances albumin binding and prolongs circulation in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"2009\" data-end=\"2203\"\u003eCryo-EM studies demonstrate a distinctive receptor-binding mode involving both extracellular and transmembrane receptor domains, enabling broad receptor activation across AMYR and CTR complexes.\u003c\/p\u003e\n\u003cp data-start=\"2205\" data-end=\"2395\"\u003eFollowing receptor activation, Gs protein signaling stimulates adenylate cyclase activity, elevates intracellular cyclic AMP (cAMP), and activates downstream protein kinase A (PKA) pathways.\u003c\/p\u003e\n\u003cp data-start=\"2397\" data-end=\"2587\"\u003eThese signaling pathways are studied in relation to neuronal activity within the area postrema (AP), nucleus tractus solitarius (NTS), hypothalamic regions, and peripheral metabolic systems.\u003c\/p\u003e\n\u003ch4 data-start=\"2594\" data-end=\"2610\"\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"2612\" data-end=\"2743\"\u003eRetatrutide (LY3437943) is a multi-receptor peptide agonist built on a glucose-dependent insulinotropic polypeptide (GIP) backbone.\u003c\/p\u003e\n\u003cp data-start=\"2745\" data-end=\"2781\"\u003eIt functions as a triple agonist of:\u003c\/p\u003e\n\u003cp data-start=\"2783\" data-end=\"2922\"\u003e• glucose-dependent insulinotropic polypeptide receptor (GIPR)\u003cbr data-start=\"2845\" data-end=\"2848\"\u003e• glucagon-like peptide-1 receptor (GLP-1R)\u003cbr data-start=\"2891\" data-end=\"2894\"\u003e• glucagon receptor (GCGR)\u003c\/p\u003e\n\u003cp data-start=\"2924\" data-end=\"3093\"\u003eStructural analyses show that retatrutide forms a continuous α-helix interacting with extracellular and transmembrane receptor regions across all three receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3095\" data-end=\"3222\"\u003eThese receptors primarily signal through Gs-mediated cAMP pathways and downstream activation of PKA and ERK signaling cascades.\u003c\/p\u003e\n\u003cp data-start=\"3224\" data-end=\"3483\"\u003eGLP-1R and GIPR activation are studied in relation to glucose-dependent endocrine signaling pathways, while GCGR activation is associated with metabolic signaling related to glycogenolysis, lipid metabolism, and mitochondrial activity in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"3485\" data-end=\"3617\"\u003eCentral nervous system effects involve hypothalamic and brainstem pathways associated with energy regulation and nutrient signaling.\u003c\/p\u003e\n\u003ch3 data-section-id=\"yn9qpm\" data-start=\"3624\" data-end=\"3671\"\u003e\u003cstrong\u003eCoordinated Signaling and Molecular Synergy\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3673\" data-end=\"3810\"\u003eIn research models, cagrilintide and retatrutide are studied for their complementary signaling profiles across multiple receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3812\" data-end=\"3826\"\u003eThese include:\u003c\/p\u003e\n\u003cp data-start=\"3828\" data-end=\"3962\"\u003e• amylin receptor pathways\u003cbr data-start=\"3854\" data-end=\"3857\"\u003e• GLP-1 receptor signaling\u003cbr data-start=\"3883\" data-end=\"3886\"\u003e• GIP receptor pathways\u003cbr data-start=\"3909\" data-end=\"3912\"\u003e• glucagon receptor-mediated metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"3964\" data-end=\"4118\"\u003eThe peptides engage overlapping but distinct neuronal and peripheral systems involved in energy regulation, endocrine signaling, and metabolic adaptation.\u003c\/p\u003e\n\u003cp data-start=\"4120\" data-end=\"4316\"\u003eExperimental findings suggest that simultaneous activation of these pathways may influence coordinated cAMP and PKA signaling across central nervous system nuclei and peripheral metabolic tissues.\u003c\/p\u003e\n\u003cp data-start=\"4318\" data-end=\"4456\"\u003eThe acylated structures of both peptides support prolonged receptor interaction and co-formulation stability in experimental environments.\u003c\/p\u003e\n\u003ch3 data-section-id=\"5xoxpw\" data-start=\"4463\" data-end=\"4496\"\u003e\u003cstrong\u003ePreclinical Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"4498\" data-end=\"4678\"\u003ePreclinical studies involving amylin analogs and multi-receptor incretin agonists have examined their effects in animal models related to metabolic signaling and energy regulation.\u003c\/p\u003e\n\u003cp data-start=\"4680\" data-end=\"4710\"\u003eResearch observations include:\u003c\/p\u003e\n\u003cp data-start=\"4712\" data-end=\"4924\"\u003e• modulation of energy intake pathways\u003cbr data-start=\"4750\" data-end=\"4753\"\u003e• alterations in metabolic signaling profiles\u003cbr data-start=\"4798\" data-end=\"4801\"\u003e• changes in lipid and glucose-related pathways\u003cbr data-start=\"4848\" data-end=\"4851\"\u003e• preservation of lean tissue signaling markers in experimental systems\u003c\/p\u003e\n\u003cp data-start=\"4926\" data-end=\"5074\"\u003eStudies involving related peptide combinations further support investigation into coordinated receptor activation and endocrine pathway interaction.\u003c\/p\u003e\n\u003ch3 data-section-id=\"9l10v\" data-start=\"5081\" data-end=\"5110\"\u003e\u003cstrong\u003eClinical Research Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5112\" data-end=\"5178\"\u003eClinical research involving the individual compounds has explored:\u003c\/p\u003e\n\u003cp data-start=\"5180\" data-end=\"5317\"\u003e• receptor signaling dynamics\u003cbr data-start=\"5209\" data-end=\"5212\"\u003e• metabolic pathway regulation\u003cbr data-start=\"5242\" data-end=\"5245\"\u003e• endocrine system responses\u003cbr data-start=\"5273\" data-end=\"5276\"\u003e• gastrointestinal signaling mechanisms\u003c\/p\u003e\n\u003cp data-start=\"5319\" data-end=\"5450\"\u003eAdditional investigations continue to examine how multi-receptor peptide systems influence complex metabolic and hormonal networks.\u003c\/p\u003e\n\u003cp data-start=\"5452\" data-end=\"5582\"\u003eAt present, direct combination studies specifically involving cagrilintide and retatrutide remain limited in published literature.\u003c\/p\u003e\n\u003ch3 data-section-id=\"pxh5eu\" data-start=\"5589\" data-end=\"5624\"\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5626\" data-end=\"5774\"\u003eThe molecular signaling characteristics of the cagrilintide + retatrutide blend make it relevant for experimental investigation in areas related to:\u003c\/p\u003e\n\u003cp data-start=\"5776\" data-end=\"5934\"\u003e• metabolic signaling systems\u003cbr data-start=\"5805\" data-end=\"5808\"\u003e• endocrine pathway coordination\u003cbr data-start=\"5840\" data-end=\"5843\"\u003e• gastrointestinal regulatory mechanisms\u003cbr data-start=\"5883\" data-end=\"5886\"\u003e• energy balance and nutrient sensing pathways\u003c\/p\u003e\n\u003cp data-start=\"5936\" data-end=\"6025\"\u003eThese studies are conducted primarily in preclinical and translational research settings.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"6032\" data-end=\"6043\"\u003e\u003cstrong\u003eSummary\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"6045\" data-end=\"6204\"\u003eThe cagrilintide + retatrutide blend is a dual-peptide research formulation studied for its interaction with multiple endocrine and metabolic receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"6206\" data-end=\"6241\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"6243\" data-end=\"6421\"\u003e• amylin receptor signaling\u003cbr data-start=\"6270\" data-end=\"6273\"\u003e• GLP-1, GIP, and glucagon receptor activation\u003cbr data-start=\"6319\" data-end=\"6322\"\u003e• cAMP-mediated intracellular pathways\u003cbr data-start=\"6360\" data-end=\"6363\"\u003e• coordinated central and peripheral metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"6423\" data-end=\"6581\"\u003eAs a research formulation, this blend is explored to better understand how multi-receptor peptide systems influence complex biological and metabolic networks.\u003c\/p\u003e\n\u003cp data-start=\"6588\" data-end=\"6727\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000814133514,"sku":null,"price":285.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000814166282,"sku":null,"price":260.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide_Retatrutide.png?v=1778074379"}],"url":"https:\/\/www.peptideregenesis.com\/collections\/all-peptides.oembed?page=3","provider":"PRG","version":"1.0","type":"link"}